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Introduction 
The Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) 
offers Ryan White HIV/AIDS Program (RWHAP) Part A and Part B grantees some flexibility in 
determining the method used for paying subgrantees for core medical and support services. 
Many Part A and Part B grantees use a traditional “cost-based reimbursement” approach, in 
which subgrantees submit budgets that include personnel costs, other direct costs related to the 
provision of funded services, and capped indirect costs (IDCs). Some grantees, however, have 
developed alternative reimbursement models for core medical and/or support services.  
This report summarizes the reimbursement approaches taken by nine RWHAP grantees. 
While not an exhaustive list, the seven Part A and two Part B grantees demonstrate a range of 
payment methods that might provide ideas for other grantees.  
This report utilizes the following terms to describe various reimbursement concepts:  
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 Cost-based reimbursement and full-time equivalent (FTE) coverage:  Generally defined 
as paying allowable costs incurred, up to a set limit. Most grantee staff interviewed use 
“cost-based reimbursement” to refer to the “traditional” reimbursement model of paying 
for line item personnel costs, including FTEs, as well as other direct costs.  
 Fee-for-service (FFS):  A FFS approach involves paying a specific, agreed-upon amount 
for each unit of service provided. As discussed in greater detail below, the fees may be 
set by the grantee, negotiated based on accounting data provided by subgrantees, or 
benchmarked using other fee schedules such as Medicaid or Medicare.   
 Unit cost reimbursement:  Unit cost reimbursement can be considered a type of FFS, in 
that payment is made for each “unit” of service provided.  The units are clearly defined 
(e.g., an x-ray conducted during a dental visit, a 15-minute unit of a face-to-face medical 
case manager visit, a bag of food, or a mile driven for medical transportation); and the 
“unit cost” is the aggregate cost of inputs associated with providing a given unit of 
service. The cost may be calculated by dividing all subgrantee costs by the number of 
units provided. A grantee could choose to calculate a standard unit cost based on the 
average costs of inputs across subgrantees; build on benchmark unit cost payment 
systems used by Medicaid or Medicare; or apply a blended approach.  
 Performance-based payment:  Also sometimes known as “pay for performance” (P4P), 
performance-based systems are based on a requirement that subgrantees meet certain 
standards set prior to the contract period. While several grantees reported using 
“performance-based” payments to describe a broad range of payment models, it appears 
that of the interviewees, only LA County has already implemented a system with 
payments that are linked to subgrantee performance.  
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In general, there are two ways a Ryan White grantee could implement performance-based 
payments:  In one model, grantees could set aside a percentage of funds allocated to that 
service category (a “withhold”) throughout the grant year. At the end of the grant year, 
grantees would then distribute the withheld funds across subgrantees that met 
performance benchmarks. Alternatively, grantees could adjust future payment rates based 
on past year performance.  Either way, payment levels would be linked to meeting certain 
performance criteria. Enhanced payment could be based on meeting certain thresholds for 
performance (e.g., testing at least X% of clients for TB in a given year) or could be scaled 
based on how well a subgrantee performs beyond the threshold level.  In theory, a Ryan 
White grantee could also base performance-based payments on patient outcomes, such as 
a certain percentage of clients having undetectable viral load.   
 
It is important to note that GW staff found in our assessment that grantees applied 
different terms for the payment models that are used. Therefore, throughout this report we 
attempt to make clear both what a grantee defines as its payment system and how the system is 
actually operationalized.   
Because HAB refers to the recipients of grantee funding as subgrantees, that term is used 
throughout this report, even where providers are technically not subgrantees but contractors.   
 
Methodology  
This analysis is based on a purposeful sample of grantees.  GW staff contacted staff at 
HAB and at the National Association of State and Territorial AIDS Directors (NASTAD) to 
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request a list of Part A and Part B grantees that use, or are considering, nontraditional payment 
models for one or more RWHAP service categories. HAB staff recommended four Part A 
grantees, while NASTAD recommended four Part B grantees. Through internal conversations, 
GW staff added three additional Part A grantees to the list. 
GW staff emailed contacts at each agency to request information about their payment 
models. GW staff received responses from six Part A grantees and three Part B grantees. In the 
course of the interviews, GW determined that one additional Part A grantee should be contacted, 
and chose to include two of the three Part B grantees in the report. GW conducted phone 
interviews with representatives of the nine grantees identified in Table 1.
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Table 1:  RWHAP Grantees Participating in the Assessment  
Part A Eligible Metropolitan Areas (EMAs) 
and Transitional Grant Areas (TGAs)    
Part B States 
Fort Lauderdale/Broward County, FL (EMA) 
Los Angeles County, CA (EMA) 
Miami-Dade County, FL (EMA) 
New York City, NY (EMA) 
Orange County, CA (TGA) 
San Diego, CA (EMA) 
St. Louis, MO (TGA) 
New York  
Washington  
 
Telephone interviews were guided by a semi-structured interview tool.  Interviews ranged 
from 30-60 minutes. All interviews were conducted with one or more staff implementing the 
RWHAP in that jurisdiction. In some cases, grantee contractor staff also participated in the 
interviews. Some grantees provided supplemental documentation, with a subset of materials 
included in the report appendices as noted, and others are available from GW.   
Staff from each grantee were asked to review their respective draft profiles for accuracy.  
Edits or concurrences were received from all grantees but St. Louis. 
                                                          
1
 GW spoke with Dawn Fukuda in Massachusetts, but did not include Massachusetts in the report at this 
time. 
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Key Findings  
We summarize key findings in this section. Full profiles of each grantee’s payment model 
can be found starting on p. 16.   
 
RWHAP Service Categories Included in Payment Models 
 There is significant variation in the extent to which grantees incorporate nontraditional 
payment models into their RWHAP programs (see Table 2 for details). At one end of the 
spectrum, Miami-Dade County and Ft. Lauderdale/Broward County Part A grantees use FFS and 
unit cost reimbursement for almost all service categories. At the other end, the Orange County 
Part A grantee uses a FFS model for specialty medical care only. Los Angeles (LA) County was 
the only grantee interviewed that has already implemented a performance-based payment model, 
as discussed in greater detail below. The New York City (NYC) and Ft. Lauderdale/Broward 
County grantees reported that they are considering adopting elements of a performance-based 
model. 
   
Fee Setting 
As Table 2 summarizes, grantees use a variety of FFS approaches to reimburse 
subgrantees for outpatient/ambulatory medical care (OAMC) and dental services. The most 
common approach is to link fees to either Medicare or Medicaid rates, with or without an 
additional rate enhancement.  For example, New York State bases its FFS payments for OAMC 
on the Medicaid fee schedule; Orange County negotiates specialty care reimbursement within a 
range of 110-130% of Medicare rates. LA County took a different approach, developing a single 
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per-visit rate for OAMC visits, whether conducted by a physician, nurse practitioner, or 
physician assistant. LA County funded a consulting firm (Mercer) to develop the rates, based on 
market research, subgrantee input, and Bureau of Labor Statistics (BLS) data for the region (see 
Appendix 2 for the Mercer rate study and the LA County profile for further detail). 
LA County also was the only grantee interviewed that has specific plans to incorporate 
performance-based elements into reimbursement within the next two years, with rate changes 
and bonuses for subgrantees that meet thresholds on a specified set of performance indicators 
(see Appendix 1 for a description of the incentive payment system). Ft. Lauderdale/Broward 
County and NYC both reported that they are considering adding such elements in the future. 
Currently in NYC, subgrantees that “over-perform” by offering more services than planned may 
receive bonus payments toward the end of the grant year, if funds are available. 
For unit cost reimbursement of service categories other than OAMC and dental, Ft. 
Lauderdale/Broward and Miami-Dade County base their rates for unit cost reimbursement on 
market research, including comparisons with other grantees. Appendix 3 summarizes Miami-
Dade County’s payments by service category.  NYC uses FFS for a majority of services and 
developed rates based on a range of calculations described in Appendix 4. 
All grantees interviewed with FFS or unit cost reimbursement place some form of 
monthly and/or annual caps on payment per subgrantee per service category. Reallocations 
(referred to commonly as “sweeps”) among subgrantees and across service categories throughout 
the grant fiscal year allow for resources to follow the needs of the clients and to be targeted to 
the actual services used.  
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Table 2:  Summary of Reimbursement and Fee Setting Methods Used by RWHAP Grantees  
Grantee Payment for OAMC and Dental Services Payment for Other Services 
Ft. Lauderdale/  
Broward 
County 
FFS, based on Medicaid rate when available For all other service categories, unit 
cost reimbursement, with price 
structure based on comparison with 
other local EMAs 
Los Angeles 
County 
For primary medical care, single rate model for visit 
with physician, NP, or PA (currently $330.12), with 
plans to incorporate performance-based adjustments 
in future years.  
 
Rate based on extensive consultation, BLS data, and 
third party rate study 
Cost-based reimbursement 
Miami-Dade 
County  
Medical:  FFS fees are based on the Medicare rate, 
with a 1.5 multiplier for evaluation and management 
only (office visits) 
 
Dental:  multiplier applied to Medicaid dental rates 
Unit cost reimbursement based on 
market research for all service 
categories other than outreach  
(which is line-item budget 
reimbursement of actual costs) 
New York City Some Part A funding supports the state’s FFS 
uninsured care program (see summary below)  
FFS for most service categories; 
medical case management paid 
daily and adjusted for intensity; 
legal services paid hourly 
Orange County FFS for specialty medical care only; negotiated at 
110-130% of Medicare rates 
 
Dental services included under master agreement. 
 
One mental health provider is also on a FFS contract 
Cost-based reimbursement 
San Diego 
County 
Primary medical care:  Federally Qualified Health 
Centers (FQHCs) reimbursed on FFS basis at FQHC 
Medicaid rate; University of California San Diego 
reimbursed at rate negotiated earlier with the County 
for low-income health program  
 
Medical specialty services:  FFS, rates negotiated 
with subgrantees  
 
Dental:  FFS, based on 130% of rates in an earlier 
Medicaid program, but planning to switch to current 
Denti-Cal rates 
Cost-based reimbursement, but 
considering shift to FFS for mental 
health services 
St. Louis Primary care and dental reimbursed on FFS basis; 
rates based on Medicaid  
Cost-based reimbursement 
New York 
State 
FFS for primary care, based on Medicaid fee 
schedule 
Cost-based reimbursement 
Washington 
State 
OAMC and dental reimbursed on FFS basis, based 
on 125% (OAMC) and 133% (dental) of Medicaid 
rate. 
Cost-based reimbursement for 
medical case management and 
several related service categories, 
but with incorporation of 
“performance-based” elements.  
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Staffing and Data Systems 
 Most grantees interviewed reported that FFS or unit cost reimbursement require staffing 
and data systems that differ significantly from those needed in a more traditional payment model. 
 
Staffing 
 Several grantees reported that FFS reimbursement is administratively simpler than cost-
based reimbursement. While subgrantees generally still must respond to an RFP or otherwise 
provide documentation of eligibility for funding, reimbursement involves fairly straightforward 
invoicing and payment. However, a FFS model does require fiscal staff to process claims and 
track spending to ensure that funding is targeted to the right service categories and reallocated on 
a timely basis as needed. In addition, grantees noted the importance of extensive desk and onsite 
monitoring to ensure that client records substantiate that the claimed services were actually 
provided at the levels reported. 
 
Data Systems 
 Grantees using FFS or single rate systems reported that having specific claims-based data 
systems is instrumental to the success of their payment models. For example, Miami-Dade 
County uses CaseWatch Millennium [aka Service Delivery Information System (SDIS)], which 
meets the EMA’s data management and federal reporting requirements, from Automated Case 
Management Systems (ACMS). This secure data system allows authorized subgrantee staff to 
enter and/or review client-level data on services provided, and maintains all program-related 
client eligibility, client demographic, health assessment, plan of care, service utilization, 
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adherence, and health outcome information in one centralized electronic record for each client. 
Access to client information is limited to appropriate staff according to the levels or components 
of the service category they work under. CaseWatch is also used to facilitate a certified referral 
process, so that documentation to support client eligibility is maintained on file at the client’s 
medical care management site, thereby relieving the client from having to take copies of the 
same documents to each provider of service. CaseWatch is also used to facilitate the EMA’s 
billing process for Part A and Minority AIDS Initiative (MAI) funding.  
 NYC’s FFS reimbursement system for OAMC services uses eSHARE (Electronic 
System for HIV/AIDS Reporting and Evaluation), a data system developed specifically for the 
grantee. Subgrantees enter client-level data, and each billable service has an associated 
reimbursement rate. A “bridge” system links eSHARE to MAPS, a contract management system 
developed by Public Health Solutions, the City’s RWHAP master contractor. If data entered by a 
subgrantee are inconsistent with agency payment policies (such as monthly limits on a given 
service per client), the system notifies the agency, and staff can contact the subgrantee to resolve 
the issue. MAPS can also be used to create reports for both the agency and subgrantees. 
LA County uses CaseWatch, a client-level data system.  One of its features is a link to 
eligibility verification, only permitting reimbursement of subgrantees that can show that a client 
is ineligible for public insurance and has no private coverage.  
Ft. Lauderdale/ Broward County uses Provide Enterprise (PE) client-level data system to 
manage all reimbursement records, service utilization, and client demographic and eligibility 
data. All FFS claims are managed in PE, with paid and denied claims recorded in the system. 
Claims data are coded using Current Procedural Terminology (CPT) codes. PE interfaces with 
the Medicaid enrollment data system to disallow RWHAP payment for Medicaid enrollees. Part 
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A staff use PE to generate standardized expenditure, utilization, and other reports, as well as to 
project under- or over-expenditure per service category and to conduct quarterly sweeps.  
For its FFS payment system for OAMC, New York State uses Emdeon, a third-party 
administrator. 
 
Benefits and Challenges in Implementing Alternative Payment Models 
Our interviews yielded several important considerations about the benefits and challenges 
of novel RWHAP payment mechanisms for grantees and subgrantees. 
 
Benefits  
 Several interviewed grantees reported that, once in place, a FFS or unit cost 
reimbursement model is simpler to administer than a traditional cost-based reimbursement model 
based on a line-item budget. Ft. Lauderdale/ Broward County grantee staff called FFS and unit 
cost reimbursement a “cleaner process,” with common understanding and clear expectations 
among the grantee and subgrantees.  Ft. Lauderdale/ Broward County staff also stated that 
oversight is somewhat easier, with the grantee conducting simpler, though still important, fiscal 
reviews and monitoring. Miami-Dade County staff also finds unit cost reimbursement to be 
simpler to administer, with less paperwork than cost-based reimbursement would entail, 
particularly given the large number of clients and high service utilization in the EMA. Grantees 
report that both FFS and unit cost reimbursement are easier for subgrantees, particularly medical 
subgrantees that already bill other payers on a similar basis.  
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 A FFS or unit cost model can also be more flexible, allowing grantees to conduct 
reallocations, either among subgrantees or service categories, multiple times during the grant 
year to make funding follow client service utilization.  
 Another significant potential benefit is the incentive created for subgrantees.  LA County 
staff noted that under a traditional cost-based reimbursement model, subgrantees had no 
incentive to increase their patient loads during a grant year, even when demand for HIV care 
would rise. A single-rate model per patient visit maintains an incentive for subgrantees to see 
more patients. In a related benefit, the model levels the playing field among subgrantees, which 
under a cost-based reimbursement system could be paid widely divergent amounts per patient 
visit. In NYC, subgrantees also have the potential to earn bonuses or increase their payment rates 
based on over-performing their target number of services.  In a performance-based system such 
as LA County’s, providers have the potential to earn more for achieving high standards on 
performance measures, with potential improvements to patient care and outcomes. 
 A FFS model, particularly for OAMC and dental services, also aligns RWHAP with the 
payment approach used by most third-party payers. Alignment ensures simpler administration for 
both grantees and subgrantees and can, in theory, allow for better integration. San Diego County 
is considering shifting to a FFS basis for mental health services, in part because it would improve 
integration by allowing subgrantees to have a care team that includes physical and mental health 
providers and to bill for all personnel on a FFS model. LA County also noted that because most 
other payers use FFS, traditional grants-based models facilitate “double dipping” or other 
concerning practices on the part of subgrantees.  
  
Challenges 
14 
 
 One of the most commonly cited challenges in a FFS or unit cost model is establishing 
payment rates and service unit definitions. For OAMC and dental services, as discussed above, a 
Medicaid or Medicare rate can be used as a benchmark. However, those rates may be 
unacceptable (or insufficient) to some or all subgrantees. LA County, which set a single per-visit 
rate independent of other payers’ rates, noted that an additional barrier was the reluctance of 
some clinics to share “true cost” information that included Part C funding.  
Outside the OAMC and dental services context, developing unit costs for other service 
categories can be challenging. NYC staff noted that there is no clear consensus on setting rates, 
and that it is difficult to match the rates to the real experience of all subgrantees. Additionally, 
rate setting is a time consuming and resource intensive process, resulting in rates only being 
updated every few years.  
Relatedly, several grantees reported that paying a fixed rate for services may result in 
over- or under-paying subgrantees.  Subgrantees may complain if rates are not updated 
frequently.  For example, in Ft. Lauderdale/ Broward County, the rate for medical case managers 
has not been adjusted, even for inflation, in ten years. However, grantee staff notes that a medical 
case manager can still generate enough reimbursed units to exceed payroll and related budget 
costs. In LA County, an initial proposed single rate payment level developed based on a detailed 
analysis by Mercer (Appendix 3) was rejected by subgrantees as too low. 
LA County noted that some subgrantees have been resistant to the idea of performance-
based payment methods. County staff noted that ultimately, some subgrantees may leave the 
program if they are unable or unwilling to meet performance goals.  
In a straight FFS context, St. Louis staff cautioned that it can be relatively difficult to 
implement HIV-based quality improvement (QI), compared to a grants-based system, because 
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subgrantees do not receive funding for QI. Staff noted that clinics that also get RWHAP Part C 
or Part D funds may be able to engage in broader HIV care QI due to an earmarked QI budget. 
Subgrantees that do not get Part C or Part D funds may not.  
Other grantees sounded a note of caution about the impact of new payment models on the 
subgrantee-patient relationship. NYC is also considering the use of performance and quality 
measures in 2015. However, staff pointed out the risk of entangling quality measures with 
reimbursement in a way that could incentivize subgrantees to cherry-pick patients. In 
Washington State, where medical case management is reimbursed on a traditional cost 
reimbursement basis (though with required performance reporting), staff felt that a FFS model 
could result in agencies trying to meet quotas at the end of each month instead of focusing on 
being generally available and responsive to their clients.  
 
Conclusion 
 Several payment models offer alternatives to traditional cost-based reimbursement in the 
RWHAP Program. Depending on its goals, HAHSTA may want to consider assessing the 
feasibility of FFS or unit cost reimbursement for one or more service categories in the EMA, 
possibly eventually incorporating performance-based elements. As other grantees have done, 
HAHSTA might initially develop a payment system for core medical services for which units of 
service are easily defined using existing billing code systems, and for which Medicaid or 
Medicare payment rates are accepted by subgrantees. Such a strategy might also promote the 
transition of some core medical providers to public third-party payment systems as a growing 
number of HIV+ DC residents become insured.  GW staff would be happy to engage in further 
research and discussions about this issue. 
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Grantee Profiles 
All information in these profiles is from interviews with grantee staff, unless otherwise 
indicated. 
 
Fort Lauderdale/Broward County 
Fort Lauderdale/Broward County has a long-standing practice of using FFS and unit cost 
reimbursement for all medical and support services. The system is based on the model 
established previously by the Miami-Dade County Part A grantee. The Palm Beach County Part 
A grantee adopted the same system, resulting in a consistent payment system across South 
Florida.  
FFS is used by the grantee to pay for medical and dental services. Reimbursement per 
procedure is generally based on Medicaid rates, where available for covered procedures. CPT 
codes are used to define specific units of service. For all other service categories, reimbursement 
is unit cost-based. When no Medicaid rate is available, the agency develops a price structure 
based on a cost comparison with other local EMAs, such as Miami-Dade County. 
All subgrantee contracts include an annual maximum reimbursement per month. Between 
80-85% of subgrantees meet their monthly maximum payment threshold. There are 12 
participating subgrantees, with each covering about eight service categories. Administratively, 
the reimbursement system employs three contract staff and three fiscal staff. The grantee 
conducts reallocations several times per year.  
The grantee has considered incorporating an element of performance-based contracting 
into the payment system, to “reward good subgrantees.” For example, subgrantees could receive 
80-90% of their reimbursement from producing units, with the remainder predicated on meeting 
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certain performance indicators. The grantee is currently considering the feasibility of this 
approach, but notes that implementation, if it occurs, would be “years down the road.” 
Grantee staff reports that FFS and unit cost reimbursement are a “cleaner process” than 
cost-based reimbursement was, with clear expectations and simple accountability. Oversight 
responsibilities are slightly easier, although the grantee fiscal staff review all submitted claims 
and track expenditures on at least a quarterly basis to ensure they are in line with projected 
drawdowns. This process requires detailed claims (including service date, CPT code, name of 
provider) to substantiate requests for reimbursement. Staff conduct reviews of randomly selected 
clients to ensure that units billed were for services that were in fact performed.  
Subgrantees may complain about inadequate reimbursement, and that the medical case 
management rates in particular have not been adjusted for inflation in ten years. However, the 
grantee staff noted that what a medical case manager can generate in reimbursed units will 
exceed the payroll and related costs of individual medical case managers.  
 
Los Angeles County  
LA County has instituted a performance-based, FFS reimbursement approach for OAMC 
services. Early in the AIDS epidemic, the grantee used a cost-based reimbursement system, 
granting funds to a handful of large non-profit AIDS Service Organizations. Over time, several 
subgrantees approached the grantee to report that their volume of services was increasing but 
their funding was not. The grantee attempted to supplement grants as needed, but the process 
was haphazard, giving subgrantees no incentive to increase patient volume. In the meantime, 
other subgrantees experienced a shrinking patient population. As a result, per-visit payment to 
subgrantees varied wildly, from $50 up to $600. The single rate model was developed in order to 
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even the playing field and maintain an incentive for subgrantees to serve more patients if demand 
exists.  
The grantee conducted a series of rate studies and consulted extensively with outside 
parties, including a subgrantee caucus and health economists. They specifically wanted to 
determine the cost of providing a unit of service, with the unit defined as an appointment with a 
physician, nurse practitioner, or physician assistant. The grantee commissioned a rate study from 
Mercer, which conducted a financial review of a subset of subgrantees.  
The rate that was initially developed was $167 per visit, fully loaded to reflect the costs 
of clinicians, ancillary staff, staff support, administration, and indirect costs. However, 
subgrantees felt that the proposed amount would be insufficient. Mercer then conducted further 
review of BLS data, as well as other relevant information on rates in the region.  
The grantee ultimately selected a range-based rate, from approximately $285 to 
approximately $375 (this falls above Medicaid rates but below FQHC rates). The range permits 
implementation of performance improvement activities (See Appendix 1 for a detailed 
description of LA County’s incentive payment system). The grantee will conduct an annual 
representative chart review to determine subgrantee performance for 24 indicators, such as viral 
load, CD4, TB screening, cervical cancer screening, and syphilis screening for men who have 
sex with men. These indicators were selected from among the HIVQUAL measures that LA 
County was already collecting. Subgrantees that meet all core performance benchmarks and 
reached all thresholds for compliance for supplemental measures will be eligible for rate 
increases and bonus payments. Some particularly important or complex performance measures, 
such as suppressed viral load, will be associated with higher bonuses than others. 
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The original thinking was that each subgrantee would receive $285 per visit (regardless 
of clinician type), plus bonuses. However, the grantee decided instead to pay each subgrantee the 
midpoint of the range, or $330.12 per visit, for the first year, in large part due to system changes 
and provider readiness issues as a result of preparation for and implementation of the Affordable 
Care Act. Staff will review a year’s worth of data and conduct chart review to determine rates for 
the second and third years (though staff notes that they may continue with the $330.12 rate for an 
additional year).  
Approximately 10,000 clients in the EMA receive OAMC services reimbursed under the 
FFS model. Many are undocumented or otherwise ineligible for other health insurance coverage. 
The grantee reimburses 25 subgrantees that operate a total of 41 patient-centered medical home 
model sites. 
LA County uses CaseWatch, a client-level data system. It is linked to eligibility 
verification records, so subgrantees are only paid if they can show that a client is ineligible for 
Medicaid and Medicare and doesn’t have private insurance. The grantee conducts oversight that 
includes visits by contract program officers, with a sampling of charts or electronic health 
records reviewed each year. Staff notes that client-level data system compliance is not always 
optimal.  
LA County has experienced several challenges in implementing the new payment system, 
including difficulty in establishing a rate that subgrantees perceive to be fair and commensurate 
with actual costs. A particular challenge that arises in this context may be subgrantee reluctance 
to share true cost data. Some subgrantees were willing to share Part A-related payroll and other 
related information, but would not share information on how they use Part C grants to 
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supplement their overall operations. LA County staff has discussed this challenge with their 
HAB project officer, as well as ways to coordinate the Part A and Part C grants.  
The grantee also reported resistance among some subgrantees to the idea of performance 
monitoring. Grantee staff note that a critical mass of subgrantees is needed who understand the 
importance of the HAB core measures, and that some subgrantees who struggle with compliance 
may not remain in the Part A program. The grantee also notes that positive competition can be 
created by giving each subgrantee its own data, as well as the average rates of other subgrantees 
to allow comparison.  
LA County staff suggest that strong performance measures are crucial for the continued 
investment of significant levels of federal RWHAP funds. In addition, they note that in a 
healthcare context with multiple funding streams, most third-party payers reimburse for services 
on a FFS basis.  Mixing grant-based payment with FFS payers increases the risk of “double 
dipping” and other inappropriate uses of public funds.  
 
Miami-Dade 
Miami-Dade County uses a unit cost/FFS payment system for nearly all local RWHAP-
funded service categories. The only exception is outreach, which is funded on a cost 
reimbursement basis because of challenges in identifying the appropriate “unit of service” and 
ensuring appropriate service delivery.  
For OAMC services, fees are based on the Medicare rate, with a 1.5 multiplier for 
evaluation and management (E and M) medical office visits, and no multiplier for other 
program-allowable medical services. In FY 2013, a total of 5,788 uninsured and underinsured 
RWHAP clients received a combined total of 71,890 medical visits that were specifically 
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reimbursed by the grantee under the Part A and Minority AIDS Initiative funding. Basing 
reimbursement on the existing Medicare payment structure facilitated the billing process for the 
high number of clients who received Part A/MAI- funded medical care in the EMA.   
For other services, unit costs are initially developed based on market research. As 
detailed in Appendix 3, unit costs vary significantly among service categories, and generally are 
sufficient to cover the percentage of salaries and fringe benefits, and other direct costs and 
administrative costs (up to 10% of the service category budget) charged to the Ryan White 
Program, as indicated on the corresponding budget and in accordance with time and effort 
reporting and fair share allocations. 
Subgrantees are selected through a Request for Proposals (RFP) process every few years. 
Because the unit costs are non-negotiable, applicants must describe their anticipated units 
provided and how they will work within the budget corresponding to the defined units of service 
and planned number of clients to be served. There are currently 14 non-profit RWHAP 
subgrantees funded, each offering between 1 and 11 service categories; as well as 2 for-profit 
subgrantees for data system, planning council staff support, and quality management (QM) 
services. 
Miami-Dade County uses CaseWatch as its centralized data system to track client 
eligibility, client demographic, health assessment, service utilization, and referral information.  It 
also uses the system for billing service utilization analysis, and federal reporting. The CaseWatch 
vendor, ACMS, is based in Los Angeles, but has a local office that houses its program support 
staff and training office for Miami-Dade County operations. CaseWatch authorizes subgrantee 
staff in different service categories to view only certain data about their client’s records in other 
categories (for example, mental health records can be viewed by only certain authorized 
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subgrantees).   CaseWatch is also used to facilitate a certified referral process, so that 
documentation to support client eligibility is maintained on file at the client’s medical care 
management site, thereby relieving the client from having to take copies of the same documents 
to each provider of service. The grantee reports that CaseWatch comes at a significant cost, but 
allows for an efficient tracking of client eligibility and services, processing of claims, and 
facilitation of the reporting process. 
Miami-Dade County has a well-organized process for the reallocation of funds, which 
occurs three to four times during the grant year, to maximize the use of available funds. 
Subgrantees report unmet need to the grantee. The local planning council, the Miami-Dade 
HIV/AIDS Partnership, then receives information from the grantee regarding the expenditure 
rates for each service category and the unmet need by service category. The Partnership then 
determines the reallocation of funds. Staff notes that their fiscal administrator is extremely 
effective in overseeing this process, tracking reimbursements to the penny on a daily basis, and 
determining the schedule/timing for the reallocation processes.  
One reported advantage of Miami-Dade County’s unit cost reimbursement model is that 
it is a quicker and more expeditious way of disbursing funds to subgrantees than grant-based 
budgets. It requires far less paperwork for review by agency staff than would a grants-based 
system that requires subgrantees to detail their costs in a line-item budget with backup 
documentation submitted and reviewed monthly to support each line item billed to the program. 
The model is also administratively simpler for subgrantees. However, grantee staff notes that 
they do not conduct annual assessments of each rate, so it is possible that rates do not rise 
quickly enough to sufficiently reimburse subgrantees. 
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Staff recommend that other grantees considering a unit cost reimbursement model 
consider several factors. The high number of clients served in Miami-Dade County makes unit 
cost reimbursement much more efficient than cost reimbursement, but they note that the same 
may not be true for smaller grantees. They also emphasized the importance of a well-developed 
client-level data system in making reimbursement work promptly and effectively. 
 
New York City 
With approximately 17,000 PLWH receiving RWHAP services, the NYC EMA began to 
implement new reimbursement models for some service categories in 2006 in an effort to better 
align reimbursement with actual performance (see the New York City, “Performance-Based 
Reimbursement” document in Appendix 4). The New York EMA covers the five boroughs of 
NYC and three counties (Tri-County Region) north of NYC.  NYC now uses per-client, per-day 
payment for care coordination, a medical case management model (21% of NYC’s grant budget); 
FFS payment for 41% of the grant budget, deliverables-based payments for 6% of the grant 
budget, and hourly payments for 4% of the grant budget. All contracts in the Tri-County Region 
(approximately 4.7% of the total grant) are paid exclusively using a traditional cost-based 
reimbursement methodology.  
Table 3:  New York City Service Categories With Alternative Payment Systems (Either FFS, 
Deliverables-Based, or Hourly) 
 Legal Services (hourly) 
 Early Intervention services  
 Housing Placement Assistance  
 Harm Reduction (Substance Abuse Services- outpatient) 
 Medical Case Management  
 Mental Health Services (Some Performance-Based and Some Cost-Based) 
 Supportive Counseling and Family Stabilization (Psychosocial Support Services) 
 Food and Nutrition Services (Food Bank/Home-delivered Meals) 
 
“NYC Ryan White Part A Service Category Scorecards 2010-2012” in HIV Health and Human Services Planning Council of 
New York and New York City Department of Health and Mental Hygiene “Needs Assessment for HIV Services: New York 
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Eligible Metropolitan Area Ryan White Part A 2014 (available at 
http://www.nyhiv.com/pdfs/Needs%20Assessment_Full%20Final.pdf).  
For FFS payment rates, NYC initially gave applicants tools to calculate the actual cost of 
their services, with the cost proposal counting toward the total bid score. In later RFPs, NYC 
staff computed the rates they believe represented the costs necessary to conduct the work – 
taking a cue, staff noted, from Miami-Dade County – and published them in the RFPs. For most 
FFS categories, rates are based on outputs such as counseling sessions or meals served. Others 
are based on short-term outcomes, such as housing placement or linkage to care. Payment rates 
were calculated by taking into account expenses (such as salary, fringe, other than personal 
services or OTPS, and administration), service time (based on certain assumptions about 
productivity), and outcomes (such as linkage to care). Staff applied programmatic knowledge to 
account for variance in the time and staffing required (see Appendix 4 for additional 
information). Rates are intended to reflect the time required for data entry, chart notes, set-up and 
breakdown for group services, and a modest allowance for client no-shows. Grantee staff 
benchmark reimbursement rates when possible to ensure reasonableness.  
To receive reimbursement, a subgrantee enters client-level data into eSHARE, a data 
system created and supported by the grantee. Every billable service has an associated 
reimbursement rate, and the system incorporates funding requirements. For example, a service 
such as group counseling might only be billable if at least three RWHAP clients participate. The 
system can also recognize caps on frequency of utilization per client, such as a ten service unit 
per month limit on mental health services. eSHARE is linked by a “bridge” system to a contract 
management system called MAPS, developed by the Part A administrative agent, Public Health 
Solutions. MAPS generates reports for subgrantees and for the grantee which itemize and 
summarize reported services.  If the system identifies inconsistencies with billing requirements, 
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grantee staff can contact subgrantees to make payment decisions and to review any problems 
during fiscal monitoring site visits.  
Administration of this reimbursement system required a change in staffing structure (note 
that part of the administration is contracted to Public Health Solutions, a non-profit corporation). 
Contract managers handle fiscal and programmatic responsibilities, including negotiation of 
budgets and service targets, and fiscal and administrative monitoring. Prior to the introduction of 
FFS reimbursement, Public Health Solutions assigned two staff members to each contract, one 
for fiscal oversight and one for program/administrative monitoring. The contract manager 
coordinates with Department of Health and Mental Hygiene (DOHMH) staff for programmatic 
assistance, and also helps contractors who are struggling to reach their targets.  
As noted above, some service categories (including food and nutrition, emergency rental 
assistance, home care, and all 10 service categories funded in the Tri-County Region) are still 
paid via a traditional cost-based reimbursement model. Medical case management is paid at a 
capitated daily rate, based on the intensity of services required.  Rate calculations for medical 
case management are included in Appendix 5. Daily rates require compliance with program 
requirements like minimum face-to-face contacts and outreach activities.  
Most of the services reimbursed on a FFS basis are discrete outputs, such as counseling 
sessions or lab tests. Others, like linkage to care, are based on a “culminating event.” The grantee 
at one point used “milestone payments” when medical case management clients shifted from 
needing more intensive to less intensive services. However, because clients shifted back and 
forth between need levels (as opposed to proceeding linearly to less intensity), the grantee 
stopped using this type of payment. [Please note that Appendix 5 includes information about 
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these discontinued “milestone” payments as well as discontinued payments for Outpatient Bridge 
Medical Care.] 
NYC EMA has slightly over 190 contracts, with 109 different subgrantees. Most 
subgrantees are multiply funded across service categories, with the largest numbers of 
subgrantees providing HIV testing and medical case management.  
The grantee conducts a review of spending several times per year, and imposes contract 
takedowns when necessary for subgrantees that are not on track to spend their awards. 
“Takedown” funds are returned to the pool to redistribute. An appeals process for the takedown 
process is available for subgrantees. The grantee determines eligibility for enhancement funding 
(i.e. specific criteria for strong year-to-date spending contract awards, programmatic 
compliance). The local Planning Council has given the grantee the flexibility to reprogram 
original funding allocations for each service category. Toward the end of the grant year, the 
grantee determines which subgrantees have outperformed their targets and are, therefore, eligible 
for additional funds. Payment beyond initial targets is not guaranteed to subgrantees and is 
contingent on the availability of funds to due to underspending by other subgrantees.  However, 
the subgrantee staff noted that the possibility of contract enhancement operates as a meaningful 
incentive for performance of a high volume of services. 
In 2015, the grantee plans to increase the use of performance and quality measures. Staff 
stated that they are trying to avoid incentivizing subgrantees to look for clients likely to lead to 
“better” outcomes.  
One challenge that NYC staff described is adjusting reimbursement rates in response to 
real experience of subgrantees. Rates are modified every few years, but there is no clear 
consensus on how to set rates, and the grantee tries to acknowledge the full costs of the program. 
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For example, there is a modest allowance made for clients who do not keep their appointments. 
While some rates have been increased, others have been decreased.  
 
Orange County 
The Orange County (California) TGA uses a FFS system for specialty medical care and 
with one mental health provider. Rates are negotiated and are generally set at 110% of the 
Medicare rate; they do not exceed 130%. In the past, RWHAP specialty medical care was 
provided by a single hospital subgrantee and reimbursed on a FFS basis. About eight or nine 
years ago, the grantee retained the FFS model, but shifted to a master agreement system in which 
subgrantees could apply to provide specialty services. Currently, at least 14 subgrantees have 
signed the master service agreement.  Dental services are also included under the master 
agreement. 
Participating Part A clients are generally uninsured. In 2013, 389 RWHAP clients used 
specialty medical services, compared to 765 in 2012. Staff attributes the decline to early 
implementation of the ACA in California, during which approximately one-half of their RWHAP 
patients became eligible for Medi-Cal (the California Medicaid program). Staff notes that the 
current patient pool is primarily people without legal residency status. The staff predicts that the 
number of clients will remain relatively stable, apart from newly identified HIV infections in 
people ineligible for other coverage. 
Administrative staff includes one contract administrator (who only spends a portion of 
her time on contracts, including annual re-signing of the master agreement with each 
subgrantee). The sub grantee also has one specialty coordinator. The staff works with a third-
party billing administrator to process reimbursement.  
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In a recent RFP for services categories other than specialty medical care, the grantee gave 
applicants the option of traditional cost-based reimbursement or proposing a FFS payment. For 
primary medical care, the grantee was curious about how the proposed rates would compare to 
those paid by Medicare. However, almost all subgrantees outside specialty medical care chose to 
continue to be paid on a cost-based reimbursement basis. 
 
San Diego 
The San Diego EMA uses a pooled services model, with FFS reimbursement for primary 
and specialty medical care and for primary and specialty dental care. Subgrantees join the “pool” 
by signing a master purchase agreement. This model was originally established by San Diego 
County to purchase healthcare for low-income people in general, and RWHAP was added later. 
Any willing and qualified subgrantee can sign the agreement and bill the grantee for treating 
RWHAP clients.  
Most of the medical subgrantees are FQHCs, and they are reimbursed for OAMC at the 
FQHC Medicaid rate. The University of California San Diego also serves as a subgrantee, 
receiving reimbursement at a rate negotiated earlier with the County for its general low-income 
health program. Medical specialty services are carved out and negotiated, because it can be 
difficult to find subgrantees to provide these services.  Dental fees are based on 130% of rates in 
an earlier Medicaid program, but the grantee is planning to switch to current Denti-Cal rates. The 
grantee uses a “not to exceed” clause to limit monthly billing per subgrantee.  
Approximately 1,600 RWHAP clients are receiving OAMC, down from 2,400 before the 
State’s Medi-Cal expansion took effect. Approximately 2,200 patients receive dental services, 
with some overlap in these service populations.  
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Mental health services are still paid on a cost reimbursement basis. However, the grantee 
is considering shifting to FFS to allow better integration with other healthcare services. 
Reimbursing mental health on a FFS basis would allow subgrantees to develop a team that 
includes OAMC, mental health, and medical case management subgrantees, and to bill for all 
services provided. 
County staff notes that the FFS system for medical and dental care offers more flexibility 
than a cost-based reimbursement model. For example, in a traditional grants model, a staff 
member’s departure from a subgrantee organization creates savings in the grantee’s budget. In 
the FFS model, a grantee only pays for services provided, and funds can be more easily shifted 
where they are needed. In addition, because it receives bills as services are provided, the grantee 
is aware of over or under-performance compared to targets in real time, instead of learning about 
issues six or seven months into a contract year.  
The system is staffed by a principal administrative analyst and a fiscal manager. They 
conduct extensive forecasting based on historical data that accounts for seasonal variability, and 
can seek approval from the Planning Council when significant changes such as the Medicaid 
expansion occur. The grantee holds monthly meetings to review expenditures, and works with 
two administrative agents to develop data reports for the grantee. 
 
St. Louis 
The St. Louis TGA uses a FFS system for OAMC and dental care. Because the TGA 
spans two states, administration is somewhat complicated. At the grantee level, the program is 
administered by five people, including one contract person. Funds are contracted through two 
benefit/fiscal administrators, one for Missouri and one for Illinois.  
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In Missouri, the agency serving as fiscal administrator finances OAMC through FFS 
subcontracts with several private subgrantees and with two clinic subgrantees (Washington 
University and Saint Louis University Hope Clinic). In Illinois, the lead agency subcontracts 
with one clinic (Washington University) on a FFS basis. Grantee staff reports that the rates are 
based on the Medicaid fee schedule. Apart from OAMC and dental services, other categories 
such as medical case management, are funded on a traditional “salary plus fringe” basis. 
In both states, the directly reimbursed OAMC services are for RWHAP clients who are 
uninsured. The number of uninsured clients is decreasing with implementation of the ACA, 
particularly in Illinois, where close to 95% of RWHAP clients are now insured. This year, the 
grantee plans to serve approximately 236 people with OAMC visits and 420 with labs tests.  
Spending projections are based on the prior year’s data. When necessary, staff makes 
estimates based on significant changes. For example, subsequent to implementation of the ACA, 
the grantee reduced allocations for OAMC by 25%, allowing allocation of additional funds to 
serve more dental clients.  
Staff states that the FFS system makes it relatively difficult to implement HIV-based QI, 
especially with the private subgrantees, who are only paid for specific services. The two 
university clinics also receive Part C funding, which allows them to do some HIV-specific 
clinical QM. 
 
New York State 
Since 1992, NY State has used a FFS system to reimburse subgrantees for OAMC 
offered to uninsured and underinsured RWHAP clients. Part B funds are supplemented with Part 
A funds to support a reimbursement pool. 
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The program currently serves approximately 23,000 clients, who are mostly uninsured. 
They are enrolled through a system integrated with the existing ADAP enrollment system. All 
enrollees receive a card that effectively functions as an insurance card for use in receiving 
services from enrolled primary care providers (subgrantees). In turn, the providers bill the State 
for reimbursement. Rates are based on Medicaid fee schedules. 
For enrollees who are insured, the grantee determines whether the insurance is adequate 
and cost effective, and if the cost of the premium is a barrier to care. If the plan is adequate and 
cost effective but the premium is a barrier to care, the grantee pays the premium. Staff also 
determine if cost sharing would exceed 2% of the enrollee’s gross income by analyzing cost 
sharing within the plan, assuming an average cost of care (including medications).  If cost 
sharing would exceed that threshold, the client is enrolled in the state’s program as underinsured.  
For covered primary care services, the grantee uses a “pay and chase” model in which it 
directly reimburses primary care providers (subgrantees) for services, and then bills the client’s 
insurer for reimbursement. This approach results in clients having no out-of-pocket costs for 
covered services.  
Approximately 300 hospitals and clinics, 200 private clinicians and over 50 stand-alone 
laboratories participate as subgrantees. Staff report that subgrantees like the system because they 
are adequately reimbursed, it is administratively simple, and it assures reimbursement for 
services provided to uninsured individuals, helping to support the HIV service delivery 
infrastructure. Staff operate the HIV Uninsured Care Programs as part of the system for 
providing quality HIV care for uninsured and underinsured individuals living with HIV in New 
York State. For Primary care claims, the program uses a third-party administrator (Emdeon) to 
process most claims.  
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Washington State 
Washington State reimburses OAMC and dental services on a FFS basis, both for 
uninsured and underinsured clients, and for insured clients who have yet to meet their 
deductibles.  Their payment rate is set at 125% of the Medicaid rate for each CPT code, and at 
133% of the Medicaid rate for dental services.   
Washington State uses an FTE reimbursement model for medical case management 
services, but incorporates “performance-based payment” elements with extensive reporting and 
monitoring required. The grantee contracts with 14 agencies, all of which provide medical case 
management services. Some subgrantees provide additional services from four service 
categories, including food and transportation. Subgrantees are required to submit invoices with 
their FTEs allocated to provision of funded services, and must report quarterly on quality 
measures related to a statewide set of performance requirements for the service category. The 
grantee conducts monthly desk audits, as well as a quarterly review of clients served, and 
quarterly review of the QM and QI reporting.  Subgrantees cannot receive reimbursement if they 
do not submit all required reports.  
Five staff administer the program, including one field monitor, one contract coordinator, 
and one data person. Grantee staff conduct annual QM site visits at which they review 50% of 
charts for RWHAP patients who are not on Medicaid and 100% of charts for Medicaid patients. 
If a subgrantee has fewer than 50 RWHAP clients, the grantee reviews all RWHAP client charts, 
regardless of insurance status. Staff report that these site visits are staff intensive and time 
consuming but very important to the program.  
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At the end of each grant year, the grantee compiles data from each subgrantee and 
calculates a cost per service unit and cost per client. This information allows the grantee to 
compare agencies’ services and performance, and to identify any problematic discrepancies. The 
grantee also provides each subgrantee with its own performance reports and with an average of 
other subgrantees’ performance rates to allow de-identified comparisons and incentives for 
improvement. The grantee also sets aside some funding each year for situations such as 
unexpectedly high transportation costs in rural counties.  
Grantee staff notes that in using FTE rather than a FFS approach, they are really paying 
for the medical case managers to be available to their RWHAP clients. One staff person 
previously worked in a state that used FFS for case managers (Iowa). She found that it created an 
incentive for medical case managers to make a lot of calls at the end of the month to meet their 
targets. Washington State staff believes that the FTE model for medical case management allows 
a more collaborative approach with the subgrantees, who they report are more patient-centered 
than they might be under a FFS model. 
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Appendix 1  
LA County: Fee-for-Service and Additional Reimbursement Incentives Guidelines  
  
ATTACHMENT 5 
 
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES 
Updated: 11/08/2012 
Page 1 
 
 
Payment for services provided shall be subject to the Fee-For-Service Reimbursement and 
Additional Reimbursement Incentives provisions described below. 
 
HIV/AIDS Medical Outpatient Services Fee-For-Service (FFS) Reimbursement 
The fee-for-service reimbursement guidelines support quality of care and efficiency of services 
performed.  To achieve this, payments are structured around providers meeting pre-established 
benchmarks for a combination of process and outcome measures.  Reimbursement ranges from 
the base rate of $284.86 per patient visit up to a maximum rate of $375.22 for providers who 
meet or exceed the established benchmarks.   
 
To assist providers in meeting performance targets and resource demands, the reimbursement 
rate for FFS Year 1 and Year 2 only is set at the rate of $330.12 per patient per visit.  This rate 
is mid-way between the base reimbursement rate of $284.86 and the maximum rate of $375.22.  
In Year 3, providers will receive a base payment rate of $284.86 but may be eligible for a 
payment rate as high as $375.22 based on their performance during Year 2. 
 
This base rate will be paid with the expectation that the provider meets established benchmarks 
with a core set of eleven (11) clinical and performance measures, listed in Table 1.  
 
Table 1. Core Measures 
 
 
           Measure Benchmark 
1.1 ART for pregnant women 100% 
1.2 ART for CD4 <500 95% 
1.3 PCP prophylaxis 95% 
1.4 Adherence assessment and counseling 95% 
1.5 Cervical cancer screen 90% 
1.6 Hepatitis C screen 90% 
1.7 HIV risk counseling 95% 
1.8 Syphilis screen 90% 
1.9 Tuberculosis screen 75% 
1.10 Patient satisfaction survey response 100% 
1.11 Data validation (Casewatch) 75% 
 
Providers will qualify for additional reimbursement incentives only if performance on each of the 
eleven (11) core measures meets or exceeds the established benchmark during the 
measurement year.  Providers, who meet the established benchmarks on all eleven (11) core 
measures, will be eligible to obtain additional reimbursement for a total of nine (9) Part A 
supplemental measures, listed in Table 2A and two (2) Part B supplemental measures listed in 
Table 2B.  
 
Table 2A.  Part A Supplemental Measures 
 
 
       Measure 
Service 
Score 
Reimbursement per Measure 
($3.03 x service score) 
Benchmark 
2.1 Chlamydia screen 1 $3.03 90% 
2.2 Gonorrhea screen 1 $3.03 90% 
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       Measure 
Service 
Score 
Reimbursement per Measure 
($3.03 x service score) 
Benchmark 
2.3 Pneumococcal vaccination 1 $3.03 85% 
2.4 Influenza vaccination 1 $3.03 75% 
2.5 Hepatitis B screen 2 $6.06 90% 
2.6 Substance abuse assessment 3 $9.09 90% 
2.7 Mental health assessment  3 $9.09 90% 
2.8 Hepatitis B vaccination 3 $9.09 90% 
2.9 Tobacco cessation counseling 3 $9.09 90% 
 
Part A supplemental measures include a total of nine (9) measures.  Each of the nine (9) Part A 
supplemental measures has been assigned a service score that reflects the level of complexity 
and time required to complete the measure.  Service scores for each of the supplemental 
measures are given a rating from one (1) to three (3).  A rating of one (1) indicates a measure 
requiring minimal effort and resources to complete or a low complexity measure.  A rating of two 
(2) indicates a measure requiring moderate effort and resources to complete or a moderate 
complexity measure.  A rating of three (3) indicates a measure requiring significant effort and 
resources to complete or a significant complexity measure.   
 
The provider’s rate of Part A supplemental reimbursement per patient is based on the number of 
Part A supplemental measures that meets or exceeds the established benchmark for the clinic 
population.  To calculate this rate, the service score for each Part A performance measure is 
multiplied by $3.03, and then added to the base rate of $284.86.  Providers will be paid at an 
increased rate per patient visit for each additional Part A supplemental measure for which 
performance meets or exceeds the established benchmark.   
 
Table 2B.  Part B Supplemental Measures 
  
            Measure Reimbursement  Benchmark 
2.10 Medical visits $18.00 90% 
2.11 
Viral load suppression <200 copies/mL 
when on ART 
$18.00 80% 
 
Part B supplemental measures include a total of two (2) outcome measures reimbursed at 
$18.00 each when the established benchmarks are met.  Providers will qualify for additional 
Part B supplemental reimbursement only if performance on each of the eleven (11) core 
measures meets or exceeds the established benchmark during the measurement year.   
 
The provider’s total amount of Part A and B supplemental reimbursement per patient visit is 
based on the number of Part A and B supplemental measures that meet or exceed the 
established benchmark.  This amount is added to the base rate of $284.86.  If all eleven (11) 
supplemental performance measure benchmarks are met, reimbursement will be at the 
maximum rate of $375.40 per patient visit.  
 
 
 
Performance Review and Rate Determination 
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Provider performance during the preceding calendar year will be reviewed to determine 
payment rate.  The first performance review, which will occur between February and June 2014, 
will examine calendar year 2013 data.  Performance on the review will determine performance-
based rates for Year 3.  Going forward, rates will be determined based on annual performance 
review for the preceding calendar year and be effective on July 1st (Figure 1). 
 
Figure 1.Performance Monitoring and Payment Determination Timeline 
 
Calendar Year 2012 2013 2014 2015
Nov-Dec Jan-Feb Mar-Apr May-Jun Jul-Aug Sept-Oct Nov-Dec Jan-Feb Mar-Apr May-JuneJul-Aug Sept-Oct Nov-Dec Jan-Feb Mar-Apr May-JunJuly-Aug Sept-..
Contract Year  Year 1 Year 2 Year 3 Year 4
Monitoring Time CY 2013 Review CY 2014 Review
Payment Rate Varies based on Performance in CY 2013 Varies- CY 2014$330.12  
 
 
Sampling for Performance Measures 
 
Patients with two (2) or more visits in the measurement year will be eligible for inclusion in the 
sampling for for all performance measures except for the following: patient satisfaction survey 
response, medical visits and viral load suppression.  The two (2)-visit minimum is used to 
ensure that providers have the opportunity to perform the necessary screens, vaccination and 
counseling that would be difficult or impossible to complete for patients with only a single visit.  
Healthy Way LA and Ryan White Program patients will be used in the sample. 
A standardized sampling methodology developed by the National HIVQUAL Project will be used 
to determine the number of patient records to be sampled at the Division of HIV and STD 
Programs (DHSP) on site reviews.  It is expected that all providers enter patient level data on 
performance measures into DHSP’s data system as described below. 
 
Patient Satisfaction Survey (Core) 
 
Patient satisfaction surveys are an essential tool to shaping patient centered care.  Surveys 
allow for the quick identification of problems that patients experience and create a space for 
dialogue with patients, letting them know that their feedback is critical to providing effective and 
efficient care.  The purpose of this measure is to determine whether the agency has 
implemented a process to routinely administer patient satisfaction surveys to its clinic 
population. This measure also determines the response rate of patients who received a patient 
satisfaction survey during the measurement year, which is important in considering the 
generalizability of the findings. 
 
Table 4 below can be used to identify the number of completed surveys needed for various 
clinic sizes.  The clinic size is determined by the number of providers (MD, DO, PA, or NP) who 
are seeing patients in the clinic regardless of the provider’s FTE or the number of patients they 
see.  The designated number of completed patient surveys determined in Table 4, must be 
obtained for every provider who practices in the clinic.    
 
          Table 4.  Sampling by Clinic 
 Number of Providers in the Clinic 
<5 5-9 =/> 10 
Number of Completed 
Surveys Per Provider Per 
Year 
15 10 5 
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For example: a clinic with 8 providers would need to obtain a minimum of 10 completed patient 
surveys for each of the 8 providers per measurement year.  If the clinic has fewer than 5 
providers, a minimum of 15 returned/completed surveys per provider are needed for every 
provider in the clinic.  
 
The eligible population for survey includes all clinic patients with at least 1 medical visit during 
the measurement year and is not limited to Ryan White Program patients. Providers with a 
smaller patient population should administer enough surveys during the measurement year to 
obtain no less than the required number of completed surveys per provider indicated in the 
above table. 
 
Data Validation (Core)  
The purpose of this measure is to determine the percentage of medical records reviewed during 
the measurement period that demonstrate consistency between DHSP’s data system and the 
client’s medical record (chart or electronic) with regard to the following twelve (12) data 
elements. 
1. Age 
2. Ethnicity 
3. Gender 
4. ART for pregnant women  
5. ART for CD4<500 
6. PCP prophylaxis 
7. Adherence assessment and counseling 
8. Cervical cancer screenin 
9. Hepatitis C screen 
10. HIV risk counseling 
11. Syphilis screen 
12. Tuberculosis screen 
 
Providers will ensure that the above data elements are entered into DHSP’s data system either 
manually or through an electronic data interface.  Data validation will be performed through a 
medical records review of these elements and comparing that documentation to data in DHSP’s 
data system.  The eligible population for survey includes Ryan White Program patients with at 
least two (2) medical visits during the measurement year.  The threshold for compliance is set at 
seventy-five percent (75%) which means that at least seventy-five percent (75%) of medical 
records reviewed will have all twelve (12) data elements reflected in each patient’s medical 
record and in DHSP’s data system. 
 
Utilization of Medical Visits and Reimbursement of Additional Visits   
 
Providers will furnish medical visits to the minimum number of clients to be served as stipulated 
in this contract.  To ensure the appropriate utilization of medical visits, a maximum of ten (10) 
visits per patient per year is established.  The ten (10)-visit per patient per year threshold only 
applies to Ryan White Program patients.  
 
Each clinic will routinely track the number of medical visits per patient per year, as well as the 
clinic’s overall total number of visits for the entire clinic patient population based on the total 
number of patients to be served.  
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Tracking medical visit utilization is essential in providing patients with access to needed clinical 
and medical care and follow-up while ensuring that providers adhere to their established 
budgeted allocations.  Given that there are conditions and special circumstances where some 
patients may need more medical visits than the established ten (10)-visit per year threshold; 
providers will follow the DHSP review and approval process outlined in the protocol below in 
order to ensure reimbursement for those additional visits.   
 
The DHSP review process will be retrospective to ensure that patient care is not compromised. 
The provider will not be able to bill any more visits over the ten (10)-visit threshold without 
DHSP’s approval.  Within this process, providers will have the option to request up to three (3) 
additional visits for patients that have reached the ten (10)-visit threshold, by providing 
appropriate justification following the protocol outlined below. 
 
There are two scenarios for patients exceeding their ten (10)-visit per year threshold.  Each 
scenario requires action as follows: 
 
Scenario 1  
A patient exceeds the ten (10)-visit per year threshold but overall total number of visits for the 
clinic’s Ryan White Program patients remains under the maximum allowed total visits per the 
approved budget.  
 
Provider will request for a retrospective (or prospective, if preferred) review of the visit(s) in 
question and approval for those visits and future additional visits up to three (3) visits.  DHSP 
will review each patient’s case and render its decision to approve visits incurred over the ten 
(10)-visit threshold and may authorize up to three (3) additional future visits or disapprove the 
visit(s) in question.  Visits over the ten (10)-visit threshold that are not approved by DHSP 
pursuant to its review, will not be reimbursed. 
 
Scenario 2 
A patient exceeds the ten (10)-visit per year threshold and the clinic exceeds overall total 
number of Ryan White Program patient visits allowed per the approved budget.  
 
In this scenario, provider will request for a retrospective review of the additional visit(s) in 
question and approval for those visits and future additional visits up to three (3) visits.  In this 
scenario, the provider will not be able to bill any additional visits for these patients, without 
DHSP’s approval.  DHSP will review each patient’s case and render its decision to approve the 
visits in question and may authorize up to three (3) additional future visits or disapprove the 
additional visit(s) in question.  Additional visits over the ten (10)-visit threshold that are not 
approved by DHSP will not be reimbursed.  
 
Protocol for DHSP Case Review, Decision and Appeals Process for Medical Visits 
Exceeding the ten (10)-Visit Per Year Threshold 
 
Providers should routinely track the number of medical visits per patient per year, as well as the 
clinic’s overall total number of visits for the entire clinic patient population based on the total 
number of patients to be served.  When a patient exceeds the 10-visit threshold per patient per 
year, the following steps will be followed: 
 
RYAN WHITE PROGRAM MEDICAL OUTPATIENT UTILIZATION INITIAL 
REQUEST AND APPEALS PROCESS 
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1. Provider completes the Ryan White Program Medical Outpatient Utilization Initial 
Request Form (URF01) and submits this form to DHSP for approval. Provider 
documents the medical justification for the visit(s) in question and requests any 
additional future visit up to three (3) visits.  Request is submitted to DHSP via: 
 
a. Mail: DHSP 
Attention: DHSP Office of the Medical Director 
600 S. Commonwealth Avenue, 10th Floor 
Los Angeles, CA 9005 
 
b. Secure Fax:    (213) 252-4506 
c.  Email:   dhsp-urqm@ph.lacounty.gov 
 
2. DHSP will review the request/justification to determine if the documentation provided 
supports the level of service requested requiring the additional medical visit(s).  DHSP’s 
decision will be based on a review of information provided on the request form and when 
necessary, consultation with the provider and/or a site visit to review the patient’s 
medical records. 
 
3. DHSP will render a decision to approve or disapprove the request. 
a. Approved Requests.  DHSP has determined that documentation received 
contains the required justifications for the level of service requested.  DHSP 
will approve the visit(s) in question.  Up to three (3) additional future visits will 
also be approved per request and will be reimbursed under the specific 
provisions outlined in case scenarios one (1) and two (2) above. 
Disapproved Requests.  DHSP has determined that documentation received 
is insufficient to approve the past visit(s) in question and the additional visit(s) 
requested.  DHSP will return the initial request form and document the 
specific reason(s) for denying the initial request. 
4. The provider accepts DHSP’s decision or files an appeal in response to DHSP’s denial 
of the initial request by completing form URF01.  Provider sends the appeal to DHSP by 
mail,  secure fax, or email as indicated above. 
 
5. DHSP will review the appeal.  If the appeal is denied, DHSP will send a final denial letter 
to the provider that will include the specific reasons for the denial.   
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Clinical Performance Measures for Adult/Adolescent Patients:  
Core Measures 
 
Performance Measure 1.1: Antiretroviral therapy (ART) for pregnant women   
Description: Percentage of HIV-infected pregnant women who are prescribed ART in the 
measurement year.  
Numerator:  
Number of HIV-infected pregnant women who were prescribed ART during 
the second and third
 
trimester in the measurement year. 
Denominator:  
Number of HIV-infected pregnant women who had a medical visit with a 
provider with prescribing privileges,
1 
at least twice in the measurement year.  
Patient 
Exclusions:  
1. Patients2 whose pregnancy is terminated by spontaneous or induced 
abortion.  
2. Pregnant patients who are in the first trimester and newly enrolled in 
care during last three months of the measurement year. 
3. Patients with documented referral to another perinatal HIV care 
program. 
4. Patients with documented refusal of ART offered by provider. 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, is the patient female? (Y/N) 
i. If yes, was she pregnant during the reporting period? (Y/N)  
1. If yes, was she on ART during this reporting period? 
(Y/N)  
Data Sources: 
• Ryan White Program Data Report, Section 5, Item 53 may provide 
data useful in establishing a baseline for this performance measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
No national benchmarks available at this time.  
DHSP Benchmark = 100% 
Outcome 
Measures for 
Consideration:  
o Rate of perinatal transmission in the measurement year  
o Number of events of perinatal transmission in the measurement year  
 
Basis for Selection:  
Treatment recommendations for pregnant women infected with HIV-1 have been based on the 
belief that therapies of known benefit to women should not be withheld during pregnancy unless 
there are known adverse effects on the mother, fetus, or infant and unless these adverse effects 
outweigh the benefit to the woman. ART can reduce perinatal HIV-1 transmission by nearly 
70%.
3  
 
Measure reflects important aspect of care that significantly impacts survival, mortality, and 
hinders transmission. Data collection is currently feasible and measure has a strong evidence 
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base supporting the use.  
 
U.S. Public Health Service Guidelines:  
Health care providers considering the use of antiretroviral agents for HIV-1 infected women 
during pregnancy must take into account two separate but related issues:  
• Antiretroviral treatment of maternal HIV-1 infection, and  
• Antiretroviral chemoprophylaxis to reduce the risk for perinatal HIV-1 transmission  
The benefits of ART for a pregnant woman must be weighed against the risk of adverse events to 
the woman, fetus, and newborn. Although ZDV chemoprophylaxis alone has substantially 
reduced the risk for perinatal transmission, antiretroviral monotherapy is now considered 
suboptimal for treatment of HIV-1 infection, and combination drug regimens are considered the 
standard of care for therapy. Initial evaluation of an infected pregnant woman should include an 
assessment of HIV-1 disease status and recommendations regarding antiretroviral treatment or 
alteration of her current antiretroviral regimen.
3
  
References/Notes:  
1A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
2
 “Patients” include all patients aged 13 years or older. 
3 
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for 
Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. 
September 14, 2011. www.aidsinfo.nih.gov/contentfiles/PerinatalGL.pdf. 
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.2: ART for CD4 <500 
Description: Percentage of patients
1
 with HIV infection and CD4 T-cell counts <500 cells/mm
3 
who are prescribed ART in the measurement year. 
Numerator:  
Number of HIV-infected patients with CD4 T-cell counts <500 cells/mm
3
or 
an AIDS-defining condition who were prescribed an ART regimen
2
 
within the 
measurement year. 
Denominator:  
Number of HIV-infected patients who have:  
• A CD4 T-cell count < 500 cells/mm3
 
or an AIDS-defining condition,
2
 
and  
• At least two medical visits with a provider with prescribing 
privileges,
3
 in the measurement year  
Patient 
Exclusions:  
1. Patients newly enrolled in care during last three months of the 
measurement year.  
2. Patients with documented refusal to take ART in medical record. 
Data Element:  
1. Is the patient HIV-infected (Y/N) 
a. If yes, is the patient diagnosed with CDC-defined AIDS? (Y/N) 
i. If yes, was the patient prescribed ART during the reporting 
period? (Y/N) 
ii. If no, does the patient have two or more CD4 counts <500 
cells/mm
3
? (Y/N) 
 a. If yes, was the patient prescribed ART during the 
reporting period? (Y/N)  
Data Sources:  
• Ryan White Program Data Report, Section 2, Items 26 and 31 may 
provide data useful in establishing a baseline for this performance 
measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• HIVQUAL reports on this measure for grantee under review  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 95% 
CDC and HIVRN data consistent that 80% of those in care “eligible for 
ART’s” 4,5,6  
National HIVQUAL-US Data:
6,7
 
 2003 2004 2005 2006 
Top 10% 100% 100% 100% 100% 
Top 25% 100% 100% 100% 100% 
Median* 100% 88.9% 95.7% 100% 
*from HAB data base  
Outcome 
Measures for 
o Rate of opportunistic infections in the measurement year  
o Rate of HIV-related hospitalizations in the measurement year  
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Consideration:  o Mortality rates  
Basis for Selection:  
Randomized clinical trials provide strong evidence of improved survival and reduced disease 
progression by treating patients with AIDS-defining conditions and patients with CD4 T-cells 
between350 and 500 cells/mm
3
.
2
 
 
Measure reflects important aspect of care that significantly impacts survival, mortality, and 
transmission. Data collection is currently feasible and measure has a strong evidence base 
supporting the use.  
U.S. Public Health Service Guidelines: 
“Antiretroviral therapy should be initiated in patients with a history of an AIDS-defining illness 
or with a CD4 T-cell count between350 and 500 cells/mm
3.”2
  
References/Notes:  
1“Patients” include all patients aged 13 years or older. 
2“Randomized controlled trials provide evidence supporting the benefit of ART in patients with 
CD4 counts <350cells/mm3. However, such evidence showing benefit for patients with higher 
CD4 cell counts is not yet available. Based on cumulative observational cohort data 
demonstrating benefits of ART in reducing AIDS- and non-AIDS associated morbidity and 
mortality, the Panel now recommends ART for patients with CD4 count between 350 and 500 
cells/mm3. For patients with CD4 count >500 cells/mm3, panel members are evenly divided: 
50% favor starting ART at earlier stages of HIV disease; 50% view initiating therapy at this 
stage as optional. Panel members favoring earlier initiation of therapy base their 
recommendation on several recent developments: (1) report from at least one recent cohort study 
demonstrating survival benefit with initiation of ART at CD4 count >500 cells/mm3; (2) 
growing awareness that untreated HIV infection may be associated with development of many 
non-AIDS-defining diseases, including cardiovascular disease, kidney disease, liver disease, and 
malignancy; (3) availability of ARV regimens that are more effective, more convenient, and 
better tolerated than ARV combinations no longer in use; and (4) increasing evidence that 
effective ART reduces HIV transmission. The other 50% of the Panel members feel that current 
evidence does not definitively demonstrate clear benefit of ART in all patients with CD4 count 
>500 cells/mm3. They also feel that risks of short- or long-term drug-related complications, non-
adherence to lifelong therapy in asymptomatic patients, and potential for development of drug 
resistance may offset possible benefits of earlier initiation of therapy. Thus, pending more 
definitive supporting evidence, these Panel members recommend that therapy in this setting 
should be optional and considered on a case-by case basis.Panel on Antiretroviral Guidelines for 
Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected 
Adults and Adolescents. Department of Health and Human Services. October 14, 2011;. 
Available at aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf  
3A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 
Gebo, JAIDS January 2005, vol. 38, pp. 96-103.  
5 
Teshale Abstract #167, CROI 2005.  
6
The National HIVQUAL data may not be directly comparable due to varying exclusions. 
Indicator definitions can be accessed at http://www.hivguidelines.org/Content.aspx?PageID=53.  
7 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf. 
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.3: Pneumocystis pneumonia (PCP) prophylaxis   
Description: Percentage of patients
1
 with HIV infection and a CD4 T-cell count < 200 
cells/mm
3
 
who were prescribed PCP prophylaxis in the measurement year.  
Numerator:  
Number of HIV-infected patients with CD4 T-cell count < 200 cells/mm
3
 
who 
were prescribed PCP prophylaxis
2,3
 in the measurement year. 
Denominator:  
Number of HIV-infected patients who:  
• had a medical visit with a provider with prescribing privileges,4 at 
least twice in the measurement year, and  
• had a CD4 T-cell count < 200 cells/mm3
 
 
Patient 
Exclusions:  
1. Patients with subsequent CD4 T-cell count < 200 cells/mm3 repeated 
within three months which rose above 200 cells/mm
3
  
2. Patients newly enrolled in care during last three months of the 
measurement year.  
3. Patients with documented refusal to take PCP prophylaxis in medical 
record. 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, was the CD4 T-cell count <200 cells/mm3? (Y/N)  
i. If yes, was PCP prophylaxis prescribed? (Y/N)  
1. If no, was the CD4 count repeated within three months? 
(Y/N)  
A. If yes, did it remain < 200 cells/mm3? (Y/N)  
I. If yes, was PCP prophylaxis prescribed? (Y/N)  
Data Sources:  
• Electronic Medical Record/Electronic Health Record  
• HIVQUAL reports on this measure for grantee under review  
• CAREWare, Lab Tracker, or other electronic data base  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 95% 
IHI Goal: 95%
5
 
 
National HIVQUAL-US Data:
 6
  
 2003 2004 2005 2006 
Top 10% 100% 100% 100% 100% 
Top 25% 100% 100% 100% 100% 
Median* 93.3% 90.9% 92.3% 94.4% 
*from HAB data base  
Outcome 
Measures for 
Consideration:  
o Rate of PCP in the measurement year  
o Mortality rates  
o Cost effectiveness  
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Basis for Selection:  
PCP is the most common opportunistic infection in people with HIV. Without treatment, over 
85% of people with HIV would eventually develop PCP. It is a major cause of mortality among 
persons with HIV-infection, yet is almost entirely preventable and treatable. Pneumocystis 
almost always affects the lungs, causing a form of pneumonia. People with CD4 T-cell counts < 
200 cells/mm
3
are at greatest risk of developing PCP.
2 
 
Before the widespread use of primary PCP prophylaxis and effective ART, PCP occurred in 
70%-80% of patients with AIDS.
7
 The course of treated PCP was associated with a mortality 
rate of between 20% and 40% in persons with profound immunosuppression. Approximately 
90% of cases occurred among patients with CD4 T-cell counts <200 cells/mm
3
.
8,9
 Measure 
reflects important aspect of care that significantly impacts survival and mortality. Data collection 
is currently feasible and measure has a strong evidence base supporting the use. 
U.S. Public Health Service Guidelines: 
HIV-infected adults and adolescents, including pregnant women and those on ART, should 
receive chemoprophylaxis against PCP if they have a CD4 T-cell count <200 cells/mm
3
 or a 
history of oropharyngeal candidiasis
 
.
2
  
References/Notes:  
1“Patients” include all patients aged 13 years or older. 
2 
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from 
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR. March 24, 2009. Volume 58. 
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4. 
3 
PCP prophylactic recommended in US PHS guidelines: TMP-SMX (preferred regimen at 1 DS 
QD, however tolerability may improve with 1 SS QD, 1 DS 3x a week), alternative regimens (in 
case of TMP-SMX intolerability) include:  1) dapsone + pyrimethamine + leukovorin; 2) 
atovaquone; 3) aerosolized pentamadine; 4) oral pyrimethamine + sulfaxodoxine (if sulfonamide 
hypersensitivity).  
4A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP..  
5
 IHI Measure reads, “Percent of Patients with a CD4 Cell Count Below 200 cells/mm3 receiving 
Pneumocystis Carinii Pneumonia (PCP) Prophylaxis”  
6 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.  
7 
Phair J, Munoz A, Detels R, et al. The risk of Pneumocystis carinii pneumonia among men 
infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. N 
Engl J Med 1990;322:161–5.  
8 
Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii 
pneumonia in human immunodeficiency virus- infected adolescents and adults in the United 
States: reassessment of indications for chemoprophylaxis. J Infect Dis 1998;178:1126–32.  
9 
Kaplan JE, Hanson DL, Jones JL, Dworkin MS. Viral load as an independent risk factor for 
opportunistic infections in HIV-infected adults and adolescents. AIDS 2001;15:1831–6.  
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.4: Adherence assessment and counseling   
Description: Percentage of patients
1
 with HIV infection on ART who were assessed for 
adherence (and counseled if suboptimal adherence) two or more times in the measurement year.  
Numerator:  
Number of HIV-infected patients, as part of their primary care, who were 
assessed for adherence and counseled 
2,3 
 two or more times in the 
measurement year. 
Denominator:  
Number of HIV-infected patients on ART who had a medical visit with a 
provider with prescribing privileges
4 
at least twice in the measurement year  
Patient 
Exclusions:  
1. Patients newly enrolled in care during the last six months of the 
measurement year.  
2. Patients who are not on ART.   
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, was the patient on ART? (Y/N)  
i. If yes, did he/she receive adherence counseling at least twice 
during the measurement year? (Y/N)  
1. If yes, list the dates of these visits  
Data Sources:  
• Electronic Medical Record/Electronic Health Record  
• HIVQUAL reports on this measure for grantee under review  
• CAREWare, Lab Tracker, or other electronic data base  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 95% 
IHI Goal: 90%
5 
 
National HIVQUAL-US Performance Data:
6 
 
 2003 2004 2005 2006 
Top 10% 95.8% 92.0% 97.5% 98.4% 
Top 25% 82.7% 79.2% 88.3% 91.6% 
Median* 57.5% 39.7% 46.8% 55.7% 
*from HAB data base  
Outcome 
Measures for 
Consideration:  
o Percent of undetectable viral loads among patients on ART in the 
measurement year  
o Percent of patients with ART-resistance developed during therapy in 
the measurement year   
o Mortality rates  
o Incidence of HIV-related hospitalizations in the clinic population  
o Incidence of patients with progression to AIDS in the clinic 
population  
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Basis for Selection:  
Adherence is a key determinant in the degree and duration of virologic suppression. Among 
studies reporting on the association between suboptimal adherence and virologic failure, non-
adherence among patients on ART was the strongest predictor for failure to achieve viral 
suppression below the level of detection. HIV viral suppression, reduced rates of resistance, and 
improved survival have been correlated with high rates of adherence to ART.
7
 
Prior to writing the first prescriptions, clinicians need to assess the patient’s readiness to take 
medication. Patients need to understand that the first regimen is the best chance for long-term 
success. Resources need to be identified to assist in success. Interventions can also assist with 
identifying adherence education needs and strategies for each patient.”
7 
 
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on 
treatment decisions that affect a sizable population. Although discussions of the importance of 
adherence to ART are important to begin prior to initiation of treatment, there is no standard of 
care for discussions to occur every six months for patients who may be years away from 
antiretroviral treatment. 
U.S. Public Health Guidelines:  
"...adherence counseling and assessment should be done at each clinical encounter"
7 
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
Assessment of adherence includes: 1) patient reports of adherence by: a) quantifiable scales, 
e.g. missed three out of ten doses; b) qualitative scale, e.g. Likert scale; or 2) quantification such 
as pharmacy dispensing records, pill counts, or direct observation therapy.  
3
Adherence assessment should be provided by the provider with prescribing privileges. 
Adherence counseling should be performed for patients who report suboptimal adherence (less 
than 100% no missed doses).  Counseling can be provided by any member of the 
multidisciplinary primary care team.  
4
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP..  
5 
IHI Measure reads, “Percent of Patients/Patients Assessed for Adherence to Antiretroviral 
(ARV) Therapy in the Past 4 Months.”  
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tsAssessedforAdherencetoAntiretroviralARVTherapyinthePast4Months.htm. 
6 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.  
7 
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 
October 14, 2011. Available at 
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.5: Cervical cancer screening   
Description: Percentage of women with HIV infection who have a PAP screen in the 
measurement year.  
Numerator:  
Number of HIV-infected female patients
1
 who had PAP screen results 
documented in the measurement year. 
Denominator:  
Number of HIV-infected female patients who:  
• were >18 years old
2 
in the measurement year or reported having a 
history of sexual activity, and  
• had a medical visit with a provider with prescribing privileges
3 
at 
least twice in the measurement year  
Patient 
Exclusions:  
1. Patients who were < 18 years old and denied history of sexual 
activity.  
2. Patients who have had a hysterectomy for non-dysplasia/non-
malignant indications.  
3. Patients with documented refusal of PAP screen in medical record. 
4. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, is the patient female? (Y/N)  
i. If yes, is she > 18 years or reports having a history of sexual 
activity? (Y/N)  
2. If yes, was the PAP screening completed during the 
measurement year?  
Data Sources:  
• Ryan White Program Data Report, Section 5, Items 42 and 52 may 
provide data useful in establishing a baseline for this performance 
measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• HIVQUAL reports on this measure for grantee under review  
• Medical record data abstraction by grantee of a sample of records  
 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 90% 
IHI Goal: 90%
4
 
National HIVQUAL-US Data: 
5  
Percent of female patients who received a pelvic examination. 
 2003 2004 2005 2006 2007 2009 
Top 10% 100% 100% 100% 100% 100% 94.1% 
Top 25% 84.3% 86.7% 87.0% 89.2% n/a  
Median* 70.5% 67.7% 71.8% 73.3% 70.0% 66.7% 
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Bottom 10%     45.5% 33.3% 
*from HAB data base  
 
Percent of female patients who received a pelvic examination and Pap test 
 2007 2009 
Top 10% 100% 90.9% 
Median 67.1% 62.1% 
Bottom 10% 43.5% 31.6% 
 
Outcome 
Measures for 
Consideration  
 
o Incidence of cervical cancer in HIV-positive women in clinic 
population 
 
Basis for Selection:  
Human Papillomavirus (HPV) is a common infection in the general population. Current 
evidence suggests that over 50% of sexually active adults have been infected with one or more 
HPV types. According to population-based prospective studies, HPV precedes the development 
of cervical cancer.
6  
‘The American College of Obstetricians and Gynecologists (ACOG) identifies additional risk 
factors that might justify annual screening, including a history of cervical neoplasia, infection 
with HPV or other sexually transmitted diseases (STDs), or high-risk sexual behavior, but data 
are limited to determine the benefits of these strategies.
7
 
Cervical cancer may be the most common AIDS-related malignancy in women. Although not a 
common diagnosis in women in the general population, according to New York City AIDS 
Surveillance data from 1990 to 1995, the observed cervical cancer cases in HIV-positive 
women were two to three times higher than the expected number of cases.
,8 
Findings such as 
these resulted in the inclusion of cervical cancer in the Centers for Disease Control and 
Prevention (CDC) expanded definition of AIDS.
9  
 
When compared with HIV-negative women, HIV-positive women with invasive cervical cancer 
present at more advanced stages and with cancer metastasizing to unusual locations. HIV- 
positive women have poorer responses to standard therapy and have higher recurrences and 
death rates, as well as shorter intervals to recurrence or death.
10,11  
The CDC currently recommends that HIV-positive women have a complete gynecologic 
evaluation, including a PAP smear, as part of their initial HIV evaluations, or upon entry to 
prenatal care, and another PAP smear six months later. If both PAP smears are negative, annual 
screening is recommended thereafter in asymptomatic women. The CDC further recommends 
more frequent screenings (every six months) for women with symptomatic HIV-infection, prior 
abnormal PAP smears, or signs of HPV infection.  
12,13 
 
Cervical cancer can often be prevented or detected in its earliest stages through effective 
screening with a PAP smear and avoidance of known risk factors. This accentuates the 
importance of routine gynecological care, which includes PAP smears for HIV-infected 
women.
14  
Measure reflects important aspect of care that impacts HIV-related morbidity and 
focuses on treatment decisions that affect a sizable population. Measure has a strong evidence 
base supporting the use.  
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U.S. Public Health Guidelines:  
“The Pap test should be obtained twice during the first year after diagnosis of HIV-infection 
and, if the results are normal, annually thereafter (AII). If the results of the Pap test are 
abnormal, care should be provided according to the Guidelines for Management of Women with 
Abnormal Cervical Cancer Screening Tests by ASCCP.” 
15
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Onset of sexual activity is not reliably reported or recorded. The age bracket of 18 years is 
selected for performance measurement purposes only and should not be interpreted as a 
recommendation about the age at which screening should begin to occur.  
3 
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 
Goal: Greater than 90 percent of female patients/clients will have a documented Pap test in the 
past 12 months. 
http://www.ihi.org/knowledge/Pages/Measures/PercentofFemalePatientsClientswithanAnnualPa
panicolaouPapTest.aspx 
5 
National HIVQUAL data looked at the percent of female patients who have an annual pelvic 
exam until 2007, when pelvic exam and Pap examination among female patients was added. 
Data was not collect data in 2008. HIVQUAL-US Performance Data Report, Ryan White Part C 
and Part D Funded Programs, Review Period: January 1, 2009 – December 31, 2009. Available 
at: http://hivqualus.org/index.cfm/8418/10039 
6 
Davis, AT. Cervical dysplasia in women infected with the human immunodeficiency virus 
(HIV): A correlation with HIV viral load and CD4 count. Gynecologic Oncology. 2001; 
80(3):350–354.  
7
 Guide to Clinical Preventive Services, 2010-2011, Recommendations of the U.S. Preventive 
Services Task Force, p 47  
http://www.ahrq.gov/clinic/pocketgd1011/pocketgd1011.pdf  Available at: 
http://www.ahrq.gov/clinic/pocketgd.htm  
8
Chiasson, MA. Declining AIDS mortality in New York City. New York City Department of 
Health. Bull NY Acad. Med. 1997; 74:151–152.  
9
Centers for Disease Control and Prevention (CDC). 1993. Revised classification system for 
HIV-infection and expanded surveillance case definition for AIDS among adolescents and 
adults. MMWR. 1992; 41(RR-17). 
http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm.  
10 
Ibid.  
11 
U.S. Department of Health and Human Services. Anderson, JA, editor. Guide to the Clinical 
Care of Women with HIV; 2005.  
12 National Institutes of Allergy and Infectious Diseases. HIV Infection in Women 
http://www.niaid.nih.gov/topics/hivaids/understanding/population%20specific%20information/
pages/womenhiv.aspx. Accessed 3/123/2012 13. Susan Richardson, MN, MPH, FNP-BC.  
Health Care of HIV-Infected Women Through the Life Cycle, in Guide for HIV/AIDS Clinical 
Care. U.S. Department of Health and Human Services, Health Resources and Services Administration 
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HIV/AIDS Bureau, January 2011   http://hab.hrsa.gov/deliverhivaidscare/clinicalguide11/ 
14
Kjaer, S. Type specific persistence of high risk human papillomavirus (HPV) as indicator of 
high grade cervical squamous intraepithelial lesions in young women: population based 
prospective follow-up study, Brit Med J. 2002; 325: 572–578. 
15
 Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents, Recommendations from 
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR 2009;58(No. RR-4) 
http://aidsinfo.nih.gov/contentfiles/Adult_OI_041009.pdf  
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.6: Hepatitis C (HCV) screening  
Description:  Percentage of patients
1
 for whom HCV screening was performed at least once 
since the diagnosis of HIV-infection. 
Numerator:  
Number of HIV-infected patients who have HCV status documented in chart 
since HIV diagnosis or initiation of care with provider
2
 
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
3 
at least twice in the measurement year  
Patient 
Exclusions:  
1.  Patient refusal of test. 
2. Patients newly enrolled in care during the last three months of the 
measurement year. 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, is there documentation of the patient’s Hepatitis C status 
(Hepatitis C Antibody positive or negative) in the medical record? 
(Y/N)  
Data Sources:  
• Ryan White Program Data Report, Section 5, Items 42 and 48 may 
provide data useful in establishing a baseline for this performance 
measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
•  HIVQUAL reports on this measure for grantee under review  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 90% 
IHI Goal: 95%
4 
 
National HIVQUAL-US Performance Data:
5 
 
 2003 2004 2005 2006 
Top 10% 100% 100% 100% 100% 
Top 25% 94.4% 100% 100% 100% 
Median* 86.2% 88.8% 90.5% 90.9% 
*from HAB data base  
Outcome 
Measures for 
Consideration:  
 
o Hepatitis C- related mortality rates in the clinic population  
 
Basis for Selection:  
Approximately 15% to 30% of people with HIV are estimated to be co-infected with hepatitis C 
virus (HCV) in the United States, and up to 90% of those with HIV secondary to injection drug 
use are co-infected. Chronic liver disease from co-infection, including cirrhosis and 
hepatocellular carcinoma, leads to significant morbidity and mortality
6 
and HCV treatment may 
exacerbate the side effects of some antiretroviral medications.
7 
 
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on 
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treatment decisions that affect a sizable population. Measure has a strong evidence base 
supporting the use.  
U.S. Public Health Guidelines:  
“HIV-infected patients should be tested routinely for evidence of chronic HCV infection”
8
 
(3/29/09)  
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Unless there is concern about ongoing exposure (e.g., via active injection drug use or sexual 
exposure), guidelines do not consistently recommend annual re-screening.  
3 
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 
IHI Measure reads, “Percent of Patients/Patients with Known Hepatitis C Status”  
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tswithKnownHepatitisCStatus.htm. 
5
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf.  
6
Medscape: HIV and Hepatitis C Co-infection: Guideline and Commentary, Douglas G. Fish, 
MD http://www.medscape.com/viewarticle/734975 
7 
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of 
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human 
Services. October 14, 2011; 1–167. Available at http://www.aidsinfo.nih.gov/ContentFiles/ 
AdultandAdolescentGL.pdf. 
8
 Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from 
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR. March 24, 2009. Volume 58. 
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4. 
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.7: HIV risk counseling 
Description: Percentage of patients
1
 with HIV infection who received HIV risk counseling
2 
within the measurement year. 
Numerator:  
Number of HIV-infected patients, as part of their primary care, who received 
HIV risk counseling within the measurement year.  
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
3 
at least twice in the measurement year  
Patient 
Exclusions:  
1. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, did the patient receive HIV risk counseling at least once 
during the measurement year?(Y/N)  
Data Sources:  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 95% 
None available at this time  
Outcome 
Measures for 
Consideration:  
o Incidence of new HIV-infection  
o Incidence of STD cases in clinic population  
o Rates of substance abuse counseling and referrals  
Basis for Selection:  
Reducing transmission of HIV in the United States requires new strategies, including emphasis 
on prevention of transmission by HIV-infected persons. Through ongoing attention to 
prevention, risky sexual and needle sharing behaviors among persons with HIV-infection can be 
reduced, and transmission of HIV-infection prevented. Medical care providers can substantially 
affect HIV transmission by screening their HIV-infected patients for risk behaviors; 
communicating prevention messages; discussing sexual and drug-use behavior; positively 
reinforcing changes to safer behavior; referring patients for services such as substance abuse 
treatment; facilitating partner notification, counseling, and testing; and identifying and treating 
other sexually transmitted diseases.
4
  
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on 
treatment decisions that affect a sizable population. Measure has a strong evidence base 
supporting its use.  
U.S. Public Health Guidelines:  
"HIV-infected patients should be screened for behaviors associated with HIV transmission by 
using a straightforward, nonjudgmental approach. This should be done at the initial visit and 
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subsequent routine visits or periodically, as the clinician feels necessary, but at a minimum of 
yearly. Any indication of risky behavior should prompt a more thorough assessment of HIV 
transmission risks."
4,5
  
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
HIV risk counseling includes assessment of risk, counseling, and as necessary, referrals. 
Counseling occurs in the context of comprehensive medical care and can be provided by any 
member of the multidisciplinary primary care team.  
3 
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 
Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical 
care of persons living with HIV: recommendations of CDC, the Health Resources and Services 
Administration, the National Institutes of Health, and the HIV Medicine Association of the 
Infectious Diseases Society of America. MMWR 2003;52 (No. RR-12). 
http://www.cdc.gov/mmwr/PDF/rr/rr5212.pdf or 
http://aidsinfo.nih.gov/ContentFiles/HIVPreventionInMedCare_TB.pdf.  
5
 
 
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 
October 14, 2011 http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 
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Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.8: Syphilis screening  
Description:  Percentage of adult patients
1
 with HIV infection who had a test for syphilis 
performed within the measurement year.  
Numerator:  
Number of HIV-infected patients who had a serologic test for syphilis 
performed at least once during the measurement year.  
Denominator:  
Number of HIV-infected patients who:  
• were >18 years old in the measurement year
2 
or had a history of sexual 
activity and were < 18 years old, and  
• had a medical visit with a provider with prescribing privileges
3 
at least 
twice in the measurement year  
Patient 
Exclusions:  
1. Patient refusal of test, documented in the medical record. 
2. Patients who are < 18 years of age4 and deny a history of sexual 
activity.  
3. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, is the patient > 18 years old or reports having a history of 
sexual activity? (Y/N)  
i. If yes, was the patient screened for syphilis with 
Nontreponemal test (RPR, VDRL) during the measurement 
year?  
Data Sources:  
• Ryan White Program Data Report, Section 5, Items 42 and 48 may 
provide data useful in establishing a baseline for this performance 
measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• HIVQUAL reports on this measure for grantee under review  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 90% 
IHI Goal: 90%
4 
 
National HIVQUAL-US Data:
5 
 
 2003 2004 2005 2006 
Top 10% 99.0% 100% 100% 100% 
Top 25% 90.4% 92.2% 95.7% 95.6% 
Median* 73.7% 78.5% 82.1% 80.0% 
*from HAB data base  
Outcome 
Measures for 
Consideration  
 
o Incidence of syphilis in the clinic population  
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Basis for Selection:  
HIV-1 infection appears to alter the diagnosis, natural history, management, and outcome of T. 
pallidum infection. Measure reflects important aspect of care that impacts HIV-related 
morbidity and focuses on treatment decisions that affect a sizable population. Measure has a 
strong evidence base supporting its use. Because the incidence of some STDs, notably syphilis, is 
higher in HIV-infected persons, the use of client-centered STD counseling for HIV-infected persons has 
been strongly encouraged by public health agencies and other health organizations. Consensus 
guidelines issued by CDC, the Health Resources and Services Administration, the HIV Medicine 
Association of the Infectious Diseases Society of America, and the National Institutes of Health 
emphasize that STD/HIV risk assessment, STD screening, and client-centered risk reduction counseling 
should be provided routinely to HIV-infected persons.
6 
 
Recommendations from CDC, the National Institutes of Health, and the HIV Medicine 
Association of the Infectious Diseases Society of America 
Routine laboratory screening for syphilis is indicated for all sexually active MSM. Screening 
tests should be performed at least annually for sexually active MSM.  
Serologic test for syphilis should be performed on all pregnant women at the first prenatal visit. 
Because many STDs are asymptomatic, routine screening for curable STDs (e.g., syphilis) should be 
performed at least annually for all sexually active, HIV-positive persons
.6
 
 
The resurgence of syphilis among persons with HIV infection in the United States underscores 
the importance of primary prevention of syphilis among persons with HIV infection. This 
should begin with routine discussion of sexual behaviors. Providers should discuss client-
centered risk reduction messages and provide specific actions that can reduce the risk for 
acquiring sexually transmitted infections and for transmitting HIV Routine serologic screening 
for syphilis is recommended at least annually for all sexually active HIV-infected persons, with 
more frequent screening (every 3--6 months) for those with multiple partners, unprotected 
intercourse, sex in conjunction with illicit drug use, methamphetamine use, or partners who 
participate in such activities. The occurrence of syphilis in an HIV-infected person is an 
indication of high-risk behavior and should prompt intensified counseling messages and strong 
consideration of referral for behavioral intervention. Persons undergoing screening or treatment 
for syphilis also should be evaluated for all common sexually transmitted diseases (STDs)
7 
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years 
is selected for performance measurement purposes only and should not be interpreted as a 
recommendation about the age at which screening should begin to occur.  
3
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 
IHI Measure reads, “Percent of Patients with Annual Syphilis Screen”  
(http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientswith
AnnualSyphilisScreen.htm)  
5 
(http://www.hivguidelines.org/public_html/center/quality-of-care/hivqual-project/hivqual-
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workshop/03-04-natl-score-top10-25.pdf)  
6 
Morbidity and Mortality Weekly Report December 17, 2010 Volume 59
 
7
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults 
and Adolescents March 24, 2009
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ATTACHMENT 5 
 
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES 
 
Updated: 11/08/2012 
Page 26 
 
Clinical Performance Measures for Adult/Adolescent Patients: 
Core Measures 
 
Performance Measure 1.9: Tuberculosis screening  
Description:  Percentage of patients
1
 with HIV infection who received testing with results 
documented for latent tuberculosis infection (LTBI) in the measurement year. 
Numerator:  
Number of HIV-infected patients who received documented testing for LTBI 
with any approved test (tuberculin skin test [TST], interferon gamma release 
assay [IGRA], or T-spot) for the measurement year. 
Denominator:  
Number of HIV-infected patients who:  
• do not have a history of previous documented culture-positive TB 
disease or previous documented positive TST or IGRA
2
; and  
• had a medical visit with a provider with prescribing privileges3
 
at 
least twice in the measurement year.  
Patient 
Exclusions  
1. Patient refusal of TST or IGRA
4
 
2. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, has the patient ever had previous documented culture-
positive TB disease or previous documented positive TST or 
IGRA? (Y/N)  
i. If no, has the patient been tested for LTBI with a TST or 
IGRA in the measurement year? (Y/N)  
1. If yes, are the results documented? (Y/N)  
Data Sources:  
• Ryan White Program Data Report, Section 5, Item 47 may provide 
data useful in establishing a baseline for this performance measure  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base 
• HIVQUAL reports on this measure for grantee under review 
• Medical record data abstraction by grantee of a sample of records 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 75%  
National HIVQUAL-US Data:
5 
 
 2003 2004 2005 2006 
Top 10% 88.9% 91.7% 88.8% 92.2% 
Top 25% 77.4% 73.5% 74.8% 78.2% 
Median* 58.8% 56.0% 57.1% 56.2% 
*from HAB data base  
Outcome 
Measures for 
Consideration  
 
o Incidence of TB disease in the clinic population  
 
ATTACHMENT 5 
 
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES 
 
Updated: 11/08/2012 
Page 27 
 
Basis for Selection:  
HIV is the most important known risk factor for progression to TB disease from LTBI after 
exposure to infectious TB patients. There is a 2% to 8% TB risk per year within five years after 
LTBI for HIV-infected adults
6,7 
versus an 8% TB risk over 60 years for adults with LTBI but 
not HIV.
8
 The TB risk for HIV-infected persons remains higher than for HIV-uninfected 
persons, even for HIV-infected persons who are taking antiretroviral medications.
9,10 
TB disease 
is an AIDS-defining opportunistic condition that can be deadly. McCombs found a three-times 
adjusted odds of being diagnosed with TB at death and a five times adjusted odds of dying 
during TB treatment for HIV-infected TB patients compared with other patients from 1993 
through 2001.
11
 
Immunologic and virologic evidence now indicates that the host immune response to M. 
tuberculosis enhances HIV replication and might accelerate the natural progression of HIV-
infection.
12 
 
Providers should screen all HIV-infected patients for TB and LTBI as soon as possible after 
HIV diagnosis. TB and LTBI testing should be conducted among HIV-infected persons 
regardless of duration of infection since they are at increased risk for progressing to TB disease. 
Thus, an HIV-infected person having a prior positive TST for which he/she did not complete 
treatment is still eligible for treatment. However, early identification and treatment of TB 
disease improves outcomes and reduces the risk of transmission. TB should be suspected in any 
patient who has had a persistent cough for more than two to three weeks, especially if the 
patient has at least one additional symptom, including fever, night sweats (sufficient to require 
changing of bed clothes or sheets), weight loss, or hemoptysis (coughing up blood). 
Identification of LTBI and completion of LTBI treatment reduces the risk of development of 
TB disease by 70 to 90 percent.
13
 
Measure reflects important aspect of care that impacts HIV-related morbidity and mortality and 
focuses on treatment decisions that affect a sizable population. Measure has a strong evidence 
base supporting its use.  
U.S. Public Health Guidelines:  
Guidelines for TB services for HIV-infected persons, such as those jointly published by the 
PHS and the Infectious Diseases Society of America
14 
or by the Centers for Disease Control and 
Prevention (CDC)
15 
call for:  
• provision of a TST or IGRA when HIV-infection is first recognized,  
• annual TST or IGRA for HIV-infected persons who are initially TST-negative and 
belong to groups at substantial risk for TB exposure or if they experience immune 
reconstitution,  
• chest radiographs and clinical evaluations to rule out active TB among those who are 
TST positive (reactions ≥ 5 mm) or who have symptoms (regardless of TST result), and  
•  LTBI treatment (once active TB has been excluded) for those having a positive 
TST/IGRA or for those who are recent contacts of persons with infectious active TB.
 16
  
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Previous documented culture-positive TB disease or previous documented positive TST or 
IGRA occurred prior to HIV diagnosis.  
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3 
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4
History of receiving BCG is NOT an exclusion to receiving TST.  See: Targeted Tuberculin 
Testing and Treatment of Latent Tuberculosis Infection. MMWR, 2000/49(RR06);1-64. 
5
”PPD screening.” 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf 
6 
Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States 
among HIV-infected persons. Annals of Internal Medicine. 1997;126:123-32.  
7 
Selwyn PA, Hartel D, Lewis VA, et al. A prospective study of the risk of tuberculosis among 
intravenous drug users with human immunodeficiency virus infection. New England Journal of 
Medicine. 1989;320:545-50.  
8
Aronson NE, Santosham M, Comstock GW, et al. Long-term efficacy of BCG vaccine in 
American Indians and Alaska Natives: A 60-year follow-up study. Journal of the American 
Medical Association. 2004;291(17):2086-91.  
9
The Antiretroviral therapy cohort collaboration. Incidence of tuberculosis among HIV-infected 
patients receiving highly active antiretroviral therapy in Europe and North America. Clinical 
Infectious Diseases. 2005;41:1772-1782. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.1: Chlamydia screen 
Description: Percentage of patients
1
 with HIV infection who had a test for Chlamydia
2
 within 
the measurement year. 
Numerator:  
Number of HIV-infected patients who received a test for Chlamydia in the 
measurement year. 
Denominator:  
Number of patients with HIV-infection who had a medical visit with a 
provider with prescribing privileges
3
 at least twice in the measurement year  
Patient 
Exclusions: 
1. Patient refusal of test, documented in medical record. 
2. Patients who are <18 yrs of age4 and deny a history of sexual activity. 
3. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, is the patient > 18 years or sexually active? (Y/N) 
i. If yes, was the patient tested for urethral, rectal and/or 
cervical Chlamydia during the measurement period? (Y/N)  
Data Sources:  
• Electronic Medical Record/Electronic Health Record 
• CAREWare, Lab Tracker, or other electronic 
• Medical record data abstraction by grantee of a sample of records.  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
None available at this time.  
Outcome 
Measures for 
Consideration 
o Incidence of Chlamydia in the clinic population 
o Incidence of pelvic inflammatory disease in the clinic population 
Basis for Selection:  
Early detection and treatment of STDs may reduce the risk for STD and HIV transmission. 
Providers should screen for STD’s to treat infections and decrease HIV transmission to sexual 
partners. Many STD’s increase the number of HIV-infected white blood cells in the genital area 
and increase the risk of transmitting HIV-infection.
5
 STD’s can also enhance the risk of 
transmitting HIV by increasing the viral burden in genital secretions.
6,7 
 
STD infections in seronegative partners increase the risk for acquiring HIV because they 
increase of the volume of white blood cells, including those that are targeted by HIV, in the 
genital region, and may cause ulcerative lesions, increasing the likelihood of infection.
8
 
Susceptibility to transmission may therefore be enhanced. Chlamydia infection in women may 
often be asymptomatic but like other STD’s can also increase the risk for HIV transmission and 
enhance transmission susceptibility. Providers should test women for Chlamydia infection at 
least annually to treat infections and to decrease the risk of Chlamydia and HIV transmission. 
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Identification and treatment of STD’s can reduce the potential for spread of these infections 
among high-risk groups (i.e., sex or drug-using networks).
7 
 
U.S. Public Health Guidelines:  
“During the first visit, consider testing all patients for urogenital chlamydial infection. For 
subsequent routine visits, repeated tests periodically (i.e. at least annually) for all patients who 
are sexually active. More frequent periodic screening (e.g. at 3-month to 6-month intervals) may 
be indicated for asymptomatic persons at higher risk.”
7 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 Vaginal screening is the preferred Chlamydia test for women.  Chlamydia screening for men 
should be site specific using the following guidelines: (a) rectal screening test for men reporting 
receptive anal sex in the past year;  and (b) urine screening test for men reporting insertive only 
sex in the past year The preferred method of Chlamydia testing currently is the molecular test 
also known as nucleic acid amplification tests (NAAT). Other methods that may be used include 
direct fluorescent antibody stain (DFA), which detects chlamydia antigens, and DNA probe, 
another test that looks for chlamydia DNA but is less sensitive than NAAT. Testing for 
Neisseria gonorrhoeae (gonorrhea) and Chlamydia trachomatis is generally done simultaneously 
as the two organisms have similar clinical presentations. 
3
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4
 Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years 
is selected for performance measurement purposes only and should not be interpreted as a 
recommendation about the age at which screening should begin to occur. 
5 
Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. 
Lancet 
1998;351(suppl 3):5--7 
6
 Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell 
counts in HIV-infected patients with new syphilis infections. AIDS. 2004 Oct 21;18(15):2075-9 
7 
CDC. Recommendations and Reports: “Incorporating HIV Prevention into the Medical Care of 
Persons Living with HIV”. July 18, 2003/52(RR12);1-24 
8
 DT Fleming and JN Wasserheit, From epidemiological synergy to public health policy and 
practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV-
infection, Sex Transm Infect 75 (1999), pp. 3–17. 
 
ATTACHMENT 5 
 
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES 
 
Updated: 11/08/2012 
Page 31 
 
Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.2: Gonorrhea screen 
Description:  Percentage of adult patients
1
 with HIV infection who had a test for Gonorrhea
2
 
within the measurement year. 
Numerator:  
Number of HIV-infected patients who received a test for Gonorrhea
 
in the 
measurement year. 
Denominator:  
Number of patients with HIV-infection who had a medical visit with a 
provider with prescribing privileges
3
 at least twice in the measurement year  
Patient 
Exclusions: 
1. Patient refusal of test, documented in medical record. 
2. Patients who are <18 yrs of age4 and deny a history of sexual activity. 
3. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, is the patient >18 years or sexually active? (Y/N) 
i. If yes, was the patient screened for urethral, rectal, pharyngeal, 
and/or cervical gonorrhea during the reporting period? (Y/N)  
 
Data Sources:  
• Electronic Medical Record/Electronic Health Record 
• CAREWare, Lab Tracker, or other electronic 
• Medical record data abstraction by grantee of a sample of records.  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
None available at this time.  
Outcome 
Measures for 
Consideration 
o Incidence of gonorrhea in the clinic population 
o Incidence of pelvic inflammatory disease in the clinic population 
Basis for Selection:  
Early detection and treatment of STDs may reduce the risk for STD and HIV transmission. 
Providers should screen for STDs to treat infections and decrease HIV transmission to sexual 
partners. Many STDs increase the number of HIV-infected white blood cells in the genital area 
and increase the risk of transmitting HIV-infection.
5
 STDs can also enhance the risk of 
transmitting HIV by increasing the viral burden in genital secretions.
6 
STD infections in seronegative partners increase the risk for acquiring HIV because they 
increase the volume of white blood cells, including those that are targeted by HIV, in the genital 
region, and may cause ulcerative lesions, increasing the likelihood of infection.
6
 Susceptibility to 
transmission may therefore be enhanced. 
Identification and treatment of STDs can reduce the potential for spread of these infections 
among high-risk groups (i.e., sex or drug-using networks.
7
 There are currently no guidelines that 
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delineate annual testing. 
U.S. Public Health Guidelines:  
“During the first visit, consider testing all patients for urogenital gonorrhea. For subsequent 
routine visits, repeated tests periodically (i.e. at least annually) for all patients who are sexually 
active. More frequent periodic screening (e.g. at 3-month to 6-month intervals) may be indicated 
for asymptomatic persons at higher risk.”8
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 Vaginal screening is the preferred Gonorrhea test for women. Gonorrhea screening for men 
should be site specific using the following guidelines: (a) rectal screening test for men reporting 
receptive anal sex in the past year;  (b) urine screening test for men reporting insertive only sex 
in the past year; and (c) pharyngeal screening test for men reporting receptive oral sex in the past 
year. The preferred method of Gonorrhea testing currently is the molecular test also known as 
nucleic acid amplification tests (NAAT). Other methods that may be used include direct 
fluorescent antibody stain (DFA), which detects antigens, and DNA probe, another test that 
looks for DNA but is less sensitive than NAAT. Testing for Neisseria gonorrhoeae (gonorrhea) 
and Chlamydia trachomatis is generally done simultaneously as the two organisms have similar 
clinical presentations. 
3
 Onset of sexual activity is not reliably reported or recorded. The lower age bracket of 18 years 
is selected for performance measurement purposes only and should not be interpreted as a 
recommendation about the age at which screening should begin to occur. 
4
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP. 
5
 Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. 
Lancet 
1998;351(suppl 3):5--7 
6
 Buchacz K, Patel P, Taylor M, et al. Syphilis increases HIV viral load and decreases CD4 cell 
counts in HIV-infected patients with new syphilis infections. AIDS. 2004 Oct 21;18(15):2075-9 
7
 DT Fleming and JN Wasserheit, From epidemiological synergy to public health policy and 
practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV-
infection, Sex Transm Infect75 (1999), pp. 3–17. 
8 CDC. Recommendations and Reports: “Incorporating HIV Prevention into the Medical Care of 
Persons Living with HIV”. July 18, 2003/52(RR12);1-24. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.3: Pneumococcal vaccination  
Description:  Percentage of patients
1
 with HIV infection who have received a pneumococcal 
vaccination within the last 5 years.  
Numerator:  
Number of HIV-infected patients who have received a pneumococcal 
vaccination within the last 5 years.  
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
2 
at least twice in the measurement year. 
Patient 
Exclusion: 
1. Patients with documented refusal of pneumococcal vaccine. 
2. Patients with hypersensitivity to pneumococcal vaccine or its 
components. 
3. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, is there documentation in the chart that the patient received 
the pneumococcal vaccine within the past five years? (Y/N) 
b. Includes dated records (e.g., personal, school, physician, or 
immunization registry) as evidence of vaccination, or 
documentation of administration of pneumococcal vaccine in 
medical record in past five years 
Data Sources:  
• Electronic Medical Record/Electronic Health Record 
• CAREWare, Lab Tracker, or other electronic data base 
• HIVQUAL reports on this measure for grantee under review 
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
National HIVQUAL-US Data:
3
 
 2003 2004 2005 
Top 10% 97.7% 95.8% 97.5% 
Top 25% 92.4% 90.1% 93.0% 
*from HAB data base  
Outcome 
Measures for 
Consideration 
o Incidence of pneumococcal infection in clinical population 
Basis for Selection:  
Bacterial pneumonia is a common cause of HIV-1 related morbidity. Incidence of 
approximately 100 cases per 1,000 HIV-1 infected persons per year have been reported, a rate 
much higher than in the non-infected population. The most consistent predictor of bacterial 
infections is CD4 cell count.
4 
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U.S. Public Health Guidelines:  
“Adults and adolescents who have a CD4+ T-lymphocyte count of > 200 cells/uL should be 
administered a single does of 23-valent polysaccharide pneumococcal vaccine (PPV) if they 
have not received this vaccine during the previous five years (BII)”. Revaccination can be 
considered for patients who were initially immunized when their CD4+ T-lymphocyte counts 
were < 200 cells/uL in response to ART (CIII).
5 
“If earlier vaccination status is unknown, patients in this group [immunocompromised, 
including HIV] should be administered pneumococcal vaccine.”6 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.
 
3 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf. 
4
 Centers for Disease Control and Prevention. Treating opportunistic infections among HIV-
infected adults and adolescents: recommendations from CDC, the National Institutes of Health, 
and the HIV Medicine Association/Infectious Diseases Society of America. MMWR 
2004;53(No. RR-15). 
5
 Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from 
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR. April 10,, 2009,58. 
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4. 
6
 Centers for Disease Control and Prevention.  Prevention of Pneumococcal Disease:  
Recommendations of the Advisory Committee on Immunization Practices (ACIP) – MMWR 
April 4, 1997, Vol 46, No. RR-8. [Update for cochlear implants] MMWR August 8, 2003 
52(31) [Update for Adults for PPSV23] MMWR September 2, 2010, 59(34) [for Children and 
high risk adolescents to 18] MMWR December 10, 2010, 59; pp 13 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.4:  Influenza vaccination 
Description: Percentage of HIV-infected patients
1
 who received influenza vaccination within 
the measurement year
2
 
Numerator:  
Number of HIV-infected patients who received influenza vaccination within 
the measurement year. 
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
3 
at least twice in the measurement year 
Patient 
Exclusions: 
1. Patient refusal of influenza vaccine documented in the chart. 
2. Hypersensitivity to influenza vaccine or allergy to its components 
including thimerosal, chicken protein, and egg protein.  
3. Previous diagnosis of Guillain-Barre Syndrome.  
4. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-infected? (Y/N) 
2. If yes, is there documentation in the chart that the patient received 
influenza vaccine in the past 12 months? (Y/N) 
a. Includes dated records (e.g., personal, school, physician, or 
immunization registry) as evidence of vaccination, or 
documentation of administration of Influenza vaccine in medical 
record in measurement year 
Data Sources:  
• Electronic Medical Record/Electronic Health Record 
• CAREWare, Lab Tracker, or other electronic data base 
• HIVQUAL reports on this measure for grantee under review 
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
None available at this time 
Outcome 
Measures for 
Consideration 
o Mortality rates from influenza and pneumonia in the clinical 
population 
Basis for Selection:  
Influenza viruses cause disease among all age groups. While rates of infection are highest among 
children, rates of serious illness and death are highest among persons aged > 65 years, children 
less than two years, and persons of any age who have medical conditions that place them at 
increased risk for complications of influenza, including HIV.
4
 
Influenza vaccination is the primary method for preventing influenza and its severe 
complications.
4
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Vaccination has been demonstrated to produce substantial antibody titers against influenza 
among vaccinated HIV-infected persons who have minimal AIDS-related symptoms and high 
CD4+ T-lymphocyte cell counts.
3
 
U.S. Public Health Guidelines:  
“As indicated in this report from the Advisory Committee on Immunization Practices (ACIP), 
annual 
influenza vaccination is now recommended for….adults and children who have required regular 
medical 
follow-up or hospitalization during the preceding year because of …immunodeficiency 
(including…human immunodeficiency virus).”
4
 
“Because influenza can result in serious illness and because vaccination with inactivated 
influenza vaccine might result in the production of protective antibody titers, vaccination might 
benefit HIV-infected persons, including HIV-infected pregnant women. Therefore, influenza 
vaccination is recommended.” 
4
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 Due to the unique nature of this measure and Influenza season/vaccine administration, the 
measurement period runs from April 1-March 31 
3
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP. 
4 
Centers for Disease Control and Prevention. Prevention and Control of Influenza: 
Recommendations from the Advisory committee on Immunization Practices (ACIP). 
MMWR2011; 60(33); pp 1128-1132 2010; 59(rr08); pp 1-62 59(31); pp 989-992. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.5:  Hepatitis B screening 
Description:  Percentage of patients
1
 for whom Hepatitis B screening was performed at least 
once since the diagnosis of HIV-infection. 
Numerator:  
Number of HIV-infected patients who have documentation of Hepatitis B 
status
2
 since HIV diagnosis or initiation of care with provider. 
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
3
 at least twice in the measurement year 
Patient 
Exclusions: 
1. Patient refusal of test. 
2. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, is their documentation of Hepatitis B serologic status in the 
medical record? (Y/N) 
Data Sources:  
o Electronic Medical Record/Electronic Health Record 
o CAREWare, Lab Tracker, or other electronic data base 
o Medical record data abstraction by grantee of a sample of records.  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
None available at this time. 
Outcome 
Measures for 
Consideration 
o Incidence of Hepatitis B in clinic population 
o Hepatitis B-related morbidity and mortality in the clinic population 
Basis for Selection:  
Hepatitis B virus (HBV) is the leading cause of chronic liver disease worldwide. In developed 
countries, HBV is transmitted primarily through sexual contact and injection-drug use. Even 
though risk factors are similar, HBV is transmitted more efficiently than HIV-1. Although up to 
90% of HIV-1–infected persons have at least one serum marker of previous exposure to HBV, 
only approximately 10% have chronic Hepatitis B, as evidenced by the detection of Hepatitis B 
surface antigen (HBsAg) in the serum persisting for a minimum of six months.
4
 
HIV-1 infection is associated with an increased risk for the development of chronic Hepatitis B 
after HBV exposure. Limited data indicate that co-infected patients with chronic Hepatitis B 
infection have higher HBV DNA levels and are more likely to have detectable Hepatitis B e 
antigen (HBeAg), accelerated loss of protective hepatitis B surface antibody (anti-HBs), and 
increased risk for liver-related mortality and morbidity.
4 
Co-infection with HIV and HBV can complicate the care and treatment of HIV, and guide the 
selection of medications for ART.  
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U.S. Public Health Guidelines:  
“It is not clear that treatment of hepatitis B virus (HBV) improves the course of HIV, nor is there 
evidence that treatment of HIV alters the course of HBV. However several liver-associated 
complications that are ascribed to flares in HBV activity or toxicity of antiretroviral agents can 
affect the treatment of HIV in patients with HBV co-infection. Therefore, providers should know 
the HBV status of all patients with HIV. This also will guide the choice of medications for HIV 
treatment in the context of any possible HBV treatment. For patients who are HBV negative, 
prophylaxis is recommended. This consists [of] 3 doses of vaccine for “all susceptible patients 
(i.e., antihepatitis B core antigen-negative).”
4,5  
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Serologic tests to evaluate for Hepatitis B immunity and chronic Hepatitis B include: 
o Hep B Surface Antigen (+/-)  
o Hep B Surface Antibody (+/-) 
o Additional markers:  Hep B Core Antibody (IgG or IgM), Hep B e Antigen 
3
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP. 
 
4 
Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from 
CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR. March 24, 2009. Volume 58. 
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4. 
5
 Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of 
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human 
Services.October 14, 2011. Available at 
http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.6: Substance use assessment   
Description:  Percentage of patients
1
 with HIV infection who have been assessed for substance 
use (alcohol and illicit substances) in the measurement year. 
Numerator:  
Number of patients with HIV infection who were assessed for substance use
2
 
within the measurement year. 
Denominator:  
Number of patients with HIV-infection who had a medical visit with a 
provider with prescribing privileges
3
 at least twice in the measurement year 
Patient 
Exclusions: 
1. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, was the patient assessed for substance use during the 
reporting period with documentation in medical record? (Y/N) 
Data Sources:  
o Electronic Medical Record/Electronic Health Record 
o CAREWare, Lab Tracker, or other electronic data base. 
o HIVQUAL reports on this measure for grantee under review 
o Medical record data abstraction by grantee of a sample of records. 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
IHI Goal: 90%
4,5
 
National HIVQUAL-US Performance Data:
4
 
 2003 2004 2005 
Top 10% 100% 100% 100% 
Top 25% 92.3% 100% 100% 
Median* 74.4% 86.4% 92.7% 
*from HAB data base  
Outcome 
Measures for 
Consideration 
o Substance use-related mortality rates 
o Rate of substance use-related hospitalizations 
o Rate of substance use referrals 
Basis for Selection:  
Patients living with HIV-infection must often cope with multiple social, psychiatric, and medical 
issues. It is important to identify co-morbid illness such as substance use, which may complicate 
ongoing HIV treatment. 
U.S. Public Health Guidelines:  
“The chronic and relapsing nature of substance abuse as a biologic and medical disease, 
compounded by the high rate of mental illness, additionally complicates the relationship between 
health care workers and IDU. The first step in provision of care and treatment for these 
individuals is the recognition of the existence of a substance abuse problem. Whereas this is 
often open and obvious, patients may hide such behaviors from clinicians. Assessment of the 
patient for the presence of substance abuse should be part of routine medical history taking and 
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should be done in a clinical, straightforward, and nonjudgmental manner”
6 
 
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 Substance abuse assessment: prior history of substance use and abuse, prior substance abuse 
treatment, current use/abuse of substances.  If patient has no history of substance abuse, annual 
monitoring for changes in substance use patterns is indicated.  
3
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
4 IHI Measure reads, “Percent of Patients/Patients Assessed for Substance Use and/or Tobacco 
Use in the Past 12 Months.” 
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/PercentofPatientsPatien
tsAssessedforSubstanceUseandorTobaccoUseinthePast12Months.htm. 
5 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf. 
6 
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 
October 14, 2011http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.7: Mental health assessment   
Description:  Percentage of patients
1
 with HIV infection who have had a mental health 
assessment in the measurement year. 
Numerator:  
Number of HIV-infected patients who received a mental health assessment
2
 in 
the measurement year. 
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
3
 at least twice in the measurement year. 
Patient 
Exclusions: 
1. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N)  
a. If yes, did the patient receive a mental health assessment during 
the reporting period? (Y/N) 
Data Sources:  
o Electronic Medical Record/Electronic Health Record 
o CAREWare, Lab Tracker, or other electronic data base. 
o HIVQUAL reports on this measure for grantee under review 
o Medical record data abstraction by grantee of a sample of records. 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
National HIVQUAL-US Data:
4
 
 2003 2004 2005 
Top 10% 100% 100% 80.6% 
Top 25% 93.0% 89.5% 35.1% 
Median* 72.9% 66.7% 2.2% 
*from HAB data base  
Outcome 
Measures for 
Consideration 
o Rate of mental health referrals 
o Mental health-related hospitalizations 
o Rate of suicide in the clinic population 
o Rate of mental health disorders being treated in the clinic population 
Basis for Selection:  
Patients living with HIV-infection must often cope with multiple social, psychiatric, and medical 
issues. Mental health is an important predictor of ART adherence, and therefore may play a 
substantial role in a patient’s ability to attain viral suppression on HIV medication.5 
U.S. Public Health Guidelines:  
“Patients living with HIV-infection must often cope with multiple social, psychiatric, and 
medical 
issues. Thus, the (initial) evaluation should also include assessment of substance abuse, 
economic factors, social support, mental illness, co-morbidities, and other factors that are known 
to impair the ability to adhere to treatment and alter outcomes. Once evaluated, these factors 
should be managed accordingly."
6
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References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2
 Mental health screen: documentation of prior mental illness, prior treatment of mental illness, 
documentation of any current mental health symptoms. If patient has no history of prior mental 
illness, annual monitoring for symptoms of mental illness (i.e. depression/anxiety) is indicated. 
3
 A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP. 
 
4 
http://www.hivguidelines.org/admin/files/qoc/hivqual/proj%20info/HQNatlAggScrs3Yrs.pdf. 
The Mental Health/Substance Use Subcommittee of the National HIVQUAL Clinical Advisory 
Committee include the following components for an annual Mental Health Screening for people 
with HIV: Cognitive function assessment, including mental status; Depression screening; 
Anxiety screening; Sleeping habits assessment; Appetite assessment; Domestic violence 
screening; Post Traumatic Stress Disorder screening; Psychiatric history (optional); 
Psychosocial assessment (optional) 
5
 Mellins CA, Havens JF, McDonnell C, et. al  AIDS Care. 2009 Feb;21(2):168-77. 
6
 
 
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents 
October 14, 2011Available at http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. 
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.8: Hepatitis B vaccination 
Description:  Percentage of patients
1
 with HIV infection who completed the vaccination series 
for Hepatitis B.  
Numerator:  
Number of HIV-infected patients with documentation of having ever 
completed the vaccination series for Hepatitis B
2,3
. 
Denominator:  
Number of HIV-infected patients who had a medical visit with a provider 
with prescribing privileges
4 
at least twice in the measurement year  
Patient 
Exclusions:  
1. Patients newly enrolled in care during the last 3 months of the 
measurement year.  
2. Patients with evidence of current HBV infection (Hep B Surface 
Antigen, Hep B e Antigen, Hep B e Antibody, or Hep B DNA).  
3. Patients with evidence of past HBV immunity (Hep B Surface 
Antibody). 
4. Patients with documented refusal of Hepatitis B vaccine in medical 
record. 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, does the patient have documentation of Hepatitis B 
immunity or HBV-infection? (Y/N)  
i. If no, is there documentation that the patient has completed the 
vaccine series for Hepatitis B?(Y/N) 
ii. Documentation includes dated records (e.g., personal, school, 
physician, or immunization registry) as evidence of 
vaccination, or documentation of administration of vaccine 
dose(s) in medical record, or combination of outside records 
and medical records to achieve three doses of vaccine 
Data Sources:  
• Electronic Medical Record/Electronic Health Record  
• CAREWare, Lab Tracker, or other electronic data base  
• Medical record data abstraction by grantee of a sample of records  
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
Published data from the HIV Outpatient Study (HOPS) reports 17% of 
patients with HIV-infection who were eligible for vaccination received at 
least three doses of vaccine.
5 
 
“Hepatitis B vaccination coverage among adults at high risk…[was] 45% in 
2004.”
6
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Outcome 
Measures for 
Consideration:  
 
o Incidence of Hepatitis B infection in the clinic population  
 
Basis for Selection:  
HBV is the leading cause of chronic liver disease worldwide. In developed countries, HBV is 
transmitted primarily through sexual contact and injection-drug use. Even though risk factors are 
similar, HBV is transmitted more efficiently than HIV-1. Although up to 90% of HIV-1–infected 
persons have at least one serum marker of previous exposure to HBV, only approximately 10% 
have chronic Hepatitis B, as evidenced by the detection of HBsAg in the serum persisting for a 
minimum of six months.
3 
 
HIV-1 infection is associated with an increased risk for the development of chronic Hepatitis B 
after HBV exposure. Limited data indicate that co-infected patients with chronic Hepatitis B 
infection have higher HBV DNA levels and are more likely to have detectable HBeAg, 
accelerated loss of anti-HBs, and an increased risk for liver-related mortality and morbidity.
3,7 
 
There is a protective antibody response in approximately 30% to 55% of healthy adults aged ≤40 
years after the first dose of vaccine. After age 40, the proportion of persons with a protective 
antibody response after a three-dose vaccination regimen declines. In addition to age, other host 
factors (e.g., smoking, obesity, genetic factors, and immune suppression) contribute to decreased 
vaccine response. Response to Hepatitis B vaccination also is reduced in other immune-
compromised persons (e.g., HIV-infected persons, hematopoietic stem-cell transplant recipients, 
and patients undergoing chemotherapy).  
Measure reflects important aspect of care that impacts HIV-related morbidity and focuses on 
treatment decisions that affect a sizable population. Measure has a strong evidence base 
supporting its use. 
U.S. Public Health Guidelines:  
“Several liver-associated complications that are ascribed to flares in HBV activity or toxicity of 
antiretroviral agents can affect the treatment of HIV in patients with HBV co-infection. 
Therefore, providers should know the HBV status of all patients with HIV. For patients who are 
HBV negative, prophylaxis is recommended. This consists [of] 3 doses of vaccine for “all 
susceptible patients (i.e., antihepatitis B core antigen-negative).”
3
  
References/Notes:  
1
“Patients” include all patients aged 13 years or older. 
2 
Patients in the middle of the vaccination series on 12/31/x would not be captured in the 
numerator in year x. They would, if the series was completed on schedule, be captured in year 
x+1.  
3
 Centers for Disease Control and Prevention. Guidelines for Prevention and Treatment of 
Opportunistic Infections in HIV-Infected Adults and Adolescents —Recommendations from 
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CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious 
Diseases Society of America. MMWR. March 24, 2009. Volume 58. 
http://www.aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=
Off&GuidelineID=211&ClassID=4. 
4
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
5 
Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD; HIV 
Outpatient Study (HOPS) Investigators. Hepatitis A and B vaccination practices for ambulatory 
patients infected with HIV. Clinical Infectious Diseases. 2004 May 15;38(10):1478-84. 
(http://www.journals.uchicago.edu/CID/journal/issues/v38n10/32448/32448.web.pdf)  
6 
Centers for Disease Control and Prevention. Hepatitis B Vaccination Coverage Among Adults 
—United States, 2004. MMWR 2006;55:509-11 
(http://www.cdc.gov/mmwr/PDF/wk/mm5518.pdf)  
7 
Panel on Antiretroviral Guidelines for Adult and Adolescents. Guidelines for the use of 
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human 
Services.October 14, 2011. Available at 
http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.  
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part A 
 
Performance Measure 2.9: Tobacco cessation counseling   
Description:  Percentage of patients
1
 with HIV infection who received tobacco cessation 
counseling within the measurement year. 
Numerator:  
Number of HIV-infected patients who received tobacco cessation counseling 
within the measurement year. 
Denominator:  
Number of HIV-infected patients who: 
• Used tobacco products within the measurement year, and 
• had a medical visit with a provider with prescribing privileges2 twice 
within the measurement year 
Patient 
Exclusions: 
1. Patients who deny tobacco use throughout the measurement year. 
2. Patients newly enrolled in care during last three months of the 
measurement year.  
 
Data Element:  
1. Is the patient HIV-positive? (Y/N) 
a. If yes, did the patient use tobacco during the reporting period? 
(Y/N) 
i. If yes, did the patient receive tobacco cessation counseling 
documented in the medical record during the reporting period? 
(Y/N) 
Data Sources:  
• Electronic Medical Record/Electronic Health Record 
• CAREWare, Lab Tracker, or other electronic data base 
• HIVQUAL reports on this measure for grantee under review 
• Medical record data abstraction by grantee of a sample of records 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison:  
DHSP Benchmark: 90% 
National HIVQUAL-US Data:
3
 
 2003 2004 2005 2006 2007 2009 
Top 10% 100% 100% 100% 100% 100% 100% 
Top 25% 93.3% 97.8% 98.4% 100%   
Median* 75.8% 90.0% 88.2% 91.7% 93.0% 94.1% 
Bottom 10%     45.5% 50.0% 
*from HAB data base  
Outcome 
Measures for 
Consideration 
o Rate of head and neck, and lung cancer 
o Rate of tobacco use in the clinical population 
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Basis for Selection:  
After Kaposi sarcoma and non-Hodgkin lymphoma, lung cancer is the most common cancer 
among HIV-infected individuals, with an incidence rate that is two to three times higher among 
HIV-infected individuals than in the general population.
 4  
.
 
Risk factors associated with an 
increased risk for bacterial pneumonia, include low CD4+ count, injection-drug use, and cigarette 
smoking (454). 
As tobacco use among HIV-infected patients poses significant health risks, tobacco-dependent 
patients should be provided assistance to enroll in smoking cessation programs. Various studies 
have shown that brief interventions by the clinician to encourage tobacco cessation and offer 
substitution programs can decrease smoking rates
5
 and tobacco use.
6
 Cessation reduces the risk 
of incidence or the progression of tobacco-related diseases and increases life expectancy.
7,8,9  
HIV care providers should provide cessation assistance in the form of counseling, pharmaco-
therapy, or referral to cessation programs.   
 
Tobacco use in all forms is the biggest risk factor for oral cancer. Alcohol abuse combined with 
tobacco use increases risk. Clinicians should be alert to the possibility of oral cancer when 
treating patients who use tobacco or alcohol. Patients should be encouraged to not use tobacco 
and to limit alcohol use in order to decrease their risk for oral cancer as well as heart disease, 
stroke, lung cancer, and cirrhosis. 
10
 
 
The U.S. Preventive Services Task Force (USPSTF)
11
  recommends that clinicians ask all adults 
about tobacco use and provide tobacco cessation interventions for those who use tobacco 
Products, (Grade: A Recommendation) and that clinicians ask all pregnant women about tobacco 
use and provide augmented, pregnancy-tailored counseling for those who smoke. (Grade: A 
Recommendation). 
 
This USPSTF recommendation applies to adults 18 years or older and all pregnant women 
regardless of age. The USPSTF plans to issue a separate recommendation statement about 
counseling to prevent tobacco use in non-pregnant adolescents and children. Various primary 
care clinicians may deliver effective interventions. There is a dose-response relationship between 
quite rates and the intensity of counseling (that is, more or longer sessions improve quit rates). 
Quit rates seem to plateau after 90 minutes of total counseling contact time. Helpful components 
of counseling include problem-solving guidance for smokers (to help them develop a plan to quit 
and overcome common barriers to quitting) and the provision of social support as part of 
treatment.  Complementary practices that improve cessation rates include motivational 
interviewing, assessing readiness to change, offering more intensive counseling or referrals, and 
using telephone “quit lines.” Combination therapy with counseling and medications is more 
effective at increasing cessation rates than either component alone. Pharmacotherapy approved 
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by the U.S. Food and Drug Administration and identified as effective for treating tobacco 
dependence in nonpregnant adults includes several forms of nicotine replacement therapy (gum, 
lozenge, transdermal patch, inhaler, and nasal spray), sustained-release bupropion, and 
varenicline.   
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Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part B 
 
Performance Measure 2.10: Medical visits 
Description:  Percentage of HIV-infected patients who are enrolled in outpatient medical 
services who had a medical visit with a provider
1
 with prescribing privileges, i.e. MD, PA, NP, in 
an HIV care setting
2
 two or more times at least 3 months apart in the measurement year. 
Numerator:  
Number of HIV-infected patients who had a medical visit with an HIV 
provider with prescribing privileges, i.e., MD, PA, NP, two or more times at 
least 3 months apart in the measurement year. 
Denominator:  
Number of HIV infected patients who were enrolled in outpatient medical 
services in the measurement year. 
Patient 
Exclusions  
1. Patients newly enrolled in care during the last six months of the 
measurement year. 
2. Patients who were incarcerated during the measurement year. 
3. Patients enrolled in another clinic during the last 6 months of the 
measurement year. 
Data Element:  
2. Is the patient HIV-infected? (Y/N)  
b. If yes, is the patient enrolled in outpatient medical care? (Y/N)  
2. If yes, did the patient have a medical visit with an HIV provider 
two or more times, at least 3 months apart within the 
measurement year?  
Data Sources:  
 
Casewatch 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
  
DHSP Benchmark: 90%  
 
No national benchmarks identified at this time.  
Outcome 
Measures for 
Consideration  
o Rate of patient retention in  care 
o Rate of HIV related hospitalizations in the measurement year 
o Rate of HIV related emergency room visits in the measurement year 
o Rate of opportunistic infections in the measurement year 
o Mortality rates 
 
Basis for Selection:  
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Numerous studies describe the adverse impacts of poor retention in care on patient outcomes. In 
particular, poor retention in care is associated with the following outcomes: decreased likelihood 
of receiving antiretroviral therapy; higher rates of antiretroviral therapy failure; increased HIV 
transmission risk behavior; increased hospitalization rates; and worse survival.  
Patients with greater initial retention in care had the greatest survival over 5 years of follow-up, 
and patients with the worst initial retention had the poorest survival
3
  Treatment guidelines 
recommend to test CD4 at entry into care then follow-up every 3-6 months before ART, every 3-6 
months when on ART, then, in clinically stable patients with suppressed viral load, CD4 count 
can be monitored every 6–12 months.4  For adherent patients with suppressed viral load and 
stable clinical and immunologic status for >2–3 years, some experts may extend the interval for 
HIV RNA monitoring to every 6 months.    
 
All patients who are clinically stable should be monitored at least every 4 months; this includes 
both patients who are receiving ART and those who are not. Visits may require more frequent 
scheduling at entry to care, for management of acute problems, or when starting or changing ART 
regimens.
5
  
 
Patients infected with HIV face a complex array of medical, psychological, and social challenges. 
A strong provider-patient relationship, the assistance of a multidisciplinary care team, and 
frequent office visits are key aspects of care. Through both the specific services they provide and 
their overall approach to patients, clinics can have a substantial impact on the quality of care for 
HIV-infected persons.
6
   
 
Greater experience among primary care physicians in the care of persons with AIDS improves 
survival.
7
  
References/Notes:  
1
A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ARV (antiretroviral) therapy.   
2An HIV care setting is one which received Ryan White Program funding to provide HIV care and has 
a quality management program to monitor the quality of care addressing gaps in quality of HIV care. 
3
Giordano, TP. Perspective: Retention in HIV Care: What the Clinician Needs to Know. Top 
Antivir Med 2011; 19(1):12-16, IAS-USA 
4
 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of 
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human 
Services. October 14, 2011; 1–167. Available at 
http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed [1/23/2012] [p. 6, 
Table 3. Laboratory Monitoring Schedule for Patients Prior to and After Initiation of Antiretroviral 
Therapy (Updated January 10, 2011)]. 
5
New York State Department of Health. Primary care approach to the HIV-infected patient. New 
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Primary care delivery is associated with greater physician experience and improved survival among 
persons with AIDS. J Gen Intern Med. 2003 Feb;18(2):157-8.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ATTACHMENT 5 
 
FEE-FOR-SERVICE AND ADDITIONAL REIMBURSEMENT INCENTIVES GUIDELINES 
 
 
 
 
 
Page 53 
 
 
 
 
Clinical Performance Measures for Adult /Adolescent Patients: 
Supplemental Measures – Part B 
 
Performance Measure 2.11: Viral load suppression < 200 copies/mL when on ART  
Description:  Percentage of HIV-infected patients on ARV therapy 12 weeks or more before last 
viral load and with at least one viral load test, with the last viral load undetectable or <200 
copies/mL in the measurement year. 
Numerator:  
Number of HIV-infected patients on ARV therapy 12 weeks or more before 
last viral load and with at least one viral load test, with the last viral load 
undetectable or < 200 copies/mL in the measurement year.   
Denominator:  
Number of HIV-infected patients on ARV therapy 12 weeks or more before 
last viral load test during the measurement year. 
Patient 
Exclusions:  
1. Patients who are not on ARV therapy. 
2. Patients who do not have a viral load test after 12 weeks or more of 
ARV therapy. 
3. Patients who were incarcerated during the measurement year. 
4. Patients who are newly enrolled in care within the last 3 months of the 
measurement year. 
Data Element:  
1. Is the patient HIV-infected? (Y/N)  
a. If yes, was the patient on ARV therapy at least 12 weeks or more? 
(Y/N) 
i. If yes, did the patient have at least one viral load test? (Y/N) 
1. If yes, was the last viral load test undetectable (‘<’) or <200 
copies/mL (list the date and result).  
Data Sources:  
• Electronic Medical Record/Electronic Health Record  
• Medical/laboratory record data abstraction of a sample of records 
• Health Way LA Data System 
National Goals, 
Targets, or 
Benchmarks 
for 
Comparison  
DHSP Benchmark: 80% 
  
National HIVQUAL-US Data: 
4  
Last viral load undetectable or <200, among patients on ARV therapy >12 
weeks
 
 2009 
Top 10% 94.1% 
Median 78.6% 
Bottom 10% 50% 
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Outcome 
Measures for 
Consideration  
 
o Rate of opportunistic infections in the measurement year  
o Rate of patients with progression to AIDS in the measurement year  
o Mortality rates  
o Virologic suppression rates (In+Care Campaign 
http://www.incarecampaign.org/) 
 
Basis for Selection:  
The plasma HIV RNA (viral load) should be measured in all patients at baseline and on a regular 
basis thereafter, especially in patients who are on treatment as viral load is the most important 
indicator of response to ART
5
.  
Measure reflects important aspects of care that significantly impacts survival and mortality. Data 
collection is currently feasible and measure has a strong evidence base supporting the use.  
Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents:  
Plasma HIV RNA (viral load) should be measured in all patients at baseline and on a regular basis 
thereafter, especially in patients who are on treatment, because viral load is the most important 
indicator of response to antiretroviral therapy (ART) (AI). Analysis of 18 trials that included 
more than 5,000 participants with viral load monitoring showed a significant association between 
a decrease in plasma viremia and improved clinical outcome [1]. Thus, viral load testing serves as 
a surrogate marker for treatment response [2] and can be useful in predicting clinical progression 
[3-4]. The minimal change in viral load considered to be statistically significant (2 standard 
deviations) is a threefold, or a 0.5 log10 copies/mL change.  
Optimal viral suppression is generally defined as a viral load persistently below the level of 
detection (<20–75 copies/mL, depending on the assay used). However, isolated “blips” (viral 
loads transiently detectable at low levels, typically <400 copies/mL) are not uncommon in 
successfully treated patients and are not thought to represent viral replication or to predict 
virologic failure [5]. In addition, low-level positive viral load results (typically <200 copies/mL) 
appear to be more common with some viral load assays than others, and there is no definitive 
evidence that patients with viral loads quantified as <200 copies/mL using these assays are at 
increased risk for virologic failure [6-8]. For the purposes of clinical trials the AIDS Clinical 
Trials Group (ACTG) currently defines virologic failure as a confirmed viral load >200 
copies/mL, which eliminates most cases of apparent viremia caused by blips or assay variability 
[9]. This definition may also be useful in clinical practice. (See Virologic and Immunologic 
Failure.)  
At Initiation or Change in Therapy. Plasma viral load should be measured before initiation of 
therapy and preferably within two to four weeks, and not more than eight weeks, after treatment 
initiation or after treatment modification. Repeat viral load measurement should be performed at 
four to eight week intervals until the level falls below the assay’s limit of detection. 
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In Patients Who Have Viral Suppression but Therapy Was Modified Due to Drug Toxicity 
or Regimen Simplification. Viral load measurement should be performed within two to eight 
weeks after changing therapy. The purpose of viral load monitoring at this point is to confirm 
potency of the new regimen. 
In Patients on a Stable Antiretroviral Regimen. Viral load should be repeated every three to 
four months or as clinically indicated. In adherent patients who have suppressed viral loads for 
more than two to three years and who are at stable clinical and immunological status, some 
clinicians may extend the interval to every six months. 
Monitoring in Patients with Suboptimal Response. In addition to viral load monitoring, a 
number of additional factors should be assessed, such as no adherence, altered pharmacology, or 
drug interactions. Patients who fail to achieve viral suppression should undergo resistance testing 
to aid in the selection of an alternative regimen.
5 
References/Notes:  
Guidelines state that viral load should be measured at least every three to four months depending 
on the stage of the disease. The timeframe of six months was determined by clinical expert 
consensus for the purpose of this measure, but can and should be measured at more frequent 
intervals if needed.  
 
1“Patients” include all patients aged 13 years or older. 
2A “provider with prescribing privileges” is a health care professional who is certified in their 
jurisdiction to prescribe ART, i.e. MD, PA, NP.  
3IHI Measure reads, “Percent of Patients/Patients with a Viral Load Test in the Past 4 Months.”  
http://www.ihi.org/IHI/Topics/HIVAIDS/HIVDiseaseGeneral/Measures/Percentofpatientswithvir
alloadtestinthepast4months.htm.  
4
 HIVQUAL-US Performance Data Report for Ryan White Part C and Part D Funded Programs 
(January 1, 2009 to December 31, 2009)  http://hivqualus.org/index.cfm/22/10039 
5
 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of 
antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human 
Services. October 14, 2011; 1–167. Available at 
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1 
Executive Summary 
The Los Angeles County Department of Health Services’ Office of AIDS Programs and 
Policy (OAPP) directs the overall response to the HIV/AIDS epidemic in the County of 
Los Angeles under the supervision of the Los Angeles County Board of Supervisors. As 
part of its mandate, OAPP manages hundreds of contracts with dozens of agencies to 
provide high quality and cost-effective services to HIV-positive and AIDS-infected 
residents of the County of Los Angeles. Currently, OAPP reimburses its contracted 
outpatient medical clinics through a traditional line-item budget process. The Board of 
Supervisors required OAPP to consider a cost reimbursement methodology that would 
encourage provider accountability and productivity, track utilization more effectively, and 
ensure that providers are utilizing other funding resources, such as Medi-Cal, when 
available. Specifically, the primary medical care services for which the Board of 
Supervisors and OAPP initially intended to develop a fee-for-service (FFS) cost 
reimbursement methodology included: 
 
 Ambulatory/Outpatient Medical Care (AOM)  
 AIDS Drug Assistance Program (ADAP) 
 Drug Resistance Testing 
 Medical Case Management 
 Medical Specialty 
 Nutritional Counseling (Medical Nutritional Therapy) 
 
The study specifications initially requested a service description and rate of 
reimbursement for referrals to Medical Specialty services. Mercer Government Human 
Services Consulting (Mercer) initially produced both a service description and rate of 
reimbursement for this referral service.  However, Public Health Services (PHS) 
standards of care dictate that specialty services must be accessible to the HIV-positive 
client by the primary care provider. The service description developed for HIV/AIDS 
AOM, which considered the PHS requirements, requires referral standards for Medical 
Specialty care.  A separate Medical Specialty service description results in redundant 
requirements. Mercer recommended Medical Specialty services not be funded as a 
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separate service description.  Continuing to fund it separately would result in duplicative 
payment for the same service requirement under two service descriptions. Therefore, this 
report contains no rate recommendations for a separately reimbursed referral to Medical 
Specialty.  
 
OAPP-funded providers have been successful in negotiating locally-derived rates of 
reimbursement that financially create access to these expensive services. Mercer 
recommends that special relationships between primary care and specialty care providers 
not be interrupted. Where there are no special relationships between providers for a 
needed specialty care service, Mercer recommends that rates of reimbursement should not 
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare 
rates (where there is no opportunity for rates derived through special relationships) is an 
established practice in publicly-funded HIV/AIDS primary health care.  
 
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed 
to incorporate drug resistance testing and counseling as a routine component of  
HIV-related primary health care. Therefore, and in interest of maintaining 
recommendations that are current with the PHS standards, Mercer recommended the 
service description for Drug Resistance Testing not be funded as a separate service 
description, but rather be included as a routine requirement within the HIV/AIDS AOM 
Care service description. No rate recommendation for a separately reimbursed Drug 
Resistance Testing service is included in this report. 
 
Further, during the time frame included in this study, Medical Case Management was 
being closely scrutinized by OAPP and the Commission on HIV. Because the 
configuration of services included in Medical Case Management was under review, this 
report contains no rate recommendation for a separately reimbursed Medical Case 
Management service. 
 
The services for which Mercer set rates and developed service descriptions that are 
included in this report include: 
 
 
Outpatient Medical Care Services 
Service Description and Rate Development 
 
 
 Ambulatory/Outpatient Medical Care (AOM)  
 AIDS Drug Assistance Program (ADAP) 
 Nutritional Counseling (Medical Nutritional Therapy) 
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Direct-Care, Staff-Driven Rate Architecture 
Objectives of this study included:  
 
 Review of national and local standards of care 
 Review of the Los Angeles HIV/AIDS Continuum of Care Model included in the 
County of Los Angeles HIV/AIDS Comprehensive Care Plan (August 2002) 
 Survey of other eligible metropolitan areas (EMAs) that have a FFS program  
 Survey of current practice regarding coding of procedures and diagnosis among 
HIV/AIDS outpatient medical clinic providers 
 Analysis of the costs of providing outpatient medical services based on the accepted 
standards of care 
 Preparation of recommendations of FFS rates for the identified outpatient medical 
services 
 Identification of services that are commonly reimbursed by third-party payers 
 Identification of barriers to implementation 
 Recommended guidelines for collection of fees 
 
Based on a competitive bid for Work Order Request No. 6-49 issued in December 2003 
by the Department of the Auditor-Controller of the County of Los Angeles, Mercer was 
engaged to complete this study and meet the aforementioned Board of Supervisors/OAPP 
objectives. 
  
 
 
Mercer’s direct-care, staff-driven rate architecture, tailored to the needs and objectives of 
OAPP, was utilized to complete this study  The four standard cost components included 
in this architecture are direct service staff wage, employment-related expenditures, 
program-related expenditures and general and administrative expenditures. 
 
The rate architecture is a unique approach to reimbursement for health services in that it 
emphasizes “hands on” staff resources provided to the people receiving services and 
varies according to the professional level and quantity of staff time. Three key principles 
serve as the foundation for this system: 
 
1. The most prominent and important variable in the determination of quality and the 
successful adherence to care standards is the direct service staff profile. 
2. All other cost components, which are equally necessary, although less directly 
variable in response to differences in standards of care, can be expressed in 
relationship to direct service staff costs. 
3. If all the compensation components are studied and their relationships to direct 
service staff cost profiles are determined, a standardized rate system can be produced 
by establishing the direct service staff profiles (in accordance with standards of care) 
and then building the total compensation (rate) according to the relationships of the 
other components to the service staff costs. 
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Study Methodology 
 
 
The methodology adopted for this study has been specifically designed and successfully 
tested in numerous environments and jurisdictions to ensure reliability and soundness of 
the rates and a strong linkage to appropriate standards of service. In general, the 
methodology consists of the following steps: 
 
 Review of study methodology with providers 
 Collection and analysis of available information including clinical standards, best 
practices, California and national regulations and codes, provider cost reports, and 
provider general ledgers 
 Development of service descriptions for each service category 
 Completion of provider survey, interviews, and on-site reviews to collect additional 
information 
 Establishment of costs associated with direct service staffing levels 
 Calculation of cost components to be incorporated into the rate architecture including 
employment-related expense, program-related expenses and general and 
administrative expense percentages 
 Synthesis of draft rates based on the combination of the various cost components 
 Completion of budget impact and provider impact analysis 
 Finalization of rates 
 
The rate architecture for AOM is discussed in general below followed by a brief outline 
of the rate development for ADAP and Nutritional Counseling.  Specific rate 
development processes are more fully outlined in Section 4. 
 
For AOM services, the direct-care, staff-driven rate architecture is based on a blend of 
costs associated with physicians, physician assistants and nurse practitioners (referred to 
as physician-like professionals) who provide direct client services.  Costs associated with 
these positions were provided by providers through submission of general ledgers and 
completion of an Encounter and Staff Information Sheet (ESIS) (Appendix F) in late 
January and early February 2008. The direct service wage utilized in the study was 
$147,519.  This was based on provider information reported on the ESIS for physicians, 
physician assistants, and nurse practitioners and then trended forward to the anticipated 
start of the year of implementation.   
 
The remaining cost components – employment-related, program-related and general and 
administrative – were each calculated as a percentage of the direct care physician-like 
average wage based on providers’ general ledger and ESIS information as described 
below. 
 
The employment-related percentage was based on the average of five providers whose 
general ledger data was deemed complete enough for use in the study. Mercer used the 
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Stakeholder Input 
 
most recent general ledger year provided.  For three providers, the time frame was 
March 1, 2006 to February 28, 2007.  For one, the time frame was July 1, 2006 to 
June 30, 2007. For the last provider, it was January 1, 2006 to December 31, 2006.  
Mercer totaled the dollars from all providers in the employment-related category and 
divided by the total dollars for all providers for direct care professionals (physicians, 
physician assistants and nurse practitioners). The employment-related percentage used in 
Mercer’s calculation was 42.07% of the direct service staff wage.  
 
The program-related percentage was based on the average of the same five providers’ 
general ledgers’ information and was calculated in the same way as the 
employment-related percentage, i.e., based on the total dollars and not the average of the 
percentages.  The program-related percentage used in Mercer’s calculation was 228.04% 
of the direct service staff wage.  
 
The general and administrative percentage was based on the average of four providers’ 
general ledgers’ information. One provider’s general and administrative expenses were 
2.5 times higher (as a percentage) than the next closest provider and the providers’ 
general and administrative dollars were held out of the calculation.  The general and 
administrative percentage used in Mercer’s calculation was 31.7% of the total, or 
171.79% of the direct service staff wage.  
 
For the ADAP and Nutritional Counseling services, Mercer utilized wage information 
available from the US Department of Labor’s Bureau of Labor Statistics (BLS) for the 
Los Angeles metropolitan area. The remaining cost components – employment-related, 
program-related and general and administrative – were each calculated as a percentage of 
the direct care wage based on a combination of providers’ submission of cost reports, 
BLS information and professional estimates.  
 
 
In April 2004, OAPP and Mercer provided an overview of the scope of the study to 
HIV/AIDS outpatient medical care providers. Virtually all of the currently contracted 
providers had representation at the meeting.   
 
Input on Financial Information 
After the orientation meeting, Mercer conducted a series of nine separate telephone 
interviews with providers of services to gain a better understanding of the financial 
operations of the providers. The interviews provided complementary and anecdotal 
information in order to support the calculations that had been performed to derive cost 
components (employment-related expenditures and program-related expenditures).  
 
Interviewees included two different individuals from AIDS Healthcare Foundation, two 
separate interviews with two different staff from Harbor UCLA Medical Center and two 
staff with Northeast Valley Health Corporation. Also interviewed were The LA Gay and 
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Lesbian Community Center, AltaMed Health Services Corporation and the Rand 
Schrader clinic. There were a series of phone calls with smaller providers that were not 
performed in the depth of those mentioned above. 
 
Subsequent to this provider input, two Mercer staff visited eight provider sites in January 
2007.  The providers were asked to submit general ledgers with specific expenditure 
line-item detail. Nine providers submitted the general ledger information.  The interview 
information and general ledger information were synthesized into an analysis resulting in 
revisions to the rates originally prepared. 
 
The rates were published in a draft report on the OAPP website in October 2007 and an 
all-provider meeting was held on October 31, 2007.  Providers voiced concerns at the 
meeting and were given until mid-January 2008 to submit written comments. 
 
As a result of provider verbal and written input after release of the draft report in late 
October 2007, OAPP again requested recent general ledgers and completion of the ESIS 
to complete the study (see Appendix F) in order to provide Mercer with the most 
up-to-date provider general ledger information and to give providers an opportunity to 
provide actual direct service wages and encounter information.  Nine providers complied 
by providing at least partial information. 
 
Input on Clinical Information  
Two specific tasks in the study related to the clinical delivery of services and necessitated 
extensive provider feedback.  The first task was to assess the current HIV/AIDS 
Continuum of Care Model, County of Los Angeles (and Commission updates for 2003, 
2004).  See Appendix A for the graphic depiction of the approved model.  Mercer staff 
conducted 11 interviews with staff representing the Commission on HIV, the Prevention 
Planning Committee, HIV/AIDS service providers and OAPP. These perspectives figured 
directly in Mercer’s assessment of the HIV/AIDS Continuum of Care Model (Appendix 
B) as adequate, which was ultimately assessed as appropriately challenging and not in 
need of revisions. 
 
The second task related to the delivery of clinical services was to develop service 
descriptions for the services for which rates would be set. To continue evaluating the 
appropriateness and effectiveness of the service descriptions for use in the County of Los 
Angeles, Mercer staff facilitated a focus group on November 8, 2004, with medical 
professionals providing HIV/AIDS services.  The focus group meeting was attended both 
by providers who are and are not currently in the OAPP provider network. Focus group 
participants received the service descriptions in advance, and then were convened for a 
group-wide discussion at OAPP. Because of time restraints, participants were asked to 
submit comments on service descriptions that were not reviewed in this meeting. These 
comments were synthesized and provided to participants prior to a group-wide conference 
call in December 2004, where all final comments were addressed.  A list of provider and 
other stakeholders having input into the study is included in Appendix C. 
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Study Outcomes 
Additionally, at OAPP’s request, a physician not currently in the provider network was 
interviewed in December 2004 regarding his review of the AOM service descriptions. 
 
Lastly, relative to the AOM services description, a Commissioner from the Commission 
on HIV provided written comments.   
 
As a result of the comments from the focus group on the Nutritional Counseling (Medical 
Nutritional Therapy) service description, an OAPP nutrition expert facilitated a review of 
the service description by nine Los Angeles-area registered dietitians. The comments and 
suggestions from these local professionals were also carefully considered and integrated 
into the Nutritional Counseling service description (Medical Nutritional Therapy).  
 
In order to make sure adequate service delivery time frames were set for the enrollment 
services required for the ADAP service description, service providers were interviewed 
by telephone, and the reports of time actually expended, together with the specific 
activities provided, were synthesized and applied to both the service description and rate 
determinations.  
 
OAPP-funded providers of home-based case management services were interviewed to 
make sure the Medical Case Management model would not duplicate these services.  This 
was in response to a concern raised by a focus group participant.  The issue of duplicating 
services was further researched with the OAPP staff and no duplications in service 
requirements were found with the Medical Case Management service description 
included in the rate study. 
 
As noted in the previous section, two Mercer staff visited eight provider sites in January 
2007. The purpose of the interviews was to gather additional and more in-depth 
information related to service provision.  The programmatic inquiry focused on the exact 
nature of clinical services with attention given to the relationship between primary care 
providers and registered nurses, as well as program-related expenditure issues.  
Additional inquiry was made related to the nature of the people served and demographic 
influences on service provision.  The information from the interviews was summarized in 
a report from Mercer titled “Summary of HIV/AIDS Medical Outpatient Services Rate 
Study:  Provider Site Visits” (Appendix D). 
 
Throughout this process, provider input, both clinical and financial, has been sought and 
considered in the development of the rates. 
 
 
 
The outcomes and findings that emerged based on this study are documented in this 
report. 
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Policy Decisions and Recommendations 
Rates were prepared for each service category based on the evaluation of national 
standards and local practice and through the analysis of provider cost reports and general 
ledgers. An impact analysis of these rates on OAPP’s budget, as well as individual 
providers, was completed. The rates developed in accordance with the study (“rate 
architecture”) methodology and recommended by Mercer are presented in the summary 
below: 
 
OUTPATIENT MEDICAL CARE SERVICES 
 
AOM Care  
Services 
ADAP Nutritional Counseling 
(Medical Nutritional Therapy) 
Proposed Rate $375.37* $31.61 
$89.36 
Initial Assessment 
 
$29.79 
Continuing Visit 
  
*The recommended rate includes a “full load” of general and administrative costs.  RWCA funds have 
historically been limited to 10% for general and administrative costs.  If the rate is limited to 10% general 
and administrative costs, the rate would be $284.86.  This is discussed is Section 4. 
 
Policy decisions were made during the course of the study. These included decisions on: 
 
 Whether to fund the referral to a Medical Specialty service as a distinct service.  
Requirements for referral to specialty care are considered standard in HIV/AIDS 
AOM care and, as a result, are included in the AOM service description. Medical 
Specialty services needed by clients that currently are reimbursed separately from 
other services should be made as referrals and specialty providers should seek 
reimbursement as appropriate.  
 Whether to fund the Drug Resistance Testing as a distinct service. Requirements for 
drug resistance testing have been revised by PHS; these services are routinely offered 
within the context of the routine medical management of HIV disease. The costs 
associated with the actual testing for drug resistance will continue to be supported 
through the State of California program; the medical tasks associated with screening 
for drug resistance and for pre- and post-test counseling are routine with the 
expectation that they be completed by the HIV/AIDS AOM care team.  
 Whether Medi-Cal certification should be mandatory. In discussions with OAPP 
senior managerial staff, the importance of maximizing all available financial 
resources was a consistent topic, together with noting the legislative restraints on the 
use of Ryan White CARE Act (RWCA) funds as a funding source of last resort. 
Mercer concurs with OAPP that Medi-Cal certification for all AOM services 
providers should be required.  All current providers are Medi-Cal certified.  Any new 
providers in the network should have Medi-Cal certification as a condition of 
admission into the network.   
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With regard to these specific policy decisions, Mercer makes the following 
recommendations: 
 
Medical Specialty 
The service description for referral to Medical Specialty services initially addressed the 
primary care provider’s assessment for the need for specialty care and the actual referral 
process. The service description, and therefore the corresponding rate of reimbursement, 
does not address the actual specialty care itself. OAPP will need to continue to fund the 
costs for medical specialty services outside of the rate study’s rates.   
 
Mercer recommends this service description no longer be funded as a distinct and 
separate service category. Referral to medical specialty services is commonplace in the 
medical management of HIV disease. The current standard of care and PHS guidelines 
fully integrate the assessment for the need for specialty care, as well as direct focused 
attention to referral tracking and monitoring for the benefit of the client being medically 
managed in an HIV/AIDS primary health care model. This service description was 
redundant with the guidelines for state-of-the-art HIV AOM care. The updated HIV/AIDS 
AOM service description incorporates the PHS guidelines addressing referral to medical 
specialty care. 
 
Drug Resistance Testing 
Because of recent changes in the PHS HIV/AIDS standards of care, Mercer recommends 
this service description no longer be funded as a distinct and separate service category. 
Drug resistance testing was earlier viewed as a highly specialized service but is now 
considered routine within the medical management of HIV disease. Therefore, the new 
expectations associated with drug resistance testing are incorporated as expectations 
within the HIV/AIDS AOM Care service description. 
 
Mercer recommends that the actual costs of the blood screening continue to be absorbed 
by the State of California, Office of AIDS, Resistance Testing Program. The Mercer 
recommendation, therefore, does not assume these lab costs will be absorbed by the 
HIV/AIDS AOM providers contracted through OAPP. The medical tasks relevant to 
client pre- and post-testing counseling and education for drug resistance are now routine 
HIV/AIDS medical management services to be provided by HIV/AIDS practitioners 
contracted through OAPP. 
 
Medical Case Management 
During the time frame included in this study, Medical Case Management was being 
closely scrutinized by OAPP and the Commission on HIV.  Because the configuration of 
services included in Medical Case Management was under review, this report contains no 
rate recommendation for a separately reimbursed Medical Case Management service. 
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Maximizing Medi-Cal Funding 
The use of RWCA funds is restricted for services for which there are no other sources of 
funding. When a client meets the Center for Disease Control and Prevention’s definition 
for a diagnosis of AIDS, the client becomes eligible for disability and thereby for 
HIV/AIDS medical services reimbursed by Medi-Cal. Undocumented individuals are not 
eligible for Medi-Cal services and therefore are eligible and remain dependent on RWCA 
funding for advanced medical management of HIV disease. OAPP may wish to audit a 
sample of medical records to ensure Medi-Cal is being used appropriately and RWCA 
funds are used only for non-Medi-Cal services and/or for non-Medi-Cal eligible clients. 
 
Currently, all providers of AOM care are Medi-Cal certified providers. Any new 
providers in the network should have Medi-Cal certification as a condition of admission 
into the network.  The RWCA (2000, as amended) permits use of funds for agency and 
system of care capacity building.  This use of funds must be prioritized and allocated by 
the local HIV Health Services Planning Council, however. OAPP may wish to work 
collaboratively with the Los Angeles Commission on HIV to consider use of these funds 
to build capacity for maximum results from Medi-Cal billing and collection. 
   
Implementation of Rates: Budget Impact Concerns 
The AOM rate developed considers the full cost related to general and administrative 
expenditures. Historically RWCA funding has been limited to 10%. This limitation, of 
course, would significantly impact the rate. In Mercer calculations, the 10% limitation 
makes a $100 difference in the rate. This issue is discussed more fully in Section 4. 
 
Mercer recognizes that changes to the funding structure may significantly impact 
providers.  For this reason, OAPP may wish to “shadow implement” the rate system.  In 
“shadow implementation”, providers are paid at historical funding levels and data is 
collected regarding what they would have been paid under the FFS system.  In this way, 
OAPP would assess if the budget impact based on historical utilization presented in this 
report was accurate and which providers fall over or under historical funding levels.   
 
If OAPP elects to implement the FFS system using a single rate for all AOM providers, 
Mercer recommends that OAPP should require an actual cash reconciliation no later than 
six months after the contract is initiated, and the rates should be reviewed based on the 
measurement of actual costs and utilization under the new system. 
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2 
Background 
On December 23, 2003, the Department of the Auditor-Controller of the County of Los 
Angeles issued Work Order Request No. 6-49 on behalf of the Department of Health 
Services OAPP. The Work Order Request sought the services of a consulting firm to 
develop appropriate FFS costs reimbursement rates for providing HIV/AIDS outpatient 
medical care services. In late February, 2004, Mercer was engaged to complete the study. 
 
With an approved budget by the Board of Supervisors, OAPP contracts with  
County-operated and private outpatient medical clinics to provide comprehensive primary 
health care to individuals diagnosed with HIV/AIDS. These clinics receive County, State 
and RWCA funds that provide funding of last resort to individuals who meet eligibility 
qualifications and do not qualify for other health insurance programs. RWCA resources 
are prioritized by the Commission on HIV and provide reimbursement for those services 
meeting OAPP contracted goals and standards of care. 
 
Because RWCA funds are funds of last resort, all outpatient HIV/AIDS medical clinic 
contractors must exhaust other sources of funds before billing the County for services. 
These include, but are not limited to, Medicare and Medi-Cal. Providers are required to 
screen and assess clients for other funding source eligibility, such as Medi-Cal, which 
must be utilized to pay for care when the client is eligible.   
 
Currently, OAPP reimburses its contracted outpatient medical clinics through a traditional 
line-item budget process. The Board of Supervisors requested that OAPP consider a FFS 
cost reimbursement methodology that encourages provider accountability and 
productivity, tracks utilization more effectively and ensures that providers are utilizing 
other funding resources, such as Medi-Cal, when available. A drawback of the current 
reimbursement methodology is that there may be a financial disincentive to enrolling 
clients in Medi-Cal, as providers may find line-item reimbursement easier and financially 
advantageous.   
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Through this Work Order approved by the Board of Supervisors, OAPP sought assistance 
in implementing a FFS cost reimbursement methodology to replace the existing 
reimbursement system for HIV/AIDS outpatient medical services. 
 
Objectives of the study included: 
 
 Review of national and local standards of care 
 Review of the Los Angeles HIV/AIDS Continuum of Care Model included in the 
County of Los Angeles HIV/AIDS Comprehensive Care Plan (August 2002) 
 Survey of other EMAs that have a FFS program  
 Survey of current practice regarding coding of procedures and diagnosis among 
HIV/AIDS outpatient medical clinic providers 
 Analysis of the costs of providing outpatient medical services based on the accepted 
standards of care 
 Preparation of recommendations of FFS rates for the identified outpatient medical 
services 
 Identification of services that are commonly reimbursed by third-party payers; 
 Identification of barriers to implementation 
 Recommended guidelines for collection of fees  
 
Specifically, the primary medical care services for which the Board of Supervisors and 
OAPP initially intended to develop a FFS cost reimbursement methodology included: 
 
 AOM  
 ADAP 
 Drug Resistance Testing 
 Medical Case Management 
 Medical Specialty 
 Nutritional Counseling (Medical Nutritional Therapy) 
 
The study specifications initially requested a service description and rate of 
reimbursement for referrals to Medical Specialty services. Mercer initially produced both 
a service description and rate of reimbursement for this referral service. However, PHS 
standards of care dictate that specialty services must accessible to the HIV-positive client 
by the primary care provider. The service description developed for HIV/AIDS AOM, 
which considered the PHS requirements, requires referral standards for Medical Specialty 
care.  A separate Medical Specialty service description results in redundant requirements. 
Mercer recommended Medical Specialty services not be funded as a separate service 
description.  Continuing to fund it separately would result in duplicative payment for the 
same service requirement under two service descriptions. Therefore, this report contains 
no rate recommendations for a separately reimbursed referral to Medical Specialty.  
 
OAPP-funded providers have been successful in negotiating locally-derived rates of 
reimbursement that financially create access to these expensive services. Mercer 
recommends that special relationships between primary care and specialty care providers 
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not be interrupted. Where there are no special relationships between providers for a 
needed specialty care service, Mercer recommends that rates of reimbursement should not 
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare 
rates (where there is no opportunity for rates derived through special relationships) is an 
established practice in publicly-funded HIV/AIDS primary health care.  
 
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed 
to incorporate drug resistance testing and counseling as a routine component of  
HIV-related primary health care. Therefore, and in interest of maintaining 
recommendations that are current with the PHS standards, Mercer recommended the 
service description for Drug Resistance Testing not be funded as a separate service 
description, but rather be included as a routine requirement within the HIV/AIDS AOM 
Care service description. No rate recommendation for a separately reimbursed Drug 
Resistance Testing service is included in this report. 
 
Further, during the time frame included in this study, Medical Case Management was 
being closely scrutinized by OAPP and the Commission on HIV. Because the 
configuration of services included in Medical Case Management was under review, this 
report contains no rate recommendation for a separately reimbursed Medical Case 
Management service. 
 
The services for which Mercer set rates and developed service descriptions that are 
included in this report include: 
 
 
Outpatient Medical Care Services 
Service Description and Rate Development 
 
 
 Ambulatory/Outpatient Medical Care (AOM)  
 AIDS Drug Assistance Program (ADAP) 
 Nutritional Counseling (Medical Nutritional Therapy) 
 
 
Mercer’s direct-care, staff-driven rate architecture is a unique approach to rate 
construction that emphasizes “hands on” staff resources provided to the people receiving 
services and varies according to the professional level and quantity of staff time. Three 
key principles serve as the foundation for this system:  
 
1. The most prominent and important variable in the determination of quality and the 
successful adherence to care standards is the direct service staff profile. 
2. All other cost components, which are equally necessary, although less directly 
variable in response to differences in standards of care, can be expressed in 
relationship to direct service staff costs. 
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3. If all the compensation components are studied and their relationships to direct 
service staff cost profiles are determined, a standardized rate system can be produced 
by establishing the direct service staff profiles (in accordance with standards of care) 
and then building the total compensation (rate) according to the relationships of the 
other components to the service staff costs. 
 
While the direct service staff profile is critical to this rate system, it is not the only cost 
component necessary to create rates. Rather, the direct service staff profile is the most 
prominent in supporting the services descriptions that promote quality care. The clear 
identification of service descriptions that promote quality care for the selected service 
categories was an integral part of this study, since the goal of the County of Los Angeles, 
as well as Mercer, was to develop rates that adequately support the provision of quality 
services, as defined by current regulations and quality care practices. 
 
This report not only provides rates for the outpatient service categories included within 
this study, it also summarizes the methodology, findings, barriers to the implementation 
of the proposed rate system and recommendations to address these barriers. The 
remaining sections of the report are outlined below: 
 
 Section 3: Service Description Development 
− Methodology for AOM, ADAP and Nutritional Counseling (Medical Nutritional 
Therapy) 
− Medical Specialty 
− Drug Resistance Testing 
− Medical Case Management 
− Review of the HIV/AIDS Continuum of Care Model 
 
 Section 4: Rate Development 
− Cost Components 
− Methodology 
− Other EMAs – Rates 
− Future Rate Change Process 
 
 Section 5: Budget Impact Analysis 
− Methodology 
− Budget Impact Results 
 
 Section 6: Third-Party Payer Reimbursement 
− Methodology 
− Findings and Results  
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
15
 
 Section 7: Barriers/Disincentives and Recommendations 
− Exceeding Accepted Standards 
− Maximizing Medi-Cal Funding 
− Medical Specialty, Drug Resistance Testing, and Medical Case Management 
 
 Section 8: Next Steps 
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3 
Service Description Development 
Methodology for AOM, ADAP and Nutritional Counseling (Medical 
Nutritional Therapy) 
Mercer’s methodology for the development of rates that support clinically-appropriate 
outpatient services for people living with HIV/AIDS is based on the documentation of 
clear and accurate standards of care for each service category under study. The 
development of standard service descriptions was the first phase of the study. To 
successfully complete this phase, Mercer adopted the following approach: 
 
Step 1: Exploratory Meetings with OAPP 
Mercer first met with OAPP through face-to-face meetings and telephonic discussions to 
better understand the current standards of care in existing contracts with selected 
providers, as well as to understand the Board of Supervisors’ expectations and OAPP’s 
program requirements for the provision of quality services.  
 
Step 2: Literature and Information Review 
Following these initial discussions, Mercer performed an in-depth review of information 
and literature from multiple sources on standards and protocols of care for outpatient 
HIV/AIDS services. These sources include but are not limited to: 
 
 OAPP Contracts and Standards of Care 
 Commission on HIV Standards of Care 
 California Code of Regulations 
 Mayor’s AIDS Leadership Council, HIV and AIDS in Los Angeles: 21st Century 
Challenges and Approaches, December 2003 
 County of Los Angeles HIV/AIDS Comprehensive Care Plan, August 2002 (and 
Commission updates for 2003, 2004)  
 HIV/AIDS Continuum of Care Model, County of Los Angeles (and Commission 
updates for 2003, 2004, see Appendices A and B) 
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 Other State Resources: Program Guidelines and Standards of Care, and Best Practices 
from the California Department of Public Health, Office of AIDS (particularly, the 
Early Intervention Program model, and guidelines for the ADAP program). 
 National Resources:  the Public Health Service, Department of Health and Human 
Services (DHHS) guidelines for the medical management of HIV infection and other 
issues surrounding HIV infection, Standards of Care published by national health care 
professional associations and Best Practice Recommendations from the AIDS 
Education and Treatment Centers National Resource Center.  
 
Step 3: Development of Service Descriptions 
After reviewing and analyzing these materials, Mercer developed draft service 
descriptions in each of the categories of services selected for this study. Mercer’s primary 
goal in preparing these documents was to ensure that the rates developed for these service 
categories were reflective of the most appropriate standards of care and were adequately 
designed to compensate providers for high quality services.  
 
Step 4: OAPP Review 
Mercer sought feedback from OAPP on the service descriptions. Several iterations were 
developed before the final drafts of the service descriptions were developed.  
 
Step 5: Provider Interviews 
Mercer conducted 11 interviews in September 2004 with staff representing the 
Commission on HIV, the Prevention Planning Committee, HIV/AIDS service providers 
and OAPP. These perspectives figured directly in Mercer’s assessment of the HIV/AIDS 
Continuum of Care Model (Appendix B) as adequate, which was ultimately assessed as 
appropriately challenging and not in need of revisions.  Additionally, these interview 
comments were considered during the revision to the initial draft of the service 
descriptions. 
 
Step 6: Provider Input into Service Descriptions 
Mercer consulted with Los Angeles County HIV/AIDS service providers in order to make 
the service descriptions as appropriate and effective as possible for use in the County of 
Los Angeles. A summarized list of provider and other stakeholder input is included as 
Appendix C.   
 
As noted previously, Mercer conducted 11 interviews in September 2004 with staff 
representing the Commission on HIV, the Prevention Planning Committee, HIV/AIDS 
service providers and OAPP. These interview comments were considered during the 
revision to the initial draft of the service descriptions. 
 
To continue evaluating the appropriateness and effectiveness of the service descriptions 
for use in the County of Los Angeles, Mercer facilitated a November 8, 2004 focus group 
with outpatient care professionals providing HIV/AIDS services. The focus group was 
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attended by both providers who are and are not currently in the OAPP provider network. 
Focus group participants received the service descriptions in advance, and then were 
convened for a group-wide discussion at OAPP. Because of time restraints, participants 
were asked to submit written comments on service descriptions that were not reviewed in 
this meeting. These comments were synthesized and provided to participants prior to a 
group-wide conference call in December 2004 where all final comments were addressed. 
 
All focus group comments and suggestions were carefully reviewed and considered for 
inclusion as revisions to the service descriptions.  
 
In order to have feedback from a physician practicing in the private sector who is not 
currently funded by OAPP. This physician was selected to review the AOM service 
description and feedback was obtained from this physician through telephone interview.  
The physician was selected by OAPP. The comments provided by the physician, 
encouraging Mercer and OAPP to continue with the development of state-of-the-art 
service standards for use in publicly-funded HIV/AIDS medical care, were summarized 
and presented to OAPP in memo format, as well as incorporated into the AOM service 
description.   
 
As a result of the comments from the focus group on the Nutritional Counseling (Medical 
Nutritional Therapy) service description, an OAPP nutrition expert facilitated a review of 
the service description by nine Los Angeles-area registered dietitians. The comments and 
suggestions from these local professionals were also carefully considered and integrated 
into the Nutritional Counseling (Medical Nutritional Therapy) service description.  
 
In order to make sure adequate service delivery time frames were set for the enrollment 
services required for the ADAP service description, service providers were interviewed 
by telephone, and the reports of time actually expended, together with the specific 
activities provided, were synthesized and applied to both the service description and rate 
determinations.  
 
OAPP-funded providers of home-based case management services were interviewed to 
make sure the Medical Case Management model would not duplicate these services. This 
was in response to a concern raised by a focus group participant.  The issue of duplicating 
services was further researched with the OAPP staff and no duplications in service 
requirements were found with the Medical Case Management service description 
included in the rate study. 
 
Step 7: Commission’s Feedback 
Copies of draft services descriptions were provided to the Commission on HIV. One 
Commissioner provided written comments to OAPP staff and these comments were 
forwarded to Mercer. The Commissioner had questions regarding the service definitions 
and their comparison to definitions within Medi-Cal and Medicare, definition of fee 
schedules, the definition of Quality Assurance and concern for additional paperwork that 
may be required of potential clients to qualify for services. These questions are more 
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appropriately addressed through the legislative definitions and requirements attached to 
the RWCA or questions related to OAPP contracting guidelines and contracts. The 
Mercer FFS project does not redefine the RWCA service definitions but rather uses them 
explicitly. This study is not producing a fee schedule but rather specific reimbursement 
rates for specific services.  
 
Step 8: Commission’s Updated Standards of Care 
During the same time period that the Mercer was developing service descriptions for this 
study, the Commission on HIV updated its Standards of Care.  The most recent Standard 
of Care for Medical Outpatient was updated effective January 13, 2006.  It notes that the 
Standard of Care “represents a synthesis of a significant number of published standards 
and research” including a key source document, the draft standard prepared for this study.   
 
Step 9: Update Based on Comparison to Commission’s Updated Standards of 
Care 
OAPP provided a comparative analysis of differences in the Commission’s updated 
Standards of Care in contrast to the service descriptions developed for this study.  The 
service descriptions were revised to ensure compatibility with the Commission’s 
Standards of Care.  
 
Step 10: Finalization of Service Descriptions 
After reviewing feedback stakeholders and reconciling differences identified in the 
Commission’s Standards of Care, Mercer developed final service descriptions.  Copies of 
service descriptions are provided in Appendix E. 
 
Medical Specialty 
The study specifications initially requested a service description and rate of 
reimbursement for referrals to Medical Specialty services. Mercer initially produced both 
a service description and rate of reimbursement for this referral service. However, PHS 
standards of care dictate that specialty services must be accessible to the HIV-positive or 
AIDS-inflected client by the primary care provider. The service description developed for 
HIV/AIDS AOM, which considered the PHS requirements, requires referral standards for 
Medical Specialty care. A separate Medical Specialty service description results in 
redundant requirements. Mercer recommended Medical Specialty services not be funded 
as a separate service description. Continuing to fund it separately would result in 
duplicative payment for the same service requirement under two service descriptions. 
Therefore, this report contains no rate recommendations for a separately reimbursed 
referral to Medical Specialty.  
 
OAPP-funded providers have been successful in negotiating locally-derived rates of 
reimbursement that financially create access to these expensive services. Mercer 
recommends that special relationships between primary care and specialty care providers 
not be interrupted. Where there are no special relationships between providers for a 
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needed specialty care service, Mercer recommends that rates of reimbursement should not 
exceed the Medicare/Medi-Cal established rates. Conceding to the Medicaid/Medicare 
rates (where there is no opportunity for rates derived through special relationships) is an 
established practice in publicly-funded HIV/AIDS primary health care.  
 
Drug Resistance Testing 
Likewise, the PHS HIV/AIDS standards of care for drug resistance testing were changed 
to incorporate drug resistance testing and counseling as a routine component of  
HIV-related primary health care. Therefore, and in interest of maintaining 
recommendations that are current with the PHS standards, Mercer recommended the 
service description for Drug Resistance Testing not be funded as a separate service 
description, but rather be included as a routine requirement within the HIV/AIDS AOM 
Care service description. No rate recommendation for a separately reimbursed Drug 
Resistance Testing service is included in this report. 
 
Medical Case Management 
Mercer worked collaboratively with select OAPP program management staff to identify 
an appropriate model for HIV/AIDS Medical Case Management, taking into 
consideration the Board of Supervisors’ expectations and OAPP’s existing service 
delivery pattern of using clinical nurses to provide care coordination. The Roy Adaptation 
Model for nursing case management was reviewed and mutually found appropriate for 
this service description initially. The service description delineated the following 
requirements for the delivery of Medical Case Management: 
 
 Medical Case Management services are provided by a Registered Nurse (RN) in good 
standing and licensed in California by the State Board of Behavioral Sciences. The 
RN must practice within the scope of practice defined in the California Business and 
Professions Code, Section 2725, RN Scope of Practice (www.rn.ca.gov). 
 
 Medical Case Managers must be certified through the OAPP HIV Case Management 
Certification Program (the OAPP Case Manager Certification Program is currently 
being revised to include training specific to Medical Case Management). 
 
 Medical Case Managers are employed in provider agencies meeting the full 
requirements for HIV/AIDS AOM Care Services. 
 
 Medical Case Management is a process of assessing, planning, coordinating, 
monitoring, and evaluating the medical services required to respond to a client’s 
HIV/AIDS prevention and health care needs. The overall goal of Medical Case 
Management is to facilitate the coordination and sequencing of primary health care 
services in order to achieve optimal health outcomes. 
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 Medical Case Management is a service in the HIV/AIDS Continuum of Care offered 
in response to the growing complexity of HIV prevention and disease management. It 
is also offered in response to the need clients have expressed for expert guidance 
through an ever-increasing complement of services that comprise the comprehensive 
HIV/AIDS Continuum of Care. 
 
 Medical Case Management focuses intentionally on the client’s access, utilization, 
retention and adherence to Primary Health Care Core Services in the HIV/AIDS 
Continuum of Care. These Primary Health Care Core Services are described in the 
County of Los Angeles HIV/AIDS Comprehensive Care Plan (2002), available 
through the OAPP. 
 
 Medical Case Management services are not required as a precondition for receiving 
other services in the HIV/AIDS Continuum of Care, neither are they intended to 
reduce or curtail the use of primary health care services. Rather, Medical Case 
Management services are intended to facilitate the client in obtaining and sustaining 
the best and most appropriate treatment. These services are client-centered and 
provided within an overall philosophy of assisting the client in becoming an effective 
self-manager of his or her own care.  
 
 While the Medical Case Manager focuses on Primary Health Care Core Services, the 
Medical Case Manager also facilitates optimal health outcomes for the HIV-infected 
client, partners and social affiliates and the diverse health care professionals providing 
services in the HIV/AIDS Continuum of Care. The Medical Case Manager facilitates 
optimal health outcomes through advocacy, liaison, and collaboration to achieve 
continuity of care, effective communication and coordination of appropriate 
HIV/AIDS prevention and treatment services. 
 
An initial rate was developed for Medical Case Management based the services 
description modeled on the Roy Adaptation Model. However, during the time frame 
included in this study, Medical Case Management was being closely scrutinized by OAPP 
and the Commission on HIV. The Commission revised its Standard of Care effective for 
Case Management, Medical Services effective May 11, 2006. Because the configuration 
of services included in Medical Case Management was under review, and continues to be 
under review, this report contains no rate recommendation for a separately reimbursed 
Medical Case Management service. 
 
Review of Continuum of Care Model 
A task identified in the Work Order requested a review of the Los Angeles HIV/AIDS 
Continuum of Care Model Strategic Planning Process (1999–2001). In 2001, the new 
HIV/AIDS Continuum of Care Model was jointly approved and adopted by the 
Commission and OAPP. 
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From the beginning, the HIV/AIDS Continuum of Care Model was a bold statement of 
commitment to improving the HIV-related health outcomes for all individuals and 
families at-risk for or infected with the HIV virus, and to reducing the disparities in 
HIV-related health outcomes for racial, ethnic, and social minorities in the County of Los 
Angeles. Moving towards fulfillment of this commitment, planners, providers and OAPP 
staff use the model to focus concretely on how the HIV/AIDS Continuum of Care 
Model’s HIV/AIDS Primary Health Care Core Services will be made available to County 
of Los Angeles citizens who depend on publicly-funded HIV/AIDS services. 
 
The HIV/AIDS Continuum of Care Model pushes beyond the single issue of “access to 
services” to a more complex question of how to assure that clients have appropriate 
access to services, utilize them consistently, are effectively retained in services over time, 
and adhere to medical regimens while receiving HIV/AIDS services. This service 
formula, “Access – Utilization – Retention – Adherence”, underscores a second 
commitment, providing care coordination services for those who need them so that 
improvements in HIV-related health outcomes may, in fact, be achieved. The HIV/AIDS 
Continuum of Care Model is a client-centered and flexible one, with multiple points of 
entry, and while it sets a clear standard by delineating the critical HIV/AIDS service 
components in a state-of-the-art Continuum of Care Model, it does not impose a single set 
of services for any one or all clients who may seek services within this Continuum of 
Care Model.  
 
There is a third commitment evidenced in the HIV/AIDS Continuum of Care Model’s 
design, a commitment to effectively integrate HIV prevention services with care and 
treatment services. HIV prevention services are an integral component of HIV/AIDS 
primary health care core services. Planners, providers and OAPP staff are focusing not 
only on how to seamlessly link the prevention and care service systems, but how to give 
equal weight to HIV prevention in the context of routine and recurring medical care.   
 
In the review conducted by Mercer, providers saw the Model’s attempt at “true 
integration” and its view of “HIV disease as a continuum, clarifying the whole spectrum 
of need” as clear strengths. Challenges to meeting the Continuum of Care Model’s 
expectations included provider training and capacity-building needs, establishing provider 
agreement on meeting the expectations when the service system is already so fully 
developed and assistance in developing the provider partnerships needed to offer any one 
client the full range of possible services. 
 
The features of the HIV/AIDS Continuum of Care Model are concretely represented in 
the service descriptions. Use of the service descriptions with updates over time will likely 
assist providers in more closely approximating the expectations described in the 
HIV/AIDS Continuum of Care Model. However, providers will need direct support to 
enhance their abilities to fully implement this Model.  
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Based on Mercer’s review of the national HIV/AIDS standards of care and on the 
commitment of the providers to implement the HIV/AIDS Continuum of Care Model, 
Mercer recommends that the Board of Supervisors support OAPP and its partners in 
planning and system development based on the Continuum of Care Model as currently 
defined.  
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4 
Rate Development 
The second phase of the project involved the development of FFS rates for services 
included in the study using the Mercer’s direct-Care, staff-driven rate architecture. To 
understand this rate methodology, an understanding of the various cost components is 
critical. The cost components, and a description of each, are presented below. 
 
Cost Components 
There are four standard cost components that are assumed to be common to all social and 
medical services. These include: 
 
1. Direct Service Staff Wage  
2. Employment-Related Expenditures  
3. Program-Related Expenditures  
4. General and Administrative Expenditures 
 
Direct Service Staff Wage 
The definition of direct service staff wage consists of the following two elements: 
 
1. The staff must be people who are performing tasks in the furtherance of the objectives 
of the service. In other words, they must be doing what they are doing in order to 
meet some objective defined in the service. They are not considered direct service 
staff solely by their qualifications. 
2. The person who is receiving the service and who is expected to benefit from it must 
be present, most of the time. “Most” is defined as 90% or more. 
 
There is a need to be specific in the definition of direct service staff because service 
descriptions often describe minimal amounts of time that should be spent in any given 
period. In some cases, this may be provided by a variety of qualifying staff. Equally, there 
may be staff associated with the program that have the same qualifications as direct 
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service staff but who do not perform tasks related to the service and so would not satisfy 
the minimum requirements of the service standard. 
 
Employment-Related Expenditures 
Simply stated, employment-related expenditures are all the benefits received by 
employees of the service agency. Benefits generally fall into two categories:  
 
1. Discretionary Benefits: those benefits that employers may elect to provide but are not 
mandated to do so by any governmental authority.  
2. Non-Discretionary Benefits: those benefits that are mandated by a governmental 
authority. 
 
Program-Related Expenditures 
Program-related expenditures are all the expenditures that support the objectives and the 
provision of the service, but cannot be tied to any particular person receiving the service. 
For this reason, program-related expenditures are considered “indirect” rather than 
general and administrative expenditures. Supervision of direct service staff, staff who do 
not spend 90% of time with clients but who work with clients, supplies related to the 
service, consultative services to general staff, client transportation and staff 
training/education are all examples of program-related expenditures. It is important to 
note that many factors influence the inclusion or exclusion of cost types in this category, 
but the two most prominent are the service descriptions and the funding source 
regulations.  
 
General and Administrative Expenditures 
General and administrative expenditures are the costs of being in business. General and 
administrative expenditures have nothing directly to do with the type of program, the type 
of service, or the product offered. These expenditures are costs that are as common to 
automotive manufacturing firms as they are to pizza parlors or as common to doctors’ 
practices as they are to amusement parks. General and administrative expenses include 
administrative salaries, insurance, travel and entertainment, office expenses, lease or 
rental costs for office space, depreciation, property insurance, equipment rental and other 
interests. In most instances, the categories of costs included in this component are similar 
in both non-profit and for-profit organizations. 
 
Methodology 
Mercer’s methodology for rate development is based on reported costs, appropriate 
clinical practices, and established service descriptions. This methodology has been 
successfully used and replicated in multiple states for a variety of health and human 
services. The process chart on the following page provides an overview of rate 
development, and each step is discussed in detail in subsequent sections of this report. 
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Rate Development Methodology – A Process Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determine the Cost Categories 
 
Determine General and Administrative 
Expenditure Percentage 
 
Gather the Financial Data 
Organize and Analyze Data 
Establish Direct Service Staff  
Wage Profile 
Determine Employment-Related 
Expenditures Percentage 
 
Determine Program-Related 
Expenditure Percentage 
Synthesize Components into  
the Rate 
Review Service 
Descriptions 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
27
The following narrative explains each step of the rate development with a description of 
the processes and actions taken by Mercer to successfully complete each of these steps. 
 
Step 1: Determine the Cost Categories 
The first step in developing standardized rates for services was to study each service 
description in great detail to determine if the four cost categories described previously 
will be sufficient, or if additional categories would be needed to address program and 
provider-specific issues. 
 
Some components will vary because of differences in the way services are described. For 
example, in some institutional settings, nursing care is considered an integral part of the 
services that each resident will need and levels of nursing are expressed as requirements 
of the service description. In this case, a nurse would be considered a Direct Service Staff 
because the two parts of the definition of Direct Service Staff (furtherance of objectives 
and 90% client contact) have been met. In other settings, nursing care may or may not 
occur, or it may be of a consultative nature to the facility itself and not specific to any 
particular client. In this case, the cost of the nurse would be a part of program-related 
expenditures. 
 
For this study, for all services (AOM, ADAP and Nutritional Counseling) Mercer used 
the component categories described earlier, including: 
 
 Direct Service Staff Wage  
 Employment-Related Expenditures  
 Program-Related Expenditures  
 General and Administrative Expenditures 
 
Step 2: Gather the Financial Data 
The next step undertaken by Mercer was to determine the nature, quantity and quality of 
existing expenditure data for providers.  The underlying questions that were addressed as 
part of this exercise were as follows (in this order):  
 
1. What are the line-item costs related to the services? 
2. Are the costs reported in enough detail so as to be identifiable in the categorizations 
determined necessary in Step 1? 
3. If not, in what manner will the information be gathered? 
4. Is the available data current? 
5. Is the available data reliable? 
6. Are the line-items somewhat consistent between providers of the same service? 
 
Data must meet the following conditions to be useable in rate development: 
 
 The data must be available (reports must exist) 
 The data should be current 
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 The data should be accurate and objectively supportable 
 The data should be in enough detail so as to allow for categorization, according to the 
determined categories necessary 
 Line-items within the data should be consistent between providers of the same service 
 
With regard to AOM Services, Mercer found that the general ledgers and ESIS provided 
by providers in late January/early February 2008, in general, met these conditions. For 
ADAP and Nutritional Counseling, the cost reports provided in the first year of the study 
were helpful but did not meet two of the criteria above.   The cost report information was 
not in enough detail to allow for categorization and line-items within the data were not 
consistent between providers.  For this reason, Mercer relied much more heavily on BLS 
data for the Los Angeles metropolitan area to develop the rate for ADAP and Nutritional 
Counseling as described in subsequent steps. 
 
Step 3: Organize and Analyze Data 
In this step, for AOM services, provider general ledger and ESIS information was 
organized so that the cost components could be compared in a consistent manner across 
providers. This organization of the information allowed for the successful completion of 
the component analysis. The final result of the component analysis was an understanding 
of each of the cost components’ relationship to Direct Service Staff costs for each of the 
service categories analyzed. These components were expressed in terms of a relationship, 
i.e., as a percentage. For ADAP and Nutritional Counseling services, cost report data and 
BLS information was organized and analyzed for the completion of the component 
analysis. 
 
Step 4: Review Standards 
In the fourth step of the rate development, Mercer reviewed the service descriptions 
prepared in the first phase of the study to establish the proper type and quantity of Direct 
Service Staffing levels and the general profiles of the Direct Service Staff specific to the 
service description. This information formed the cornerstone of the completed rates. 
 
Step 5: Establish Direct Service Staff Wage Profile 
Mercer then proceeded to establish the wages associated with the staff described in the 
service descriptions as Direct Service Staff. Depending on the unique nature of the 
service being studied, this can be performed in a number of ways. Wage and benefit 
studies can be performed, analysis of provider data can be completed, research into 
objective sources of wage and benefit information such as BLS can be done, prevailing 
market wages currently paid by providers in the area can be reviewed, and finally, 
administrative discretion may be used to set wage levels as a matter of policy.  
 
For this particular study, Mercer used the analysis of the provider general ledger data to 
establish direct service staff wage levels for physician-like staff for AOM services.  The 
average physician-like costs from the usable provider general ledger data was 
$147,519.85. Mercer first trended individual providers’ average physician-like wage at 
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4% annually from the midpoint of the most recent year of the reported expenditures on 
the ESIS to the midpoint of the year of the anticipated start date, March 1, 2009, and then 
averaged all providers’ physician-like wages. 
 
For ADAP and Nutritional Counseling services, Mercer utilized data from BLS wage 
information. For ADAP, Mercer selected the occupation called Medical Records and 
Health Information Technician (code 29-2071) for the Los Angeles metropolitan area.  
The annual wage identified in the most recent BLS report was trended at a 4% increase 
per year from the midpoint of the year of the available data to the midpoint of the year of 
the anticipated start date, March 1, 2009.  The annual direct service staff wage level for 
an ADAP worker for purposes of the rate development was $46,110.91. 
 
For Nutritional Counseling, Mercer selected the occupation called Dieticians and 
Nutritionists (code 29-1031) for the Los Angeles metropolitan area. The annual wage 
identified in the most recent BLS report was trended at a 4% increase per year from the 
midpoint of the year of the available data to the midpoint of the year of the anticipated 
start date, March 1, 2009. The annual direct service staff wage level for a 
Dietician/Nutritionist for purposes of the rate development was $84,107.39. 
 
Step 6: Determine Employment-Related Expenditures Percentage 
Mercer calculated the employment-related expenditure percentage using provider general 
ledger information for the AOM service. The average employment-related expenditures 
percentage expressed as percentage of direct service staff wage level was 42.07%. The 
employment-related percentage was based on the average of five providers whose general 
ledger data was deemed complete enough for use in the study.  Mercer used the most 
recent general ledger year provided. For three providers, the time frame was 
March 1, 2006 to February 28, 2007. For one, the time frame was July 1, 2006 to June 30, 
2007. For the last provider, it was January 1, 2006 to December 31, 2006. Mercer totaled 
the dollars from all providers in the employment-related category and divided by the total 
dollars for all providers for direct care professionals (physicians, physician assistants and 
nurse practitioners).   
 
For ADAP and Nutritional Counseling, Mercer used historical BLS information, 
considered the rise in trend of benefit costs, and ultimately used 30%. 
 
Step 7: Determine Program-Related Expenditures Percentage 
For the AOM service, Mercer isolated all accounts from information provided in provider 
general ledgers that were identified as program-related. Then the amounts in those cost 
line-items were totaled and compared to direct care staff costs in order to derive a 
percentage (228.04%) that expressed the relationship. The program-related percentage 
was based on the average of the same five providers’ general ledgers’ information and 
was calculated in the same way as the employment-related percentage, i.e., based on the 
total dollars and not the average of the percentages. The program-related percentage used 
in Mercer’s calculation was 228.04% of the direct service staff wage.  
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For the ADAP and Nutritional Counseling services, Mercer used initial analysis from cost 
reports and estimated expenditures related to program-related needs, and ultimately 
utilized 68% for ADAP services and 49% for Nutritional Counseling. 
 
Step 8: Determine General and Administrative Expenditure Percentage 
According to early discussions with OAPP and the Health Resources and Services 
Administration (HRSA), the federal agency responsible for the award, administration, and 
regulation of RWCA funding, OAPP is permitted to compensate provider agencies for 
general and administrative expenditures, but only up to a maximum of 10% across all 
provider agencies. In other words, the general and administrative percentage funding 
cannot exceed 10% for the entire system. It is permitted to compensate individual 
provider agencies at different general and administrative percentage levels provided that 
the entire dollar expenditure in this category, taken in total, does not exceed 10%. 
 
Based on this information, a general and administrative percentage of 10% was 
calculated. The direct service staff wage plus the employment-related expenditures plus 
the program-related expenditures constitutes a subtotal (subtotal 1), which is adjusted for 
the general and administrative by “grossing up” the total by the general and 
administrative percentage such that: 
 
 Subtotal 1 divided by (1 – General and Administrative Percentage) = Total Rate 
 
Review of the providers’ general ledgers for AOM services show that the reported true 
costs borne by providers exceed the 10% cap. On average, provider general and 
administrative costs were approximately 32% of total program costs.  It is important to 
note that Mercer’s categorization of reported general and administrative costs included 
facility costs such as rent and equipment. Providers may argue that they must have 
specialized facilities and equipment to treat HIV-positive/AIDS-infected persons in a 
primary care setting.    
 
The goal of the rate development study was to develop a rate that considered all costs.    
All costs should be considered and the final rate reflects the true reported cost of services.  
The general and administrative percent of total program reported costs was 31.7% or 
171.79% of the direct staff care wage.  The general and administrative percentage was 
based on the average of four providers' general ledgers’ information. One provider’s 
general and administrative expenses were 2.5 times higher (as a percentage) than the next 
closest provider and the providers’ general and administrative dollars were held out of the 
calculation.  The general and administrative percentage used in Mercer's calculation was 
31.7%. 
 
In Step 9, below, Mercer has included two calculations of the AOM Rate for OAPP’s 
consideration:  one rate with 10% general and administrative costs and one with 31.7% of 
total costs (or 171.79% of the direct staff care wage).  
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The general and administrative rate for ADAP and Nutritional Counseling was calculated 
at 10%. The direct service staff wage plus the employment-related expenditures plus the 
program-related expenditures constitutes a subtotal (subtotal 1), which is adjusted for the 
general and administrative by “grossing up” the total by the general and administrative 
percentage such that: 
 
 Subtotal 1 divided by (1 – General and Administrative Percentage) = Total Rate 
 
Step 9: Synthesize Cost Components into the Rate 
In this step, the individual calculations in the previous steps were combined to formulate 
the rates for individual services. Once the percentages for the three components 
(employment-related, program-related and general and administrative) have been 
calculated, the final step is to identify the “denominator”, i.e., the number of encounters 
expected to be delivered.  For AOM services, Mercer calculated the average number of 
encounters provided in the most recent year as reported on the provider ESIS resulting in 
2,130 per year.  For ADAP services, Mercer estimated 35 minutes per average encounter, 
i.e., blended average encounters for new admissions and recertifications, for a total of 
3,566 encounters per year adjusted by 10% less as a capacity adjustment for a total of 
3,209 encounters per year.  Similarly, for Nutritional Counseling services, Mercer 
estimated 60 minutes per encounter for an initial assessment and 20 minutes per 
encounter for a continuing visit for a total of 2,080 and 6,240 encounters per year, 
respectively, adjusted by 10% less as a capacity adjustment for a total of 1,872 and 5,616 
encounters per year, respectively.   
 
AOM with 10% General and Administrative Cap 
Direct Care Staff Wage = $147,518.85 $  147,519 
Employment-Related = 42.0749% of direct care staff wage $    62,068 
Program-Related = 228.0417% of direct care staff wage $  336,404 
Subtotal $  545,991 
General and Administrative = 10% of total $    60,665 
Total $  606,656 
Encounters = 2,129.6462 ÷      2,130 
Rate $    284.86 
 
AOM with Actual General and Administrative 
Direct Care Staff Wage = $147,518.85 $  147,519 
Employment-Related = 42.0749% of direct care staff wage $    62,068 
Program-Related = 228.0417% of direct care staff wage $  336,404 
Subtotal $  545,991 
General and Administrative = 31.7% of total or 171.7852% of 
direct care staff wage 
$  253,416 
Total $  799,407 
Encounters = 2,129.6462 ÷      2,130 
Rate $    375.37 
 
ADAP 
Direct Care Staff Wage = $46,110.91 $    46,111 
Employment-Related = 30% of direct care staff wage $    13,833 
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Program-Related = 68% of direct care staff wage $    31,355  
Subtotal $    91,299 
General and Administrative = 10% of total $    10,144 
Total $  101,443  
Encounters = 3,209 ÷      2,130 
Rate $      31.61 
 
Nutritional Counseling – Initial Assessment 
Direct Care Staff Wage = $84,107.39 $    84,107 
Employment-Related = 30% of direct care staff wage $    25,232 
Program-Related = 49% of direct care staff wage $    41,213  
Subtotal $  150,552 
General and Administrative = 10% of total $    16,728 
Total $  167,280 
Encounters = 2,129.6462 ÷      1,872 
Rate $     89.36 
 
Nutritional Counseling – Continuing Visit 
Direct Care Staff Wage = $84,107.39 $    84,107 
Employment-Related = 30% of direct care staff wage $    25,232 
Program-Related = 49% of direct care staff wage $    41,213  
Subtotal $  150,552 
General and Administrative = 10% of total $    16,728 
Total $  167,280 
Encounters = 2,129.6462 ÷      5,616      
Rate $     29.79 
 
Other EMAs – Rates 
Mercer interviewed three EMAs for comparisons on approaches to FFS contracting and 
reimbursement methods. The EMAs were selected by OAPP. 
 
1. Miami-Dade EMA: This EMA uses the Florida Medicare Part B rates as the basic 
structure of a “unit cost” system. There are two sets of codes that are carved out for 
special rates: one subset of codes is reimbursed at 150% of the Medicare Part B rate 
and the fees for another subset of “supplemental” codes are individually negotiated 
per provider. These codes are “supplemental” in the sense that they represent 
procedures/services not covered under other fee schedules. Providers are issued a 
contract with a line-item budget that describes acceptable expenditures and bill by 
unit cost or by code. At the end of the contract period, should billings exceed actual 
expenditures, providers must return the excess. Providers are not reimbursed for more 
than the contract budget. 
2. Harris County (Houston) EMA: This EMA uses a “unit cost model” that is not based 
on actual costs as determined by the providers. The administrative agency and 
planning council review customary payments for services from other payers (private 
insurance, and especially Medicaid and Medicare), review the historical pattern of 
numbers of visits/encounters the EMA has financially supported, and considers the 
maximum funding available for each service category. A “unit cost” is subjectively 
negotiated from these reviews. Each provider agency is reimbursed at this standard 
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unit cost. The unit cost is actually a “maximum allowable” billing rate and providers 
tend to bill at the maximum allowable rate. Unit definitions are very broadly defined. 
Providers are contracted at a finite amount and these contracts are not augmented 
within any one contract period.  
3. St. Louis EMA: This EMA “borrowed” from the rates established by the State ten 
years ago and these rates still exceed the Medicaid/Medicare rates for Missouri. 
Providers sign a simple agreement to accept these reimbursement rates and bill by 
CPT codes. The codes largely relate to a defined visit and are not procedure-driven. 
All providers use a single lab, and the lab negotiates directly with the administrative 
agency. There is a strong individual private provider network in this EMA.     
 
If these three EMAs, taken with the Los Angeles County EMA as a fourth, are 
representative of the approaches to FFS reimbursement, the following can be noted: 
 
 EMAs tend to use the Medicaid/Medicare rates as a basis to rate-setting, practically 
and creatively building on these rates in varied ways. The end result is often specific 
to the EMA, and reflects a negotiated “acceptability” between the RWCA 
administrative agency and the contracted providers of RWCA services.  
 The decision to address actual costs, and to use these cost analyses in rate-setting, 
varies with the EMAs capacity for cost-based analyses (i.e., whether there are 
financial data management systems in place to collect and manipulate actual 
cost-based information). The “amount of work” for providers in establishing true and 
actual costs is frequently mentioned as a justification for conceding to 
Medicaid/Medicare rates with some negotiated variations or augmentations that speak 
to provider-identified concerns with public sector rates. 
 There is an operative assumption that the RWCA funds are not sufficient to fully 
reimburse for true and actual costs for providing care. This is particularly acute when 
discussing medical care services. There is always an assumption that the amount of 
service delivery would have to be severely curtailed if true and actual costs were 
reimbursed through RWCA funds alone. 
 Each EMA relies on a sense of “charity” within large institutional providers to show a 
willingness to take care of HIV-positive clients knowing that only a reasonable 
amount of the costs will be reimbursed through the RWCA funds. 
 
Future Rate Change Process 
The direct staff wage rate architecture is adaptable to change by making appropriate 
adjustments to the calculations within the architecture. Mercer has provided OAPP with 
the detailed rate modeling analytical files in Microsoft Excel that allow for adjustments to 
various rate components which will result in automatic recalculation of rates. Some areas 
where changes could occur are as follows: 
 
 If political will exists to increase the assumption of direct service staff wage levels 
over time (Mercer assumed a 4% annual increase) and the decision to increase them is 
made and funded, the wage levels can be immediately changed and the rates will 
automatically recalculate. 
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 If unfunded mandates become funded, those changes can be made to the appropriate 
component (usually employment-related expenditures or general and administrative 
expenditures) and again, the rates will automatically recalculate. 
 Service descriptions will usually either affect the Direct Service Staff profile or the 
program-related expenditure percentage. If so, these may involve a more complicated 
recalculation of the rate system components but the architecture remains unchanged.  
 
Data Manipulation Capacity:  Claims Adjudication 
At the request of the OAPP, Mercer performed an analysis of the Casewatch® data 
management system. The purpose of the analysis was to express an opinion about the 
system’s ability to process and report claims and authorization information in a format 
and process compatible with that required by Medicaid (Medicaid Management 
Information System). Mercer performed the analysis with the following findings: 
 
 The Casewatch® system contains fields which would allow for the prior-authorization 
of services by modality code as identified by OAPP or through the use of Common 
Procedural Terminology (CPT) procedure codes.  
 The system reporting capacities are quite flexible and can be designed to fit the needs 
of the user in a variety of ways. 
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5 
Budget Impact Analysis 
In any rate development exercise, the importance of evaluating the impact of the rates on 
the program budget at the existing level of funding cannot be overemphasized. 
Additionally, it is also critical to assess and seek to quantify the impact of the rates on the 
individual providers. This is especially important for HIV AOM services in the County of 
Los Angeles, where different compensation systems have been developed over long 
periods of time, with different negotiation characteristics. In such an environment, the 
replacement of these reimbursement amounts with a standardized published rate system 
will result in increases in rates for some providers while others may see decreases in 
reimbursement rates. For this reason, Mercer performed an in-depth budget analysis to 
study the impact of the rate system on each provider to determine the amount of increase 
or decrease they will experience.  This information was provided in the draft report 
released in October 2007.  However, the provider community argued that the encounters 
supplied by OAPP, against which the rate was multiplied, were problematic and should 
not be used.  In this final report, Mercer could only analyze the net gain/loss for those 
AOM providers who had submitted an ESIS and a general ledger. 
 
Methodology 
The process used to perform the budget impact analysis for Los Angeles County 
consisted of the following steps: 
 
 Establish existing allocation: This was provided by providers on the ESIS. 
 Establish proposed rates: The development of proposed rates is discussed in this 
report in Section 4. 
 Calculate budget variance: Mercer calculated the difference between current 
allocations and anticipated allocations if the new rate was implemented.  
 Measure impact on individual providers: The impact of the proposed rate system on 
each individual provider agency was then calculated and expressed in total dollar 
amounts. 
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Budget Impact Results 
A comparison to previous AOM allocation to anticipated allocation for those providers 
who submitted an ESIS are provided below: 
 
Provider Net Gain or Loss 
at $375.37 Rate 
Net Gain or Loss  
at $284.86 Rate 
1 $    (737,047.59) $    (3,515,187.20) 
2 $      666,290.96 $         156,007.49 
3 $          9,356.75 $       (146,769.36) 
4 $    (961,383.38) $    (1,663,181.54) 
5 $      (85,422.36) $       (275,850.96) 
6 $      164,714.91 $         106,337.32 
7 $    (444,172.57) $       (568,982.95) 
8 $        68,965.43            $           23,711.49 
9 $      116,707.86 $       (327,414.35) 
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6 
Third-Party Payer Reimbursement 
In delivering any health or health-related service, the presence of multiple funding and 
payer sources inevitably results in high levels of complexity, both in terms of billing 
practices and reimbursement mechanisms. This is all the more true for publicly-funded 
systems such as the HIV/AIDS services that owe the majority of their budgets to funding 
sources of last resort. Typically, processing claims as a payer of last resort is a function 
described as Coordination of Benefits and relates to billing the appropriate entity 
responsible for payment. Coordinating payment from multiple funding sources including 
Medicare (Title XVIII), Medicaid (Title XIX), HRSA Ryan White CARE Act funds, 
State and County, private-sector or private insurance can be daunting when a client is 
eligible for more than one insurance or funding program. To better understand the 
complexities of multiple reimbursement mechanisms and to create a rate system that 
encourages the appropriate and optimal use of available funding sources, OAPP included 
an evaluation of third-party reimbursement as a component of this rate study. 
 
Methodology 
To address the issue of third-party reimbursement and to identify whether services for 
people living with HIV/AIDS are being reimbursed by other insurers or third-party 
payers, Mercer performed a series of investigatory activities that are summarized in the 
steps outlined below.  
 
Mercer focused on a review of an array of services associated with people living with 
HIV/AIDS for the purpose of analyzing the status of Coordination of Benefits. Mercer 
also reviewed current processes for determining client co-payments. 
 
Step 1: Collect Information on OAPP Data Systems  
Mercer obtained existing information from the client information systems from OAPP 
staff. The specific “screen prints” from the current OAPP prior-authorization and claims 
processing information systems that were collected and reviewed include: 
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 Client Basic Data 
 OAPP Report Demographics 
 HRSA Client Level Information 
 
Step 2: Analyze Information System Elements and Reports 
Upon receiving the screen prints, Mercer evaluated each one for evidence of three 
components of Coordination of Benefits among the funding sources:  
 
 Indication that the person receiving services was eligible for coverage under one of 
the other funding programs, particularly at the time of eligibility for services, through 
OAPP. 
 Identification of the agent that gathers the information for billing purposes and at 
what stage of assessment or services the information is gathered from the person 
receiving services. For example, was the information gathered at the time the referral 
was being considered by the provider, during an eligibility or intake review, by the 
provider at the time services were to be provided, or even later during services? 
 Any evidence that the data field in which the information would be entered is a 
required field and whether it would be of the sort that might link to a claims 
processing or prior-authorization module that would be able to pend a claim or a 
prior-authorization as a result of the field being populated with the specific evidence 
of third-party coverage. 
 
Step 3: Discuss Initial Observations with OAPP 
After the initial review and analysis, Mercer met with staff of OAPP and the Office of the 
Auditor-Controller staff to discuss preliminary findings and to seek clarification on 
certain issues related to third-party coverage. Through these discussions, many of 
Mercer’s observations were confirmed.  
 
Step 4: Review Public Sources of Funding 
For the primary care services included within this study, Mercer evaluated other public 
sources of funding available in the County of Los Angeles to determine if the services are 
covered by these public programs and if so, whether providers are maximizing these 
funds for the clients that they serve.  
 
Step 5: Review Commercial Insurance Coverage 
Another key area of focus for this rate study was the availability of commercial insurance 
coverage for the service categories included in this study. To address this, Mercer 
reviewed benefit packages of national and local commercial insurance providers and also 
interviewed experts in insurance benefit design to determine existing levels of coverage 
for these services. 
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Findings and Results 
The observations made as a result of this analysis are presented in this part of the report 
under the following sub-sections:  
 
 Third-party Coverage and Reimbursement 
 Coordination of Benefits 
 Co-payments and Client Fees 
 
Third-Party Coverage and Reimbursement 
For the primary care services included within this rate study, RWCA funds obtained 
through HRSA must be considered funds of last resort. This is clearly mandated in the 
CARE Act of 2000 legislation. Outside this funding source, Mercer found that in the 
County of Los Angeles, a number of third-party funding programs currently exist and 
may be utilized to serve HIV/AIDS clients. Each of the key funding sources is discussed 
below and wherever possible, the amount of funding available from each source is also 
outlined. 
 
Federally Qualified Health Center Program 
Because the PHS Section 330 Community Health Center Program and the Federally 
Qualified Health Center Programs are considered “sister” programs with other 
federally-funded special population health programs, Mercer debated briefly the 
advantages and disadvantages of OAPP-funded medical providers becoming federally 
qualified health centers (FQHCs).  This was considered because it would provide a way 
to take advantage of the cost-based reimbursement the FQHC program provides to 
community and public health centers. However, the organizational development 
challenges that come with this designation proved to be too onerous for some of the 
currently-funded community health providers. For example, the Board of Directors of an 
FQHC must comply with the PHS Section 330 51% consumer member standard. The 
administrative and financial reporting requirements are quite sophisticated and would 
make for comprehensive technical assistance needs for some community providers, 
together with demanding substantial financial development to support the corresponding 
organizational development and management needs. Most important, however, is the 
wholesale change of organizational focus this designation would require as FQHCs must 
demonstrate a capacity to provide comprehensive general primary care to all clients. 
Currently, OAPP funds are used to support specialized HIV/AIDS primary care only and 
some of the currently funded providers do not directly provide general comprehensive 
primary care to their clients, let alone to the client’s family members or social affiliates. 
Therefore, to recommend this designation be pursued by all OAPP-funded providers at 
this time is too sweeping an organizational, financial and mission change. 
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Medi-Cal Program 
Medi-Cal is the State of California’s Title XIX Medicaid entitlement program and the 
largest source of publicly-funded care services in the State. Medi-Cal is governed by 
stringent and complex federal regulations, as well as California-specific rules, to ensure 
optimal and appropriate use of public funds for health care delivery.   Physical health 
providers appear to be more aware of Medi-Cal funding regulations and utilize this fund 
source where appropriate.  However, providers should be clear that the expectation is that 
all Medi-Cal allowable service reimbursement be collected and the contracts should 
reflect this requirement. 
 
On the surface, obtaining Medi-Cal reimbursement may seem a fairly simple process 
linked to three main criteria: 
 
 Service must be a covered Medi-Cal benefit 
 Client must be eligible and enrolled in Medi-Cal or the designated waiver  
 Provider must be certified to participate in Medi-Cal 
 
However, the more one delves into the program and its regulations, the more complicated 
and elaborate the system becomes. For providers, the complexity of Medi-Cal begins with 
the large number of unique programs that exist under the Medi-Cal umbrella. Some of 
these programs are structured as traditional FFS reimbursement models while others are 
covered through managed care arrangements. States, such as California, have exercised 
the option made available through the Social Security Act to “waive” certain federal 
requirements and implement innovative health delivery programs through both program 
waivers (Section 1915(b) and (c)) and research and demonstration waivers (Section 
1115). Each of these waiver programs targets a specific population, has its own unique 
eligibility criteria and often has distinct services covered within the program’s benefit 
package. Adding to this complexity, each individual Medi-Cal program has its own 
provider application process. This process may also vary by provider category. 
 
Medi-Cal Covered Services 
As a way of assessing whether the Mercer rates of reimbursement are within the public 
sector range, Mercer conducted a review of services covered by Medi-Cal. For this 
particular set of medical services, the attempt to make one-to-one comparisons with 
Medi-Cal was not possible. This is because of the particular approach used by OAPP in 
the delivery of a service (e.g., the Roy Adaptation model for medical case management), 
because there were no one-to-one correspondences in services (e.g., the State model for 
ADAP enrollment services), or because of the recent revisions to PHS guidelines that are 
changing HIV/AIDS medical service delivery. The service descriptions developed by 
Mercer were based on the service delivery approaches discussed with OAPP and 
stakeholders. Additionally, the Mercer rate setting architecture is a method that weds 
reimbursement rates with the most current standards of care. Therefore, as the following 
summary will demonstrate, the Mercer rates are not comparable to Medi-Cal rates (with 
the exception of Nutritional Counseling (Medical Nutritional Therapy): 
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1. HIV/AIDS AOM Care Services: This service description has two new aspects that are 
not paralleled in the service model underlying current Medi-Cal rates. First, the 
service description includes new service components, implemented in the routine 
medical encounter, that are based on the PHS guidelines’ recent emphasis on the 
integration of HIV prevention within primary medical care, the significance of 
treatment adherence services and the essential attention to nutrition. These 
requirements expand the scope and duration of the routine medical encounter, and 
define enhanced areas of expertise needed by the primary care provider in each 
routine medical encounter. 
 
Second, the service description (and corresponding rate of reimbursement) is based on 
a specific personnel model (physician-like professionals). 
 
 As a result the Mercer rate of reimbursement incorporating these features is not 
comparable with current Medi-Cal FFS rates of reimbursement nor with the service 
model on which the Medi-Cal rates are based. 
 
2. Eligibility, Education and Enrollment Services for ADAP: California service 
components in this service description are defined and specified by the California 
Department of Public Health, Office of AIDS and they are distinctive to how the 
RWCA, AIDS Drug Assistance Program is implemented in California. There is no 
comparable Medi-Cal program with which to compare rates of reimbursement for this 
service. 
 
3. Nutritional Counseling (Medical Nutrition Therapy): There is a Medi-Cal 
reimbursement rate for Medical Nutrition Therapy; however, this rate was established 
January 1, 1993, for the AIDS Medi-Cal Waiver Program (MCWP). The development 
of AIDS Waiver Programs preceded advances in health outcomes as a result of  
HIV-related pharmaceuticals, and State health financing departments established 
them as a way to keep AIDS patients out of expensive hospital and/or nursing home 
care. 
 
The Medi-Cal rate is: Nutritional Counseling $33.48/hour 
 
The OAPP service description and corresponding reimbursement rate currently does 
not include the costs for nutritional supplements as a discrete billable item, and 
neither does the above Medi-Cal rate. In the MCWP, “Nutritional Supplements/Home 
Delivered Meals” are capped at $150.00 per client per month. This cap also was 
established January 1, 1993.  The Mercer rate study uses current, geographically 
relevant Bureau of Labor Statistics data as an indicator of actual personnel hiring 
costs, and then factors these costs with other real-time program and administrative 
costs derived from actual agency cost reports. Therefore, the Mercer rate of 
reimbursement is a more realistic reimbursement rate for this service in 2007. 
 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
42
A note from Medicare/Medicaid:  The American Dietetic Association (ADA) 
proactively works to assist Registered Dietitians in understanding billing procedures 
and actively describes appropriate billing codes. There are Medicare/Medicaid CPT 
codes for Medical Nutrition Therapy released by the Centers for Medicare and 
Medicaid Services (CMS) and included in the American Medical Association’s 
(AMA) Current Procedural Terminology CPT book. Medi-Cal has not adopted these 
codes for reimbursement. 
 
Coordination of Benefits (Third-Party Payment) 
Coordination of Benefits is described as the function of identifying third-party coverage 
for services needed by a client and to bill these multiple third-party payers before 
accessing funds of last resort. This is often the responsibility of the provider of service 
and oversight and monitoring is provided by the funding agency. In many cases, a 
designated third-party administrator may also be used to assist in this process. As 
demonstrated through the preceding discussion, there are multiple funding sources for  
AOM Care services in the County of Los Angeles and the task of Coordination of 
Benefits across all these funding sources becomes all the more critical especially in the 
wake of increasing costs of care and flat or declining budgets for service delivery. 
 
On examination of OAPP information system screen prints, Mercer found that there is a 
single question in the group of screen prints that, if filled in, would indicate whether or 
not the individual was covered for services by a third-party insurance plan. Mercer also 
found that third-party coverage information is supposed to be gathered by provider 
agencies at referral and periodically thereafter. 
 
Mercer was able to confirm that while the data field in the current system is a required 
field for providers and that the information is sometimes gathered about third-party 
coverage, the submission of the data confirming third-party payment is not linked to any 
outside claims adjudicating system. Therefore, there is no process within OAPP to 
actually track whether the client has third-party coverage and if the provider submitted a 
third-party claim.  
 
Utilization of third-party payer information in a client information file by 
cross-referencing the information in claims adjudication assures a “cost avoidance” 
approach as opposed to a “pay and chase” approach. The cost avoidance approach is 
recommended by federal funding sources, such as Medicaid. However, linking the data 
field related to third-party payer to prior-authorization and claims adjudication systems 
that are apart from the systems containing third-party information, and particularly when 
used by agents other than the prior-authorization and claims processing agencies (as is the 
case with OAPP), can involve major systems restructuring and be prohibitively 
expensive. 
 
Due to the costs associated with the integration of systems to link third-party payer 
information to prior-authorization and claims adjudication data, Mercer recommends that 
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the most efficient and cost-effective solution is to build on the processes already in place. 
Specifically, by ensuring that the data field for third-party payment is a required field and 
the information system links the field to the invoice from the provider, OAPP will have 
this information available for its back-end review and follow up. Through discussions 
with OAPP staff it was noted that currently OAPP does review fee determination and 
third-party payer coverage as part of their on-going monitoring processes. This 
retrospective monitoring process is often time-consuming and complicated. 
 
In practical terms, OAPP could employ one of two different options to accurately track 
third- party coverage information: 
 
Option 1 
OAPP could require that the providers submit an invoice that contains third-party payer 
information. When a client has third-party payer coverage, the invoice must be 
accompanied by an Explanation of Benefits from the insurer as evidence the insurer has 
been billed for covered services. OAPP then can reimburse providers only for the 
uncovered service up to the amount of the published rate. 
 
The Health Insurance Portability and Privacy Act (HIPAA) contains certain clauses 
related to claims processing and Coordination of Benefits which though once were 
recommendations of the General Accounting Office, are now requirements under HIPAA. 
Clause §162.1801 Coordination of Benefits Transactions and Clause §162.1802 
Standards for Coordination of Benefits require that all electronic claims be submitted in 
ASC X 12N 837- Health Care Claim format which includes any prior paid components of 
the claim. Towards this end, HIPAA Subpart P – Health Care Payment and Remittance 
Advice §162.1601(b) Health Care Payment Remittance Advice Transaction requires the 
submittal of Explanation of (Medicare) Benefit (EOB, EOMB) documentation as part of 
claim submission, again in ASC X 12N 835 format. 
 
This means that it is now required for publicly-funded health and social services which 
are subject to HIPAA to submit all claims after having been determined to be coverable 
by any third party, that such documentation be submitted with the claim in the proper 
format, and that only the unpaid (net) amount be claimed by the HIPAA-compliant 
agency.  
 
Option 2 
A second option for OAPP could be the use of a Third-Party Administrator (TPA) or a 
similar external entity to work with the providers to provide confirmation of client 
eligibility prior to reimbursement and to verify that the primary insurer has been billed for 
covered services. This option may be a simpler alternative to implement given the 
complexity of current funding streams and should be explored further by OAPP.  
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Co-payment and Client Fees 
Co-payment is a cost-sharing arrangement in which a person pays a specified charge for a 
specified service, such as $10 for an office visit. The covered person is usually 
responsible for payment at the time the health care is rendered. The service provider has 
responsibility for collection of the co-payment because insurance payments to the 
provider are made net the co-payment. However, in the case of Medi-Cal enrollees and 
Medi-Cal-funded services, it is not permissible for an agency to assess a co-payment from 
the person receiving services. 
 
Providers interviewed in the first phase of this project universally reported that most of 
their clients were not assessed a co-payment. According to the providers, two issues made 
collecting co-payments problematic.  Providers worried about the administrative burden 
of collecting the co-payment and about their liability if they refused services because the 
client did not have the co-payment. 
 
Co-payment is probably not an avenue for significant additional revenue collection by 
OAPP. Hence, AOM rates that have been proposed as part of this study are designed to be 
net of any client fees or co-payments.  
 
OAPP should develop a standard policy specifying the management of client fees. The 
Medicare program has established some guidelines relating to the management of client 
fees and may be referenced in establishing this policy. The guidelines are incorporated 
within various chapters of the Medicare Claims Processing Manual. 
 
It is important to note that based upon early conversations with HRSA staff, Mercer 
found that HRSA does not have any specific recommendations on client fees and allows 
individual HIV/AIDS Agency discretion as to the structure and management of such an 
arrangement with appropriate  disclosure. 
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7 
Barriers/Disincentives and Recommendations 
The best designed and most successful rate systems are those that are based on 
requirements for quality care. Mercer has sought to adapt the rate architecture based on 
service descriptions developed based on a combination of current program requirements 
and recognized best practices. Throughout this process, Mercer identified barriers to the 
implementation of the proposed rate architecture that could potentially discourage or even 
prevent cost-effective, high quality service delivery. Specific attention was given to the 
following areas: 
 
 Restrictions on financial compensation methodologies 
 Restrictions from outsourced labor and the collection of donations 
 Any guiding regulations that may impede the ability of the County of Los Angeles to 
develop the provider network related to procurement 
 Prohibitive regulation for management and establishment of sites 
 Excessive restrictions and requirements that are not feasible in the County of Los 
Angeles 
 Community-based restrictions, such as availability of qualified staff that meet staff 
requirements 
 
Some of the key barriers identified through the course of this study are listed and 
discussed below. Wherever appropriate, Mercer has recommended strategies that the 
Board of Supervisors through OAPP could explore to address or alleviate these barriers or 
disincentives. 
 
Exceeding Accepted Standards 
In Work Order No. 6-49, Mercer was asked to suggest ways to incentivize providers to 
exceed the accepted standards; however, Mercer found that the adoption of the new 
HIV/AIDS Continuum of Care Model set a high standard for all providers of HIV-related 
medical services in Los Angeles County. The model was based on earlier 
federally-funded pilot or “demonstration project” innovations (e.g., the integration of 
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prevention and treatment services in medical settings) that are now accepted standards in 
the PHS Primary Care Guidelines. To date, the Office of AIDS Programs and Policy and 
the Commission on HIV are cooperating in system planning and agency infrastructure 
development initiatives that will facilitate fulfilling these accepted standards. When 
interviewing providers, Mercer found them in full support of the new HIV/AIDS 
Continuum of Care Model but also interested in technical support and capacity-building 
opportunities that will assist them in meeting the Model’s expectations. The 
recommendation at this time is to solidly implement the accepted, higher standards of 
care that support the HIV/AIDS Continuum of Care Model.  
 
Because the science and practice of HIV/AIDS medical management continues to rapidly 
evolve, exceeding the current PHS standards in any one year is rarely achieved. Mercer 
recommends OAPP and the Commission on HIV continue to implement its public health 
role in announcing and distributing standards of care revisions and updates, and continue 
their roles in agency and provider education, training, development and capacity-building 
as a way to remove barriers to meeting these standards of care. 
 
Maximizing Medi-Cal Funding  
As discussed in the previous section of this report, Medi-Cal is a significant, albeit a 
complex, source of funding for HIV/AIDS services and it is critical that providers 
maximize the funding available through this entitlement program.  
 
Mercer Recommendations: CARE Act of 2000 legislation mandates that CARE Act 
funds be the payer of last resort, and HRSA has mandated that wherever other programs 
such as Medicaid exist for HIV/AIDS services, these funds must be maximized before 
using RWCA funding. Based on these mandates, many states and jurisdictions require 
their HIV/AIDS providers actively participate in the Medicaid program. For the selected 
services in the County of Los Angeles, Mercer recommends the following: 
 
 OAPP and the Commission should work closely with the California Department of 
Public Health to identify and clearly define HIV/AIDS services that could be 
reimbursed by Medi-Cal and to identify the appropriate Medi-Cal programs/waivers 
that HIV/AIDS providers may participate in.  
 The collaboration with California Department of Public Health could extend to the 
task of increasing awareness and knowledge among HIV/AIDS providers of the 
importance and need for maximizing Medi-Cal funding for individual service 
components that are delivered. The California Department of Public Health provides 
training sessions to providers on various topics related to the Medi-Cal program. 
Providers should be encouraged to avail of these training opportunities. 
 OAPP could use its established training curriculum to offer additional training and 
technical assistance to providers on the utilization of Medi-Cal as a fund source. This 
is an area that has been deemed a HRSA priority and RWCA grant funds have been 
utilized in other states to offer this type of technical assistance. In the past, HRSA has 
provided third party payment training in the County of Los Angeles. Attendance at 
these types of training should be mandatory for providers that contract with OAPP. 
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 OAPP may wish to audit a sample of medical files to determine if Medi-Cal funding 
is underutilized. 
 
Medical Specialty, Drug Resistance Testing and Medical Case 
Management 
Mercer Recommendation: Mercer recommends the service description written for 
Referral to Medical Specialty Service not be funded as a separate and distinct 
reimbursable service. The requirement to assess for, refer to, and track specialty care 
services is an integrative component of the PHS guidelines for HIV-related primary 
medical care. Therefore, the separate service description for Referral to Medical Specialty 
Service is redundant and duplicative of the service description for Ambulatory/Outpatient 
Medical care services. 
 
In making this recommendation, Mercer is also recognizing and recommending the long 
term RWCA “best practice” of local provider-to-local specialty provider negotiated rates 
for specialty care be continued.  This practice and the subsequent negotiated rates 
customarily have a charity basis that has prevented significant use of RWCA funds for a 
single expensive specialty care service and thereby permitted distribution of these limited 
funds across many needed medical services. 
 
This recommendation in no way is intended to lessen the focus and attention given by 
OAPP to continue to fund medical specialty services; however, as prior discussion in the 
report has emphasized, a single rate of reimbursement for medical specialty service is 
neither feasible nor desirable. 
 
Mercer Recommendation:  Because of changes in the PHS HIV/AIDS standards of care, 
Mercer recommends this service description no longer be funded as a distinct and 
separate service category. Drug resistance testing was earlier viewed as a highly 
specialized service but is now considered routine within the medical management of HIV 
disease. Therefore, the new expectations associated with drug resistance testing are 
incorporated as expectations within the HIV/AIDS Ambulatory Outpatient Medical Care 
service description. 
 
Mercer recommends that the actual costs of the blood screening continue to be absorbed 
by the State of California, Office of AIDS, Resistance Testing Program. The Mercer 
recommendation, therefore, does not assume these lab costs will be absorbed by the 
HIV/AIDS AOM providers contracted through OAPP. The medical tasks relevant to 
client pre- and post-testing counseling and education for drug resistance are now routine 
HIV/AIDS medical management services to be provided by HIV/AIDS practitioners 
contracted through OAPP. 
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Mercer Recommendation:  Because the configuration of services included in Medical 
Case Management was under review, this report contains no rate recommendation for a 
separately reimbursed Medical Case Management service. Mercer worked collaboratively 
with select OAPP program management staff to identify an appropriate model for 
HIV/AIDS Medical Case Management, taking into consideration the Board of 
Supervisors’ expectations and OAPP’s existing service delivery pattern of using clinical 
nurses to provide care coordination. The Roy Adaptation Model for nursing case 
management was reviewed and mutually found appropriate for this service description 
initially. An initial rate was developed for Medical Case Management based on the Roy 
Adaptation Model. During the time frame included in this study, Medical Case 
Management was being closely scrutinized by OAPP and the Commission on HIV. The 
Commission revised its Standard of Care effective May 11, 2006. However, Medical 
Case Management continues to be reviewed and revised as a service and no service 
description or rate recommendation is included in this report.  
 
Acuity Modifier 
OAPP asked Mercer to explore an acuity modifier in the rate development process. The 
construction of such a modifier should follow these steps: 
 
1. Identify the co-morbidity(s) that would most probably result in a more intense level of 
need (e.g. hepatitis). 
2. Select the case files of individuals for whom the co-morbidity diagnosis applies. 
3. Pull the expenditure records for the individuals with co-morbidities and make a 
comparison between those cost profiles and those of the general patient population. 
4. Express the modifier as a percentage applied to the proposed rates. 
 
The use of a diagnostic profiling approach (International Classification of Disease) or 
service procedure approach (CPT codes) is not recommended unless the consistency and 
accuracy of the use of diagnostic and procedure codes can be established and linked to 
expenditure records in a meaningful way. 
 
It is also possible to adjust the rates by providers based on the percentage of 
AIDS-infected persons treated versus the percentage of HIV-infected people treated. The 
table below shows a list of current providers and the range of the clients’ status. 
 
Providers’ Self-Reported Percentage of AIDS Patients (January 2007) 
Provider % AIDS-infected 
Harbor UCLA 90% 
Catalyst 60% 
St. Mary’s 60% 
City of Pasadena 54% 
El Proyecto 50% 
AltaMed 47% 
T.H.E. Clinic 47% 
Watts 35% – 40% 
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Provider % AIDS-infected 
North East Valley 30% – 40%  
AIDS Health Care Foundation 35% 
MLK/OASIS 32% 
Children’s Hospital 20% – 30% 
Gay and Lesbian Center 13% 
 
Lastly, OAPP could consider an adjustment based on the status of the client in treatment:  
New Patient/Newly Diagnosed, Regular Visit, Follow-Up/Brief Visit.  However, current 
cost data is not available to differentiate the rates but could be studied over time. 
 
Mercer Recommendation:  Because accurate cost data on acuity differentials is not 
readily available, Mercer recommends OAPP initially pay providers a single rate, 
reconcile payment against actual costs on a routine basis, and develop an acuity adjuster, 
if necessary, as the issue is studied further. 
 
Implementation of Rates: Budget Impact Concerns 
Mercer Recommendation:  Finally, Mercer offers recommendations related to the 
implementation of the standardized rate system.  The first recommendation addresses the 
issue of the general and administrative percentage to be used for the final rate calculation 
and the second recommendation relates to reconciliation of the allocation paid to 
providers at the single rate versus the true costs. 
 
Mercer recommends that OAPP engage in internal policy decisions regarding the general 
and administrative percentage to be used for a single provider rate. At the 10% cap rate, 
providers may be under-funded for their true total costs. 
 
OAPP should consider a reconciliation process that compares paid rates against true costs 
for providers after six months. OAPP could choose to “shadow implement” the rates, 
paying the providers with the historical funding methodology and comparing it to what 
payment would have been if providers had been paid the single rate.       
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8 
Next Steps 
Through this study, an actuarially sound and locally relevant rate system has been 
proposed that supports clinically appropriate services for people living with HIV/AIDS in 
the County of Los Angeles. A critical next step in the implementation of the rates is the 
finalization of policy and process decisions related to the level of budget funding 
available for these services. This will also involve policy decisions regarding the level of 
impact that OAPP will allow individual providers to sustain as a result of the new rates. 
Adjustments to the rates can be made based on these policy decisions. 
 
It is commendable that throughout the study, OAPP has demonstrated a strong 
commitment to ensuring a collaborative process in rate development. To that end, OAPP 
and Mercer have met with and interviewed providers on an on-going basis. To facilitate 
the successful implementation of this proposed rate architecture, this level of County and 
provider collaboration should be continued and strengthened.  
 
In any rate development exercise, the initial hurdles and barriers that may be encountered 
are numerous. This is clearly demonstrated in the list of barriers that were identified 
through the course of this rate study and that were presented in this report. While Mercer 
has sought to present recommendations and potential solutions that address or mitigate 
these barriers, it is clearly understood that implementation will not be without issues. The 
issue of the general and administrative percentage to use in the rate calculation is an 
example of an immediate policy issue that must be considered and resolved.  Some 
recommendations deserve immediate attention while others should be addressed in and 
throughout the RFP process. Other issues may require a more sustained and long-term 
approach and can be addressed after the release of the RFP. A summary of the 
recommendations are presented in the table below.  
 
Mercer is privileged to have had the opportunity to work with OAPP and the County of 
Los Angeles on this exciting and innovative rate study. Based upon Mercer’s experiences 
in the areas of HIV/AIDS and rate development across the United States, it is clear that 
the County of Los Angeles is a leader in the effort to link HIV/AIDS reimbursement to 
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appropriate clinical standards and practices thereby ensuring both high quality and 
cost-effective service delivery. Mercer is confident that through the collaboration of the 
County and its HIV/AIDS providers, a planned and coordinated implementation strategy, 
and appropriate training for all those involved, OAPP will be able to successfully 
implement this rate architecture and serve as a model for structured and equitable 
reimbursement methodologies for other HIV/AIDS programs nationwide. 
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HIV/AIDS Continuum of Care Model, County of Los 
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The Commission on HIV approved the HIV/AIDS continuum October 14, 2004 
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HIV/AIDS CONTINUUM OF CARE MODEL, COUNTY OF LOS ANGELES 
 
5. ENHANCEMENT SERVICE 
 Psychosocial Support 
         Service HIV Support 
Food Bank, Home DM,  
   Nutritional supplements 
Housing assistance  
    & services 
Transportation 
Child care 
Case Management, Psychosocial 
Case Management, Medical 
Translation/interpretation 
HIV Counseling/Testing 
Partner Counseling/Referral 
Heath Education/Risk Reduction 
Medical outpatient 
      General and Specialty 
      Treatment Adherence 
 Nutritional Counseling 
      HIV/AIDS Medications 
Mental health: Psychiatric 
Mental health: Psychological  
Oral Health 
Substance Abuse Services 
Legal Services 
Permanency planning 
6. PROGRAM SUPPORT 
 Service Coordination 
 Capacity Building 
 Service Enhancement 
 Evaluation 
 Training and Education 
 Program Research/Review 
 Rate and Fee Review 
7. PLANNING COUNCIL SUPPORT 
 Priority- and Allocation-Setting 
 Evaluation Activities 
 Public Awareness Efforts 
 Training Activities 
 Staffing Pattern 
 
 
  Only funded service 
  categories are listed 
  Prevention Services 
  (not CARE Act-Funded) 
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Review of HIV/AIDS Continuum of Care Model 
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HIV/AIDS Medical Clinics Fee-for-Service Reimbursement Rate Study 
County of Los Angeles, Department of Health Services, Office of AIDS Programs and Policy 
 
 
 
 
 
 
Mercer Government Human Services Consulting 
Work Order Request No. 6-49 (January 2004) 
Work Plan Task III.a.3: Review Continuum of Care Model  
Melanie L. Sovine, PhD 
November 22, 2004 
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Introduction 
The HIV/AIDS Continuum of Care Model is an outcome of the County of Los Angeles 
Strategic Planning Process (1999-2001). In 2001, the new Continuum of Care was jointly 
approved and adopted by the County of Los Angeles Commission on HIV (Commission), 
the Prevention Planning Committee (PPC), and the Office of AIDS Programs and Policy 
(OAPP).  
 
The model was first adopted for use in health systems planning and development, and 
planners and staff continue to use this model as a foundation in the annual “Priority and 
Allocations Process” required by the Ryan White CARE Act (RWCA). The model 
figured prominently in the development of the County of Los Angeles HIV/AIDS 
Comprehensive Care Plan (August 2002) and has proven helpful in broadening the focus 
of planners and providers beyond government resources when financial planning and 
development needs are raised.  
 
Improving HIV-Related Health Outcomes. From the beginning, the HIV/AIDS 
Continuum of Care Model was a bold statement of commitment to improving the HIV-
related health outcomes for all individuals and families at risk for or infected with the 
HIV virus, and to reducing the disparities in HIV-related health outcomes for racial, 
ethnic, and social minorities in the County of Los Angeles. Moving towards fulfillment of 
this commitment, planners, providers, and OAPP staff use the model to focus concretely 
on how the Continuum of Care Model’s HIV/AIDS Primary Health Care Core Services 
will be made available to County of Los Angeles citizens who depend on publicly-funded 
HIV/AIDS services. 
 
Patient Care Coordination. The HIV/AIDS Continuum of Care Model pushes beyond 
the single issue of “access to services” to a more complex question of how to assure that 
clients have appropriate access to services, utilize them consistently, are effectively 
retained in services over time, and adhere to medical regimens while receiving HIV/AIDS 
services. This service formula, Access-Utilization-Retention-Adherence, underscores a 
second commitment (i.e., providing Patient Care Coordination services for those who 
need them so that improvements in HIV-related health outcomes may, in fact, be 
achieved). The HIV/AIDS Continuum of Care Model is a client-centered and flexible 
one, with multiple points of entry, and while it sets a clear standard by delineating the 
critical HIV/AIDS service components in a state-of-the-art continuum of care model, it 
does not impose a single set of services for any one or all clients who may seek services 
within this Continuum of Care Model.  
 
Integration of Prevention and Care Services. There is a third commitment evidenced in 
the HIV/AIDS Continuum of Care Model’s design; a commitment to effectively 
integrating HIV prevention services with care and treatment services. HIV prevention 
services are an integral component of the HIV/AIDS Primary Health Care Core 
Services. Planners, providers, and OAPP staff are focusing not only on how to seamlessly 
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link the prevention and care service systems, but how to give equal weight to HIV 
prevention in the context of routine and recurring medical care.   
 
The HIV/AIDS Continuum of Care Model is a conceptual tool that helps planners, 
providers, and staff review service needs from a comprehensive perspective, not just in 
terms of the services categorical funding sources are willing to support. It is being used to 
better inform quality assurance and standard of care activities, and is used as a general 
guideline when monitoring the practice of clinicians and other health/social service 
practitioners. Finally, the HIV/AIDS Continuum of Care Model is currently being used by 
OAPP staff to revise funding program “Requests for Proposals,” and one provider 
interviewed for this report described using the model to “better integrate and manage the 
core team” now needed in the HIV/AIDS primary health care program she supervises.     
 
Approach to Model Review. As a part of The HIV/AIDS Medical Clinics Fee-for-
Service Reimbursement Rate Study (Work Order Request No. 6-49, January 2004), 
Mercer Government Human Services Consulting (Mercer) agreed to review the 
HIV/AIDS Continuum of Care Model noting specifically: 
 
 the key strengths and weaknesses of the current model; 
 existing barriers to the attainment of the goals of the model; 
 opportunities to address these barriers and enhance the model; and 
 opportunities to link this model with appropriate incentives. 
 
Mercer reviewed the model and related goals described in the County of Los Angeles 
HIV/AIDS Comprehensive Care Plan (August 2002). Because the Commission continues 
to improve the model through its planning processes, Mercer also reviewed the most 
current version of the model approved by the Commission on October 14, 2004.  
 
The Work Order Request called for interviews with Commission members, HIV/AIDS 
service providers, and OAPP staff. OAPP and Commission staff jointly identified the 
individuals to be interviewed by Mercer. They included individuals capable of speaking 
from both the prevention services and care services perspectives. A set of open-ended 
interview questions was developed to permit interviewees to respond to each of the four 
areas listed above. Mercer conducted the interviews by telephone and sorted the 
responses into the same four areas listed above. The interview responses are presented in 
summary form in this report. 
 
Relying significantly on the interview material, Mercer completed the review by drawing 
observations from the collected perspectives and formulated suggestions provided in the 
last section of this report. 
 
Mercer Peer Review. All work performed by Mercer is subjected to a strict quality 
assurance process. Mercer has clear professional standards regarding the process of “peer 
review” (quality control) at various steps in product development. Mercer utilized this 
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HIV/AIDS Continuum of Care 
Primary Health 
Health Care Core Services 
 
HIV Counseling and Testing 
Partner Counseling and Referral 
Health Education and Risk 
Reduction 
Outpatient Medical 
Outpatient Medical Specialty 
Psychiatric Services 
Psychological Services 
Nutritional Counseling 
Oral Health Care 
Substance Abuse Services 
Treatment Adherence 
Hospice Services 
peer review process in the development of this report. We applied peer review from a 
number of perspectives, reviewing this work product as follows: 
 
 Technical Peer Review to ensure accuracy and overall reasonableness; 
 Consulting Peer Review to ensure the soundness of the approach and to ensure that 
the appropriate issue/question has been completely addressed in a clear manner; 
 Editorial Peer Review for grammatical and spelling correctness as well as 
professional appearance; and 
 Final Look Peer Review to ensure a professional work product appearance that meets 
the delivery and other specifications. 
 
OAPP Internal Review. Before release of this report, Mercer reviewed its contents with 
the managerial staff of OAPP and incorporated the revisions suggested by them. Drafts of 
the report were reviewed by managerial staff representing both HIV prevention and 
care/treatment services. 
 
The HIV/AIDS Continuum of Care Model 
 
The HIV/AIDS Continuum of Care Model is conceptually 
defined by a core of HIV/AIDS Primary Health Care 
Core Services considered to be essential to improving the 
health outcomes for all citizens of the County of Los 
Angeles at risk for or infected with HIV/AIDS. Primary 
care in this model includes services for physical and 
emotional health, and the core gives mutual weight to 
both HIV prevention and care and treatment services. 1  
Medication services are a component of Outpatient 
Medical Services, provided to interrupt or delay the 
progression of HIV disease, prevent and treat 
opportunistic infections, and promote optimal health. 
 
The Primary Health Care Core Services is supported 
by Wrap-around Services categorized as services for the 
Removal of Barriers, for Patient Care Coordination and 
Language Services, services related to Economic Wellbeing, and Enhancement Services. 
While the Wrap-around Services are related generally to improving health outcomes, 
these services, when combined with the Primary Health Care Core Services, are 
especially related to reducing the disparities in health outcomes experienced by racial, 
ethnic, and social minorities in the County of Los Angeles. They are also intended to 
assure clients access and receive appropriate primary care services.  
                                                 
1
 For a thorough description of the HIV/AIDS Continuum of Care Model, see the County of Los Angeles HIV/AIDS 
Comprehensive Care Plan (August 2002), pp. 1-3 through 1-8, available through OAPP. 
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Medical Services Rate Study 
 
 
Ambulatory/Outpatient 
Medical Care 
Referral to Medical Specialty 
Services 
Drug Resistance Testing 
 
Medical Nutrition Therapy 
 
Medical Case Management 
 
ADAP Enrollment 
The services listed within Removal of Barriers are designed to help optimize the critical 
paths through which clients access, utilize, are retained in and are adherent to primary 
care services. Patient Care Coordination and Language Services provide clients with the 
expert guidance needed to fully utilize continuum of care services. Services related to 
Economic   Wellbeing assist in the amelioration of poverty and the removal of financial 
roadblocks to continuing in prevention and care services. Enhancement Services are self-
help oriented services designed to improve the quality of life for specific populations or 
communities. 
The HIV/AIDS Continuum of Care Model is intended to guide planners and service 
providers in the development of quality, state-of-the-art services in HIV/AIDS. It is 
intended to promote a more equitable development and access to HIV/AIDS Primary 
Health Care Core Services in the County of Los Angeles, and intended to permit a more 
culturally-appropriate development of Wrap-around Services within and across 
communities in the County of Los Angeles. 
 
The Model Review’s Relationship to the Rate Study 
The medical services rate reimbursement study focuses on six services that are critical 
components to the HIV/AIDS Continuum of Care Model’s Primary Health Care Core 
Services. The study includes a thorough review and revision of service descriptions 
according to national standards of care, and takes into consideration costs and service 
delivery issues related to meeting the national standards. 
 
The study is designed to facilitate OAPP in procuring and 
providing quality, state-of-the-art HIV prevention, and care 
services. Therefore, the rate study includes a general review of 
the HIV/AIDS Continuum of Care Model in order to flag 
variables that strengthen and/or challenge the provision of 
these services within the prescribed HIV/AIDS Continuum of 
Care.  
 
The Continuum of Care Model review is not a full-scale 
evaluation of the HIV/AIDS Continuum of Care Model, but 
rather a supporting activity that offers broad perspective and 
helpful suggestions to improve the model that cradles the 
medical services in the rate reimbursement study. 
 
Summary of Model Review Interviews 
The summary that follows is paraphrased from 11 telephone interviews conducted by 
Mercer. Phrases presented in quotation marks are direct, anonymous quotes from 
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Fariba S. Younai, DDS 
“HIV disease is a continuum. You cannot say one service 
is more important than the other. A client’s overall care 
is a continuum.” 
Debbi Collins, MPAS, PA-C 
 
“Management of HIV disease is complicated. It cannot be 
managed without all the disciplines cohesively involved. 
The Continuum of Care model supports the ‘good 
management’ of care that crosses many areas of life, 
community, and families.” 
interviewees. A few quotes are selected for emphasis in text boxes and are linked, with 
permission, to the interviewee that made the statement.2 
 
Key Strengths and Weaknesses. Planners, providers, and staff all expressed full support 
for the HIV/AIDS Continuum of Care Model, saw it as providing appropriate direction 
for HIV/AIDS services in the County of Los Angeles, and described weaknesses more in 
terms of challenges in implementing the model. Interviewees tended to pair strengths and 
weaknesses rather than to list discrete or unrelated strengths or weaknesses. 
 
 The model is a “true attempt at integration” and looks at “HIV disease as a Continuum 
of Care.” However, it is “difficult to get providers to look at HIV in this same way,” to 
not look at the service they provide as a distinct unit. Providers need to work within the 
linkages and “view the client’s overall care as a continuum.” 
 
 The HIV/AIDS Continuum of Care 
Model recognizes that each client is an 
individual with “a specific need for a 
specific set of services.” However, the 
geography of the County of Los Angeles is 
very large and is “hard to navigate 
services.” This allows for “splitting and 
duplication of services” within the 
Continuum of Care Model. 
 
The model “clarifies the whole spectrum of need” but it is sometimes “unclear that just 
because the service is needed does not mean RWCA funds will provide it.” 
 
 The model actually synthesizes “all that has gone on before in HIV” and presents this 
as a “phenomenal Continuum of Care Model.” However, the presentation is “not simple 
enough” for those who do not have “a historical background in HIV.” It is hard to “get the 
whole meaning of the recipe” and there is “not enough room to learn” about the model. 
 
 The model identifies needs overall and “allows the County of Los Angeles to take a 
look at how the County should respond” to these needs. The model “shows that services 
are interlinked and there must be collaboration among the agencies.” However, the model 
does not have “specific pathways” that describe how the 
model will be implemented across the County of Los 
Angeles. 
 
 The model “envisions a continuum that is not linear.” 
It is “holistic and it reflects accurately the multiple 
points of entry” needed in a Continuum of Care Model. 
                                                 
2
 Any misstatement in the paraphrased or directly quoted  
phrases is the unintended error of Mercer. 
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  Wilbert C. Jordan, MD, MPH 
 
“’Barriers’ is the wrong word. I am not sure we 
are aware, it has not been put to us right. My 
plate is full. We need someone to come and point 
out to us what we need to do on-site.” 
 
“We have to find people who are interested in 
broadening their horizons. We need people with 
greater interests. Then, we have to teach them 
when they do become interested. We need a way 
to feed each other within regions or districts, not 
just at the Commission where things have gotten 
very technical.” 
The model promotes the understanding that “not everyone will experience the Continuum 
of Care Model the same.” Not actually a weakness of the model, but when applying the 
model “it is difficult to comply with the requirements of funders who are more rigid and 
more linear in their thought patterns.” 
 
 The “concept is ideal. People are not linear and need many things.” However, “we need 
to communicate it better” and the model “assumes that people have skill sets they don’t 
have, like prevention skills.” 
 
 The model “wants you to institute other aspects of care, not just medical care, and it 
supports patient involvement. It supports the Primary Health Care Core Services 
having linkages between the patient and the community. It breaks down a lot of barriers 
for people with chronic illness.” However, the model is challenged by “changing dollars” 
and by “changing types of patients” whose health management is more difficult.  
    
Barriers to Attaining the Model’s Goals.  
The goals related to the HIV/AIDS Continuum of Care Model discussed in this review are 
those described in the County of Los Angeles HIV/AIDS Comprehensive Care Plan 
(August 2002). Interviewees were encouraged to refresh themselves generally on these 
goals prior to the interview.  
 
 The procurement process cannot be “based solely on the Continuum of Care Model” 
and both the “preservation of historically-funded agencies” and “stakeholder protection” 
is sometimes barriers to making the changes needed in the service delivery system. 
 
 The “system had already developed and grown large” before the new Continuum of 
Care Model was approved. Changes after-the-fact are difficult to make. Also, providers in 
the Continuum of Care “get funding through different streams” and these funders have 
“existing mind-sets” that differ from the goals of the HIV/AIDS Continuum of Care 
Model. 
 
 The goal of the Continuum of Care Model “is really seamless services and the barriers 
are logistic. Seven to ten ‘Centers of Excellence’ are needed that are medically-centered 
with support services built around them.” 
 
 The goals require “changes to the way services 
have been organized traditionally” and “working 
with new partners” is sometimes a barrier for 
providers who have been “working within the same 
structures for 15 to 20 years.” It is “hard for some 
providers to affect ‘cultural diversity’ because of 
who they are and where they are.” 
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 The Continuum of Care Model’s goals and objectives are “not yet incorporated into 
agency contracts” and many providers “do not know there are goals related to an 
HIV/AIDS Continuum of Care Model.” Most providers are “responding to the contract 
deliverables only and are not involved in setting the goals” and “do not see how the 
money plays out according to the new continuum.” 
 
 Agencies do not have the funds and “lack the infrastructure to make this [meeting the 
goals] happen. Medical staffs are being pulled off to get other things done. There is a 
nursing shortage.” 
 
 It is hard to know if goals are being met when data is not being collected that is needed 
to measure the goals. Agency staff is not “computer savvy” and “overall technological 
capacity is low.” There needs to be an “integrated, standardized Continuous Quality 
Improvement Program across the board.” 
 
 HIV/AIDS is a “difficult disease to manage and you have to help clients manage their 
lives” to manage HIV disease well. “You have to have help; you must be a part of a 
network and providers lack knowledge about how this type of network works.”  
 
Opportunities to Address Barriers and Enhance the Model. The interviewees were 
uniformly engaged in offering suggestions for how to address barriers they identified. 
Rather than offering suggestions on ways to change the conceptual model, suggestions 
were made for how to enhance abilities to fully implement the model as currently defined. 
The suggestions may be summarized as follows: 
 
1) Continuing education and technical support is needed to assist planners and providers 
in transitioning from thinking about discrete services to thinking about services in a 
Continuum of Care Model and how one set or category of HIV services relates to 
other sets or categories of services. 
 
 Staff providing services need education and on-site support to apply “this 
thinking” to direct patient prevention and care services. 
 
2) More attention should be directed toward a “system-wide approach” to evaluation and 
Continuous Quality Improvement Program, together with concrete support to agency 
staff to collect and synthesize computerized service utilization and service outcome 
data. 
 
3) Hands-on assistance to develop effective partnerships and practical training on how to 
work within service partnerships, across professional, cultural, social, and 
geographical boundaries is needed. 
 
 Medical care and social service providers need to “better align themselves as 
equally necessary partners, creating cohesion and unity in the continuum.” 
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4) Opportunities for providers and planners within regions or districts to “talk about how 
the whole continuum is evolving” should be available, and an improved 
approach/method for needs assessment must be developed. 
 
Linking Incentives to the Model. This section of the Work Order Request was 
conceptualized when the County of Los Angeles HIV/AIDS service environment 
included a few providers who, on their own initiative or through special demonstration 
funding, were attempting to innovatively restructure services in a way that now 
corresponds to the HIV/AIDS Continuum of Care Model. The question was how to 
motivate or “incentivize” all agencies to exceed program standards and adopt the 
innovations, particularly the integration of prevention with care and treatment services, 
when federal program guidance did not yet require these changes.  
 
The development of the HIV/AIDS Continuum of Care Model occurred during this same 
period. Many of the innovative features of the model were included as a way to prepare 
the County of Los Angeles service providers for the anticipated adoption of these same 
features as program standards by federal sources like the RWCA and the Community HIV 
Prevention Planning Programs. Over the last two years, national standards of care and 
federal program guidance indeed have been revised. Service innovations once seen as 
exceeding the requirements are now national standards within federally-required models 
of service delivery.  
 
While some technical aspects and innovative features of the HIV/AIDS Continuum of 
Care Model may not be fully understood by all County of Los Angeles providers, 
interviewees agreed the model has become the normative standard to guide an evolving 
HIV/AIDS service delivery system in the County of Los Angeles. Interviewees were 
uniformly in support of incentives (i.e., technical assistance, educational opportunities, 
skills, and capacity-building initiatives) to encourage continual organizational 
improvement among all agencies. “Money” was described as a tool, an appropriate and 
needed tool, for providing quality services or for constructing a changed system of care. 
Interviewees uniformly agreed provider agencies should be fully reimbursed for actual 
costs associated with fulfilling the expectations of the model. However, interviewees also 
uniformly agreed agencies “should not simply be given more money” because they meet 
the expectations of the HIV/AIDS Continuum of Care Model.  
 
While interviewees acknowledged the growing problem of increasing administrative and 
service mandates in a shrinking funding environment, most were more concerned about 
how to capture financial information in order to be able to “maximize the use of RWCA 
funds” to fully support needed services. Planners, providers, and staff wanted to know 
how to stretch funds efficiently to meet unmet needs rather than augmenting agency 
budgets as a way to motivate compliance with Continuum of Care Model standards. 
Others expressed a priority for addressing disparities in agency funding and capacity that 
are evident across districts and the County of Los Angeles service planning areas before 
“rewarding agencies with more money.” 
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Mercer Observations and Recommendations: the 
County of Los Angeles HIV/AIDS Continuum of Care 
Model 
 
1) Based on Mercer’s review of the current national HIV/AIDS standards of care and the 
commitment of those interviewed to implementing the HIV/AIDS Continuum of Care 
Model, Mercer recommends OAPP and its partners in planning and systems 
development; continue on the established course with the model as currently defined.3 
 
 One interviewee commended the HIV/AIDS Continuum of Care Model’s ability 
to “define the relationship between services.” This is a critical point: the model 
clusters services in relationship to desired health outcomes, suggesting that certain 
clusters of services must be available to any one single patient if a specific health 
outcome is desired. Other interviewees noted the necessity of providing services 
within a network of providers; necessary because, again, certain clusters of services 
are needed to produce certain desired health outcomes, and no one agency offers all 
services within the HIV/AIDS Continuum of Care Model. 
 
 Providers are socialized into thinking more categorically and singularly about the 
services they provide. Mercer recommends continuing education of provider agencies 
on the “relationship between services” as this will facilitate agency partnership 
development and will lead naturally into a shared quality assurance approach for the 
resulting service delivery system.  
 
2) Having turned a sophisticated corner in defining a state-of-the-art HIV/AIDS 
Continuum of Care Model and setting expectations for its full implementation, Mercer 
concurs with OAPP’s first step of establishing the costs associated with the provision 
of state-of-the-art services and determining a rate of reimbursement to financially 
support agencies in providing these services.  
 
 While financial reimbursements are typically prominent in discussions of service 
delivery expectations, adequate financial reimbursements alone will not assure the full 
implementation of the HIV/AIDS Continuum of Care Model. Mercer suggests OAPP 
engage in technical assistance and capacity-building efforts targeted specifically to 
                                                 
3
 Due to the legislative requirements for Priority and Allocations in the RWCA, the Commission and OAPP 
engage in discussions annually about the rank order of services in the HIV/AIDS Continuum of Care 
Model. This activity is relevant to meeting grant requirements but is no longer particularly helpful in 
solving more complex implementation problems posed by providing HIV/AIDS services in the County of 
Los Angeles. Therefore, “as currently defined” indicates, Mercer finds the components of the HIV/AIDS 
Continuum of Care Model to be well defined; it does not indicate support for or against the rank ordering of 
services in any one specific grant year.   
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agencies needing support to fulfill the service expectations set by the HIV/AIDS 
Continuum of Care Model. 
 
3) HIV/AIDS is still a service environment where key individuals personally impact the 
availability and quality of services within and among agencies. Mercer encourages 
efforts by OAPP to develop and sustain visionary leadership among agency directors 
(and other managers) and among health care providers employed in managerial roles. 
A shared vision and continued inspiration for the HIV/AIDS Continuum of Care 
Model among agency medical and managerial leaders will directly impact the success 
if its implementation across the County of Los Angeles.  
 
 Leadership development among direct care providers is another area to target for 
HIV/AIDS Continuum of Care Model support. Because of the conflict of interest 
concerns in RWCA and Community HIV Prevention Planning, finding a way to 
involve direct care providers in system of care development can be a challenge. 
Providers will be interested most in how the HIV/AIDS Continuum of Care Model 
concretely, practically is applied in direct care or practice settings. Mercer 
recommends OAPP create special opportunities to support peer relationships among 
health care practitioners, and use these relationships as a way of mutually encouraging 
and supporting state-of-the-art service provision.   
 
Mercer wishes to express gratitude to the following individuals for their insight and 
perspectives on the HIV/AIDS Continuum of Care Model provided through interviews. 
 
Commission and PPC Members/Staff 
Fariba S. Younai, DDS 
Clinical Professor, Oral Biology and Medicine 
UCLA School of Dentistry 
 
Anna Long, Chief of Staff of Public Health 
County of Los Angeles, Department of Health Services 
 
Kathy Watt, Executive Director 
Van Ness Recovery House 
 
Wilbert C. Jordan, MD, MPH 
Medical Director, Oasis Clinics HIV/AIDS Programs 
 
Craig Vincent-Jones, Executive Director 
Commission on HIV 
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HIV/AIDS Service Providers 
Deborah O. Collins, MPAS, PA-C 
Director, Preventive Health Clinical Services 
City of Long Beach, Department of Health and Human Services 
 
Andrew Signey, Assistant Director 
St. Mary’s Medical Center, CARE Programs and Clinics 
 
Nick Rocca, LCSW 
Clinic Administrator, HIV Division 
Katrin Dayanim, Grants and Contracts Manager 
North East Valley Health Corporation 
 
 
OAPP Staff 
Sophia Rumanes, Program Supervisor 
Prevention Services Division 
 
Rochelle Floyd, RN, MSN, FNP 
Program Manager, Medical Outpatient, CARE Services Division 
 
Phillip Barragan, Program Manager 
Medical Outpatient, CARE Services Division 
 
Shirlissa Johnson-Edwards, RN, BSN 
Public Health Nurse, Medical Outpatient, CARE Services Division 
 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
 
C 
Provider and Other Stakeholder Input 
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Stakeholder and Provider Input into the Mercer Rate Study 
 
As described in the report narrative in Section 3, “Service Description Development”, 
Mercer received input from stakeholders and HIV/AIDS service providers during the 
course of the study. The individuals providing input are listed below, categorized 
according to the specific aspect of the study in which they participated. 
 
1. Review of the HIV/AIDS Continuum of Care Model 
   
Commission and Prevention Planning Committee (PPC) Members/Staff included:  
 Fariba S. Younai, DDS, Clinical Professor, Oral Biology and Medicine, UCLA 
School of Dentistry; Anna Long, Chief of Staff of Public Health, County of Los 
Angeles, Department of Health Services; Kathy Watt, Executive Director, Van 
Ness Recovery House; 
 Wilbert C. Jordan, MD, MPH, Medical Director, Oasis Clinics HIV/AIDS 
Programs; and,  
 Craig Vincent-Jones, Executive Director, Commission on HIV.  
 
HIV/AIDS Service Providers included:  
 Deborah O. Collins, MPAS, PA-C, Director, Preventive Health Clinical Services, 
City of Long Beach, Department of Health and Human Services; 
 Andrew Signey, Assistant Director, St. Mary’s Medical Center, CARE Programs 
and Clinics;  
 Nick Rocca, LCSW, Clinic Administrator, HIV Division;  
 Katrin Dayanim, Grants and Contracts Manager, North East Valley Health 
Corporation.  
 
OAPP Staff included:  
 Sophia Rumanes, Program Supervisor, Prevention Services Division; 
 Rochelle Floyd, RN, MSN, FNP, Program Manager, Medical Outpatient, CARE 
Services Division;  
 Phillip Barragan, Program Manager, Medical Outpatient, CARE Services 
Division; and  
 Shirlissa Johnson-Edwards, RN, BSN, Public Health Nurse, Medical Outpatient, 
CARE Services Division. 
 
2. Service Description Focus Group 
 
Participants were asked to sign an OAPP sign-in sheet. Representatives from the 
following agencies (listed in order of signing) attended the Focus Group:  
 
 Mallory Witt, MD and Julie Rees from Harbor-UCLA;  
 Adam Ouderkirk, Peter Reis and Scott McKenzie from AIDS Health Care 
Foundation;  
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 David Burdem and Wilbert C. Jordan, MD, from OASIS;  
 Maxine Liggins from Public Health/SPA 5 and 6; and,  
 Felix Carpio, MD from AltaMed.  
 
OAPP Staff attended the Focus Group also, including Jan King, MD, Medical 
Director, who provided comments. 
 
3.  Private Physician Unfunded by RWCA 
 
Feedback from a physician practicing in the private sector, not currently funded by 
OAPP, was provided by Mark Katz, MD (Regional HIV/AIDS Physician Coordinator, 
Department of Internal Medicine, West Los Angeles Kaiser Permanente) reviewed the 
HIV/AIDS Ambulatory/Outpatient Medical Care Services service description. Mark Katz, 
MD was selected by OAPP as a reviewer representing the private sector. 
 
4. ADAP Enrollment Clarifications 
 
Providers giving input on timeframes for enrollment for ADAP services were Irma 
Ramirez and Deama Sherman, both ADAP enrollment coordinators in locally funded 
agencies. 
 
5. Home Based vs. Medical Case Management Clarifications 
 
The question as to whether the new Medical Case Management model would duplicate 
services provided in the Home Based Case Management Program was raised by Felix 
Carpio, a Focus Group participant. The question was further researched with the OAPP 
Attendant Care and Homemaker Services staff members, Roberta Young and Bonnie 
Moore.  
 
6.  Written Comments from a Commission Member 
 
Brad Land, HIV+ Fifth District Commissioner, sent written questions to OAPP that were, 
in turn, forwarded to Mercer.  
 
7.  On-site Provider Reviews 
 
Two Mercer staff visited providers in January 2007.  Please see Appendix D for more 
information. 
 
8.  Provider Meeting on Draft Report 
 
Mercer presented information and listened to provider feedback in a meeting on October 
31, 2007 after release of draft report. 
 
9.  Review of Provider Written Comments 
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Provider comments provided from November 2007 to January 2008 were reviewed. 
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D 
Executive Summary of HIV/AIDS Medical Outpatient 
Services Rate Study:  Provider Site Visits (January 
2007) 
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Executive Summary 
The Los Angeles County (County) Department of Public Health, Office of AIDS 
Programs and Policy (OAPP) directs the overall response to the HIV/AIDS epidemic in 
the County under the supervision of the County’s Board of Supervisors. As part of its 
mandate, OAPP contracts with numerous service providers (Providers) in various 
categories to provide high quality and cost-effective care services to HIV-positive 
residents of the County. OAPP contracts with both County operated and private 
outpatient medical clinics to provide comprehensive primary care to individuals 
diagnosed with HIV/AIDS. Currently, OAPP reimburses its 24 contracted outpatient 
medical clinics through a traditional line-item budget process. The Board of Supervisors 
requires OAPP to consider a cost reimbursement methodology that will encourage 
Provider accountability and productivity, track utilization more effectively, and ensure 
that Providers are utilizing other funding resources, such as MediCal, when available. 
Based on a competitive bid for Work Order Request No. 6-49 issued by the Department 
of the Auditor-Controller of the County, Mercer Government Human Services Consulting 
(Mercer) was engaged to complete this study and meet the aforementioned Board of 
Supervisors/OAPP objectives. Because of the number and complexity of services 
included in primary care ambulatory outpatient medical care, and in an effort to ensure 
Providers are not overburdened with billing and reporting requirements, the rate 
architecture for this particular service is being developed separately and will be discussed 
in the final report. 
 
As part of the rate study development process, Mercer drafted service descriptions for 
four service areas including medical outpatient care. A careful review of the draft service 
descriptions was completed by both the Commission on HIV (COH) and the OAPP 
contracted HIV/AIDS outpatient service Providers. This analysis prompted a series of rate 
study related questions from community stakeholders, including the HIV Medical 
Outpatient Providers Caucus (Caucus). In response to the concerns raised related to the 
rate study development process, OAPP revised the Mercer rate study deliverables to 
include six to eight on-site visits to medical outpatient Providers, and one community 
stakeholders meeting to allow for additional rate study input and clarification. In 
consideration of recommendations offered by the Caucus, OAPP scheduled site visits for 
Mercer that reflected the diversity of the Provider types (small, large, HIV only, HIV in a 
primary care setting, rural, single site, multi-site, hospital-based, County Provider site, 
etc.) and represented each Service Planning Area (SPA). Providers not hosting a site visit 
were invited to attend the Stakeholders meeting with Mercer and OAPP to be held after 
the completion of the scheduled site visits. The Stakeholders meeting was open to all 
OAPP-funded medical outpatient Providers and offered an opportunity to share any 
additional rate study related input not captured through the site visits.  
 
To assist in this information gathering effort, a Discussion Guide was created by OAPP, 
with input from the Caucus, and was distributed prior to the site visits. Providers hosting 
a site visit were advised to be prepared to answer questions listed in the Discussion Guide 
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at the time of the site visit. Providers not hosting a site visit were encouraged to complete 
the Discussion Guide and submit their responses to OAPP. 
 
To ensure that the clinical complexities in the treatment of HIV/AIDS and the breadth and 
depth of the services being delivered by the Providers would be captured during this 
process, OAPP requested that a clinician with expertise in HIV/AIDS conduct the site 
visits. Mercer’s Linda Shields, RN, BSN, of the Clinical and Behavioral Health Services 
division conducted a total of seven site visits, two Provider interviews at the OAPP 
offices, and participated in the Stakeholders meeting. Additionally, Mercer’s John 
Villegas-Grubbs, Rate Architect Consultant, participated in the series of visits, interviews, 
and meetings in order to gain a better understanding of the financial operations of the 
Providers. Mr. Villegas-Grubbs provided clarification on the methodology of the rate 
architecture, as well as gathered anecdotal information to support calculations to be 
performed on the cost components being used in the study. Providers were asked to 
submit general ledgers as well as cost reports to assist in the calculations. 
 
On-site visits were conducted with AIDS Healthcare Foundation, The Catalyst 
Foundation, City of Pasadena Andrew Escajeda Clinic, St. Mary Medical Center 
C.A.R.E. Clinic, Northeast Valley Health Corporation, L.A. Gay & Lesbian Center, and 
Harbor-UCLA Medical Center. A joint interview session was conducted at the OAPP 
offices with Watts Healthcare Corporation and T.H.E. Clinic, Inc. A total of 11 Providers 
attended the Stakeholders meeting including AIDS Healthcare Foundation, The Catalyst 
Foundation, City of Pasadena Andrew Escajeda Clinic, St. Mary Medical Center 
C.A.R.E. Clinic, L.A. Gay & Lesbian Center, Northeast Valley Health Corporation, Watts 
Healthcare Corporation, T.H.E. Clinic, Inc., AltaMed Health Services, El Proyecto del 
Barrio, and Martin Luther King Jr. / Charles Drew OASIS Clinic. An additional 5 
Providers completed the Discussion Guide questionnaire, including: AltaMed Health 
Services, El Proyecto del Barrio, Martin Luther King Jr. / Charles Drew OASIS Clinic, 
Childrens Hospital Los Angeles Division of Adolescent Medicine, and East Valley 
Community Health Center HIV Comprehensive Care Clinic. General ledgers were 
submitted by Watts Healthcare Corporation, AltaMed Health Services, The Catalyst 
Foundation, City of Pasadena Andrew Escajeda Clinic, Northeast Valley Health 
Corporation, AIDS Healthcare Foundation, L.A. Gay & Lesbian Center, St. Mary 
Medical Center C.A.R.E. Clinic, and El Proyecto del Barrio. A summary of Provider 
participation is included as Appendix A. 
 
 
Findings 
The outcomes and findings that emerged during this information gathering phase of the 
study are documented in the report in detail and sorted by individual Provider. 
Additionally, an overview of the collective findings is presented below.  
 
 The patient demographics within each SPA varied tremendously. There were 
differences noted between individual Providers within the same SPA. This diversity is 
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not significantly unusual, as it appears to be a reflection of the diversity of the general 
population of the County itself. Demographics varied by age, race, and lifestyle. The 
average patient’s age fell within the 25 – 49 year old range. Although Caucasians 
made up a large portion of the HIV/AIDS population, there was a significant number 
of ethnic minorities represented. Males made up the majority of the cases; however, 
the number of females was reportedly growing. Substance Abuse and homelessness, 
as well as an increasing number of undocumented clients, was noted throughout the 
County. 
 
 Comorbidities consistent across each SPA were Depression/Mental Health, Substance 
Abuse, Hepatitis C, and Cardiovascular Conditions, particularly Hypertension. The 
lack of antihypertensives on AIDS Drug Assistance Program (ADAP) formulary 
presented treatment issues for many. Also notable was the rise in the incidence of 
sexually transmitted diseases (STDs) including a high reinfection rate. The most 
prevalent of which being Syphilis.  
 
 
 Service delivery patterns of each Provider appeared to be adapted to meet the specific 
needs of their community and the patient demographics they served. Community 
dynamics varied around each Provider location from an existing HIV/AIDS stigma 
and phobia to a strong history of activism, acceptance, and general support.  
 
 Providers indicated they were overburdened with billing and reporting requirements 
from various Funders, both private and government. There were multiple forms to 
complete and numerous data entry screens necessary to input required client 
documentation. Most found the information system “Casewatch” to be cumbersome 
to navigate, and resource intensive with issues such as: connection drops; mandated 
fields for every entry; difficult to update; confidentiality concerns using a shared 
system; conflicts with Providers internal organizational Privacy Policies; lack of 
interface with existing systems, and a backlog of cases to be entered. Also, extensive 
time was noted to be spent by Direct Care Staff completing supplemental services 
forms such as Housing, ADAP, Dental, Disability, Food Provisions, as well as 
reviewing and processing medication refills, lab and testing results, and clinical trial 
progress. There were eligibility, payment and denial issues, as well as difficulties in 
getting clients enrolled in other programs such as MediCal.  
 
 The majority of Providers struggled with treatment issues resulting from lack of 
timely access to specialists and subspecialists. The most difficult referrals to obtain 
throughout the County were consistently those to Orthopedics, Neurology, 
Dermatology, and Gastroenterology. Additionally, lack of access to Preventive Health 
services was noted within every SPA particularly in the areas of colon cancer 
screenings (flex sig/colonoscopy) and breast cancer screenings (timely 
mammograms). 
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 Transportation costs and coordination was a barrier to service and care for many. 
Whether it was due to the geographic distances between necessary services, or the 
homelessness and transience, or the poverty level of the clients who had neither a car 
nor funds for a bus, it remained a concern throughout the County.  
 
 The staff at each site visited appeared to be dedicated and personally committed to 
serve the population. Many of whom would work additional uncompensated hours, 
and/or donate needed resources. However, the Nursing shortage and lack of qualified 
medical staff (HIV experience and interest) as well as insufficient, noncompetitive 
salaries and benefit packages is causing staffing challenges for all Providers. 
 
 
Recommendations 
The report provides recommendations intended to assist OAPP and key stakeholders in 
addressing the barriers to service and care delivery and to ensure successful 
implementation of the new rate architecture.  
 
 Because the science and practice of HIV/AIDS medical management continues to 
rapidly evolve, Mercer recommends OAPP continue to collaboratively work with 
Providers to remove barriers to delivering and providing access to quality care and 
service within the County by such means as:  
 
– Encourage the use of the Caucus as a forum for Quality Improvement initiatives, 
such as the sharing of best practices in both care and service. 
 
– Continue to implement its public health role, in collaboration with Providers, in 
distributing standard of care revisions and updates. 
 
– Assess and respond to the unique needs within specific patient demographics and 
evaluate service variances. 
 
– Continue in its role in Provider education, training, development, and capacity-
building. 
  
– Reevaluate OAPP’s data needs and collection methods, assessing the impact of 
the reporting requirements to the Providers overall resources, as well as potential 
integration with their existing Informatics and Financial Systems. 
 
– Work collaboratively with the Caucus, the local Physician community, and 
existing stakeholders to evaluate methods of attracting and retaining Specialty and 
Subspecialty services for the HIV/AIDS population. 
 
 
 MediCal is a significant, albeit, a complex source of funding for HIV/AIDS services 
and it is critical that Providers maximize the funding available through this 
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entitlement program. The Ryan White Comprehensive AIDS Resources Emergency 
(CARE) Act legislation mandates that CARE Act funds be the payer of last resort, 
and the Health Resources and Services Administration (HRSA) has mandated that 
wherever other programs such as Medicaid exist for HIV/AIDS services, these funds 
must be maximized before using Ryan White CARE Act funding. Based on these 
mandates, many states and jurisdictions require their HIV/AIDS Providers actively 
participate in the Medicaid program. For the selected services in the County, Mercer 
recommends the following to OAPP:  
 
– Work closely with the Providers to identify and clearly define HIV/AIDS services 
that could be reimbursed by MediCal and to identify the appropriate MediCal 
programs/Waivers that Providers may participate. 
  
– Collaborate with the California Department of Public Health/Office of AIDS to 
increase awareness and knowledge among Providers of the importance and need 
for maximizing MediCal funding for individual service components that are 
delivered. DHS provides training sessions to Providers on various topics related to 
the MediCal program. Providers should be encouraged to participate in these 
training opportunities. 
 
– Consider use of OAPP’s established training curriculum to offer additional 
training and technical assistance to Providers on the utilization of MediCal as a 
funding source. This is an area that has been deemed a HRSA priority and Ryan 
White grant funds have been utilized in other states to offer this type of technical 
assistance. In the past, HRSA has provided third party payment training in the 
County. Attendance at these types of training should be mandatory for Providers 
that contract with OAPP. 
  
– Audit a random sample of medical files and claims information from various 
Providers to determine if MediCal funding is underutilized. Additionally, conduct 
an analysis of trends in MediCal denials (reasons and frequency), as well as issues 
in eligibility. 
 
Mercer is privileged to have had the opportunity to work with OAPP and the Providers in 
the County on this exciting and innovative segment of the rate study. Based upon 
Mercer’s experiences in the areas of HIV/AIDS and rate development across the US, it is 
clear that the County is a leader in the effort to implement a structured model of equitable 
reimbursement methodology for HIV/AIDS services, while upholding appropriate clinical 
standards and practices, thereby ensuring both high quality and cost-effective service 
delivery. Mercer is confident that through the collaboration of the County and its 
HIV/AIDS Providers, a planned and coordinated implementation strategy, and 
appropriate training for all those involved, OAPP will be able to successfully implement 
this rate architecture and thereby serve as a model for other HIV/AIDS programs 
nationwide. 
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Department of Public Health  
Office of AIDS Programs and Policy 
 
Medical Clinic Services 
 Special Rate Study 
 
HIV/AIDS AMBULATORY/OUTPATIENT MEDICAL CARE 
SERVICES DESCRIPTION  
 
This service description is adopted by the County of Los Angeles, Department of Public 
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the 
development and implementation of HIV/AIDS Ambulatory/Outpatient Medical 
(AOM) Care Services to individuals at risk for and living with HIV/AIDS. Federal 
legislation, policy and program guidance, and State of California statutes, regulations, and 
rules governing licensing and service provision, supersede the HIV/AIDS AOM Care 
Services description. 
 
SERVICE 
HIV/AIDS AOM Care Services  
 
TABLE OF CONTENTS Page 
Description ..................................................................................... 1 
Program Requirements .................................................................. 2 
Definition of Encounter ................................................................ 10 
Required Staffing ......................................................................... 11 
 
DESCRIPTION 
HIV/AIDS AOM Care Services are provided by a Medical Doctor (MD) or Doctor of 
Osteopathic Medicine (DO), Physician’s Assistant (PA), or Nurse Practitioner (NP) in an 
outpatient, community-based, or office-based setting. HIV/AIDS AOM Care Services 
are provided in accordance with the Los Angeles Commission on HIV Standards of Care, 
Medical Outpatient Services (final January 13, 2006) and form the critical foundation of 
the HIV/AIDS Continuum of Care adopted on October 14, 2004. 
     
HIV/AIDS AOM Care Services are guided by practice guidelines and protocols (i.e., 
www.hopkins-aids.edu, www.hivguidelines.org, or www.hab.hrsa.gov) consistent with 
the Public Health Service (PHS) guidelines (www.aidsinfo.nih.gov/) and the Los Angeles 
Commission on HIV Standards of Care. 
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Clinic Management 
Policies, Protocols, and Procedures 
For assistance in developing 
administrative policies and 
procedures related to clinical 
and health program 
management, consult the 
technical assistance and training 
services available through the 
National Association of 
Community Health Centers, 
HIV/AIDS AOM Care Services funded by the OAPP are implemented in a service 
delivery environment where other models of HIV/AIDS primary care are developed and 
supported by other funders (e.g., the “Early Intervention Program” funded through the 
State of California, Office of AIDS). While there may be differences in the service 
delivery requirements among these programs, it is the intent and practice of OAPP to 
collaborate and cooperate with other funded programs so as to not create unnecessary 
barriers or impediments for clients who utilize these programs. 
 
PROGRAM REQUIREMENTS 
The following requirements are minimum for HIV/AIDS AOM Care Services; provider 
agencies providing these services may exceed these requirements. 
 
General Requirements: The provider agency must ensure its ability to meet the needs of 
the client by meeting the following general requirements: 
 
 Administrative and Clinical Policies and Procedures. The provider agency must 
develop, implement, and revise, as necessary, standardized administrative policies and 
procedures and clinical protocols to comprehensively guide the HIV/AIDS AOM 
Care Services, including assessment, treatment, and referral of clients. The 
procedures and protocols must be submitted to OAPP for review and approval upon 
request. Upon request, revisions to the procedures and protocols may require OAPP 
approval.  
 
Provider agencies must have a Client Grievance 
Policy and Procedure that is reviewed with each 
client in a language and format the client can 
understand. A written copy must be provided to 
each client and a signed and dated receipt form 
must be included in each client record. All 
AOM professionals must comply with the 
established process for client grievances. 
 
 Tuberculosis Screening. All HIV/AIDS AOM 
Care Services staff, other provider agency 
employees, volunteers, and consultants must be 
screened for tuberculosis when providing services to persons with HIV disease or 
AIDS and who have routine, direct contact with clients. Provider agencies must 
comply fully with the “Guidelines for Tuberculosis Screening” required for all 
agencies with County of Los Angeles contracts. 
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Clinical Trials 
AIDS Clinical Trials Group (ACTG):  
AIDS Clinical Trials Info: (800) 874-2572 
HIV/AIDS Treatment Info Service: 
www.aidsinfo.nih.gov 
  
New Guidelines: nPEP 
 
Antiretroviral Postexposure 
Prophylaxis After Sexual, 
Injection-Drug Users, or Other 
Nonoccupational Exposure to 
HIV in the United States: 
Recommendations from the U.S. 
Department of Health and Human 
Services. MMWR 2005;54 (No. 
RR-2). 
 
 Postexposure Prophylaxis (PEP). Provider agencies must have a policy and procedure 
to reduce the risks for occupational HIV and Hepatitis exposure. Provider agencies 
must aggressively promote and monitor risk reduction behaviors and must actively 
support HIV/AIDS AOM primary care professionals in PEP (National Clinician’s 
PEP Hotline: (800) 448-4911 or www.ucsf.edu/hivcntr; Hepatitis Hotline: (888) 443-
7232 or www.cdc.gov/hepatitis; Reporting of Occupationally Acquired HIV: (800) 
893-0485). 
 
 State Mandated HIV Reporting. Consistent with the State Health and Safety Code 
(Section 2643.5), all AOM practitioners and OAPP-funded County of Los Angeles 
and community-based HIV medical outpatient clinics must comply with the mandated 
reporting of clients whose laboratory test results indicate HIV, a component of HIV, 
or antibodies to or antigens of HIV. Each HIV/AIDS AOM practitioner must, within 
seven calendar days of receipt of a client’s confirmed HIV test, report the client's full 
name, date of birth, and gender.  
 
 Clinical Trials. The provider agency’s 
HIV/AIDS AOM Care Services must 
be directly linked with AIDS clinical 
treatment units and research consortia 
of community physicians. 
 
 Clinical Care Protocols. The HIV/AIDS AOM Care Services must be consistent 
with the PHS guidelines (www.aidsinfo.nih.gov) and the Los Angeles Commission on 
HIV Standards of Care.  AOM Care primary care professionals must utilize 
established practice guidelines in order to facilitate consistency in providing state-of-
the-art prevention and care services for all clients. 
   
HIV/AIDS prevention and care practice guidelines may be downloaded or ordered in 
bulk from the following websites: Los Angeles Commission on HIV Standards of 
Care (www.hivcommission-la.info/soc.asp) Johns Hopkins AIDS Service 
(www.hopkins-aids.edu), New York Department of Health 
AIDS Institute (www.hivguidelines.org), federal HIV/AIDS 
Bureau (www.hab.hrsa.gov), and CDC’s Division of AIDS 
Prevention-Treatment (www.cdc.gov). [A Guide to Primary 
Care for People with HIV/AIDS, 2004 provides clinical 
 Guidelines for Tuberculosis Screening 
The TB Control Program 
2615 S. Grand Avenue, Los Angeles, CA 90007 
(213) 744-6151 
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National HIV 
Telephone 
Consultation Service 
Warmline 
 
(800) 933-3413 
treatment guidelines in a question-and-answer format to health professionals treating 
adults living with HIV/AIDS. CD-ROM, 
www.ask.hrsa.gov/detail.cfm?id=HAB00355, with a Pocket Guide, 
www.hab.hrsa.gov/tools/HIVpocketguide/index.htm.]  
  
HIV/AIDS AOM health care professionals are encouraged to remain current with the 
research literature related to adherence by referencing the American Public Health 
Association’s special HIV/AIDS treatment adherence initiative: “Best Practices: 
Adherence to HIV Treatment Regimens” (www.apha.org: “Science & Programs”). 
 
 AOM HIV Prevention and Disease Management Competency. The provider agency 
must have personnel policies and procedures requiring and supporting the continued 
education of all HIV/AIDS health care professionals. Provider agencies are expected 
to budget costs for HIV/AIDS continuing education, specifically in HIV prevention 
and disease management, to purchase practice guidelines in formats easily accessible 
and usable for practitioners, and to provide routine access to computerized 
educational and prevention/care treatment problem-solving (i.e., 
www.thebodypro.com, www.hivinsite.ucsf.edu, www.hopkins-aids.edu, or 
www.nlm.nih.gov/medlineplus/aids.html).  
 
 
 
 
 
 
 
Provider agencies must have consultation protocols to assist 
HIV/AIDS AOM health care professionals in easily seeking 
expert advice and consultation whenever there is any 
question about the best way to manage a specific client. This 
is especially important when a client is experiencing ARV 
treatment failure or when a client with advanced HIV 
disease is vulnerable to multiple opportunistic processes. 
Seeking expert advice and utilizing the many local or 
regional university-based consultation services is evidence 
of competent prevention and disease management. 
 
 Client-Staff-Colleague Communication. Provider agencies must have current written 
policies and procedures addressing communications between the AOM staff, clients, 
or other professionals. 
 
 Client Appropriateness for Provider Agency Services. Prior to or during an initial 
assessment, if it is determined the medical needs of the client cannot be met by the 
agency providing HIV/AIDS AOM Care Services, a referral must be made to an 
Clinical Management of the HIV-Infected Adult: A Manual for Mid-Level Clinicians 
http://bphc.hrsa.gov/quality/HIVAIDSManual.htm 
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Medical Record  
has Current? 
 
Problem Lists 
Medication Lists 
Flow Sheets 
Lab Reports 
Special Study Reports 
Consult Reports 
Inpatient Discharge 
Summaries 
Immunizations 
Risk Assessments 
Verification of HIV Status 
Patient 
Records of Health Maintenance Activities Appropriate 
for HIV Infected Individuals 
Influenza Vaccine 
Tetanus/Diphtheria Update 
Pneumovax 
Pap Screening 
Hepatitis Screening, Vaccination 
TB Screening 
Family Planning 
Counseling on Safer Sex 
Counseling on Food and Water Safety 
Counseling on Nutrition 
Harm Reduction for Alcohol and Drug Use 
alternate provider. The HIV/AIDS AOM Care Services staff must directly assist the 
client with access to another HIV/AIDS AOM provider.  
 
 Client Satisfaction. The agency providing HIV/AIDS AOM Care Services must 
perform semi-annual assessments of clients’ needs and satisfaction by conducting 
random, anonymous client surveys. 
 
 Client Records. The agency providing HIV/AIDS AOM Care Services must 
maintain a client record for each client, documenting each face-to-face 
patient/practitioner encounter. Documentation must be consistent with the agency’s 
clinical policies and procedures for client record keeping. 
 
 
 
 
 
 Records Maintenance. Provider agencies must have a formal process for storing, 
maintaining, and managing client files. Client file systems must be organized for ease 
in information retrieval and synthesis. Client records must be secure to ensure 
confidentiality and should not be disclosed without the client authorization, guardian 
authorization, or other legal requirement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Service Evaluation. The client record must include a record of services provided by 
multiple professionals and paraprofessionals in sufficient detail to permit an 
evaluation of these multidisciplinary services. 
 
Eligibility: Eligibility requirements ensure that OAPP funds are used only for the 
purchase of HIV/AIDS AOM Care Services that cannot be paid for through other 
sources. Clients are eligible for HIV/AIDS AOM Care Services after a financial 
screening that validates OAPP funds are the payer of last resort for the client’s care. In 
addition, clients must meet all of the following criteria: 
 
HIV/AIDS Clinical Charting Forms? 
The Florida/Caribbean AIDS Education and Training Center offers a comprehensive set 
http://www.faetc.org/charting_forms/index.asp 
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 HIV Status. Client must provide verification of HIV status. Acceptable verification 
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa 
and Western Blot) from the test provider, (b) a signed document from a physician 
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during 
the client’s lifetime that show the presence of the human immunodeficiency virus, or 
(d) written verification from a psychosocial or medical case manager or other health 
and social services provider who has one of the above documents in the client’s file. 
 
 County of Los Angeles Residence. Client must provide information to establish 
residency in the County of Los Angeles.  
 
 Income. Clients must provide proof/documentation of income to verify OAPP funds 
will be used as the payer of last resort for the service. Clients who do not have 
coverage under or are ineligible for Medi-Cal or other third-party payment, are 
eligible for OAPP-funded services. Income eligibility must be verified annually. 
 
All clients must be assessed for ADAP, Medi-Cal, Medicare, VA Benefits, HMO, or 
private insurance. Providers are required to screen clients for eligibility to these 
programs before providing services supported by CARE Act Part A funding. 
 
Client Rights: All clients requesting and/or receiving HIV/AIDS AOM Care Services 
have rights and responsibilities outlined in “People with HIV/AIDS Bill of Rights and 
Responsibilities” adopted by the County of Los Angeles Commission on HIV Health 
Services (April 2004).  
 
Provider agencies must have a Client Rights and Responsibilities Statement that is 
reviewed with each client in a language and format the client can understand. A written 
copy must be provided to each client and a signed and dated receipt form must be 
included in each client record. 
 
Client-Centered Treatment: HIV/AIDS AOM Care Services must ensure that clients 
are given the opportunity to ask questions and receive accurate answers regarding health 
and social services provided by HIV/AIDS AOM practitioners. In addition, clients must 
be given the opportunity to ask questions and receive accurate answers on services to 
which they are referred, especially (but not limited to) the full compliment of services 
making up the Primary Health Care Core Services in the HIV/AIDS Continuum of Care. 
 
Patient and health care provider discussions during prevention and care services 
encounters form the foundation of a relationship built on trust and confidence where 
clients are seen as active partners in the decisions about their personal health care 
regimen. HIV/AIDS AOM practitioners are encouraged to review client-oriented 
HIV/AIDS prevention and care websites to become more familiar and versatile in 
discussing HIV/AIDS from a client-centered approach (i.e., www.projectinform.org, 
www.aidsnutrition.org,or www.thebody.com).  
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Clients must be fully educated about their medical needs and treatment options within the 
standards of medical care. Client education must be documented in the client record with 
details of each intervention. 
 
Referral and Coordination of Care: HIV/AIDS AOM Care Services must have written 
procedures and protocols in place for referring clients to health and social services. The 
referral system must include a process for tracking and monitoring referrals and for 
documenting the results of referrals from the providers of health and social services to 
which clients are referred. HIV/AIDS AOM practitioners are required to follow the 
provider agency’s established referral policies and procedures for services beyond their 
internal HIV/AIDS AOM Care Services.  
 
 Medical Specialists and Required Memoranda of Understanding (MOUs).The 
provider agency must have written MOUs with all medical specialists, treatment 
adherence educators, Registered Dietitians (RDs), and psychosocial case managers 
used by the provider agency’s AOM practitioners for referral. The MOUs must 
describe the procedure for both written and verbal communications between the 
referring HIV/AIDS AOM practitioner and the consulting health or social service 
professionals. All MOUs must be submitted to OAPP’s Medical Director for review 
before the MOUs are formally executed. All revisions to the MOUs, and revisions to 
provider agency referral policies and procedures, must be approved by OAPP.  
 
 California Regulations on Referrals to RDs. In California, referrals to RDs must be 
made by health care providers authorized to prescribe dietary treatments. The referral 
must be accompanied by a written prescription signed by the health care provider 
detailing the client’s diagnosis and including a statement of the desired objective of 
dietary treatment. An RD may accept or transmit verbal orders or electronically-
transmitted orders from the referring physician consistent with an established protocol 
to implement Medical Nutrition Therapy (California Business and Professions Code, 
Sections 2585-2585.8). Provider agency policies and procedures for making and 
receiving referrals for Medical Nutrition Therapy must comply with California 
regulations. 
 
Quality Management (QM): Provider agencies funded to provide HIV/AIDS AOM 
Care Services are required to have a QM Program that will facilitate the delivery of 
state-of-the-art HIV/AIDS services. Provider agencies needing technical assistance (TA) 
guidance on the development of QM Programs are encouraged to consult the Quality 
Management Technical Assistance Manual (this TA document is available at 
www.hab.hrsa.gov/). 
 
The provider agency’s QM Program must include: 
 
 QM Plan. The QM Program must be based on a provider agency-wide, written QM 
Plan that addresses both HIV prevention and care services. 
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 QM Committee. The QM Program must be guided by a provider agency QM 
Committee formally convened minimally quarterly to assure the QM Program’s goals 
and objectives are met. 
 
 Client Feedback Process. The QM Program must describe how ongoing client 
feedback will be obtained and utilized to improve access, utilization, retention, and 
adherence to HIV preventative services and care. 
 
 Client Grievance Process. The QM Program must describe the implementation of the 
provider agency’s Client Grievance Process (see requirement for Client Grievance 
Policy and Procedure above). Client grievance data must be tracked, trended, and 
reported to the provider agency’s QM Committee for use in making improvements in 
HIV services and care. 
 
The provider agency’s QM Program must be able to meet the following expectations: 
 
 Medical Record System. Routine and recurring audits of the provider agency’s 
medical record system must demonstrate service records are organized, complete, and 
current. HIV/AIDS service delivery information must be organized clearly and 
consistently, supporting ease of review and consideration by any and all social and 
health care practitioners. Reports from these audits must describe the identification of 
concrete problems in HIV/AIDS services record keeping, together with practical 
solutions and documentation for problem-resolve. 
Basic HIV/AIDS Medical Records Policy and Procedure Checklist 
 
 Uniform format with a logical flow of information 
 Information, including prescriptions, legible 
 Timely entry of data 
 All information appropriately dated 
 Problem-oriented in SOAP format: including documentation of reason for every visit, past and present medical 
histories, findings of physical examinations, documentation of special studies ordered, documentation of clinical 
assessments or diagnoses, health education and risk reduction activities, documentation of referrals and consults, 
treatment plans (return appointments, drug therapy, referrals, etc.), and HAART discussion 
 Necessary patient and family identifiers 
 Signed consents for prevention and treatment services 
 Consents signed by client for release of information for each referral made 
 Provider signatures legible  
 Conspicuous listing of quantitative viral measures, drug allergies, and drug resistance 
 Documentation of patient education (risk reduction, treatment regimens, adherence, nutrition, and health 
maintenance, etc.) 
 Evidence of screening or referral of patients at risk for TB, hepatitis, or sexually-transmitted disease (STD) 
infection 
 Evidence of screening and referral of patients for medical nutrition therapy 
 Evidence of referral for health care maintenance, including immunizations 
 Evidence of coordination of services among providers 
 Evidence of assessment for the need and/or provision of psychosocial and/or medical case management 
 Evidence of assessment for mental health and/or substance abuse services 
 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
 
 Consistency of HIV Practice Patterns. The provider agency QM Program must make 
routine and recurring audits of service delivery records in order to assess the degree to 
which individual practitioners are providing services consistent with the federal 
guidelines for the medical management of HIV infection and other issues surrounding 
HIV infection. OAPP strongly encourages internal peer review as an approach to 
continually improving quality and consistency in HIV practice patterns. The federal 
guidelines are available at www.aidsinfo.nih.gov. 
 
In order to specifically focus the provider agency’s audits for compliance within the 
guidelines, provider agencies are encouraged to adopt currently published HIV/AIDS 
practice guidelines that assist practitioners in following concrete and specific service 
protocols. These practice guidelines are typically available from the websites 
supported by the respective professional associations and from selective HIV/AIDS 
academic research institutions (i.e., www.hopkins-aids.edu or 
http://hivinsite.ucsf.edu). Practitioners providing HIV prevention in medical settings 
must consult and comply with “Incorporating HIV Prevention into the Medical Care 
of Persons Living with HIV,” (MMWR: July 18, 2003/Vol. 52/No. RR-12).  
 
 Required Provider Agency Indicators. The provider agency QM Program must 
identify quality assurance indicators documenting successful clinical and service 
delivery outcomes in the following areas: 
 
(a) Documenting the completion and incorporation of needed referrals from across 
the HIV/AIDS Continuum of Care Primary Health Care Core Services and the 
integration of referral results and recommendations into the client’s primary care 
treatment process. 
 
(b) Documenting the successful integration of care and treatment services in medical 
care settings. 
 
(c) Documenting the provider agency’s success in achieving adherence with care and 
prevention treatment plans. 
 
(d) Documenting the clinical outcome indicators as required by OAPP. 
 
 Required System-Wide Indicators. Finally, provider agencies are required to 
participate in all system-wide QM reviews conducted by OAPP. The specific 
indicators for the system-wide review will be identified annually by OAPP and will 
focus on four critical areas:  
 
(a) Reducing disparities in health outcomes for the County of Los Angeles’ social, 
racial, and/or ethnic minorities. 
 
(b) Increasing health outcomes for all recipients of services in the HIV/AIDS 
Continuum of Care. 
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Resources on Culturally-Competent Health Care? 
UCSF School of Medicine, Department of Medicine 
 “Primary Care: Clinical Practice Guidelines” 
http://medicine.ucsf.edu/resources/guidelines/culture/html 
“National Standards for Culturally and Linguistically Appropriate Services in Health Care” 
http://www.omhrc.giv/clas/finalcultural1a.htm 
“Rationale for Cultural Competence in Primary Care” 
Policy Brief 1, National Center for Cultural Competence 
http://gucchd.georgetown.edu//nccc/nccc6.html 
 
 
(c) Prevention of HIV infection and prevention of progression to HIV-related illness 
and disease, disability, and death. 
 
(d) Indicators related to the HIV/AIDS Continuum of Care’s emphasis on the 
continuity of access, utilization, retention, and adherence for clients. 
 
Cultural Sensitivity and Linguistic Competence: Clients have the right to HIV/AIDS 
AOM Care Services provided by a qualified, HIV-knowledgeable and capable primary 
health care practitioner who is culturally- and linguistically-competent, who 
communicates and educates in culturally-congruent ways, and who works in collaboration 
with the client’s team. The AOM staff must demonstrate cultural sensitivity and linguistic 
competency specifically in the service they provide. The AOM staff must also 
demonstrate cultural sensitivity and linguistic competency for the target population they 
are serving (see, “The Provider’s Guide to Quality and Culture,” 
http://bphc.hrsa.gov/quality/Cultural.htm). 
 
Translation/Language Interpreter’s federal and state language access laws (Title VI of the 
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act) 
require health care facilities that receive federal or state funding to provide competent 
interpretation services to Limited English Proficiency (LEP) patients at no cost, in order 
to ensure equal and meaningful access to health care services. 
 
 
 
 
 
 
 
 
 
 
Documentation: Provider agencies providing HIV/AIDS AOM Care Services are 
required to meet all expectations for client and service delivery contract reporting and 
documentation. Provider agencies must utilize the County of Los Angeles’s “Casewatch” 
system to register the client’s eligibility data, demographic/resource data, enter service 
utilization data, medical and support service outcomes, and to record linkages/referrals to 
other service providers and/or systems of care.  
 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
 
For clients not receiving Medi-Cal benefits, providers are required to document if a client 
was referred to apply for Medi-cal, if recently applied for Medi-Cal, date/ applied, 
application status, and if not referred, must document why the client was not referred.   
 
The “Casewatch” system must be used to invoice for all delivered services, to 
standardized reporting, to improve efficiency of billing, to support program evaluation 
processes, and to provide OAPP and participating contractors with information relative to 
the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies must ensure 
data quality and compliance with all data submission requirements. 
 
DEFINITION OF ENCOUNTER 
The US Department of Health and Human Services/Health Resources and Services 
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting 
Instructions for Section 330 Grantees (last updated in 2006).  The definition of an 
encounter is:  
 
“Encounters are Documented, face-to-face contact between a patient and 
a provider who exercises independent professional judgment in the 
provision of services to the individual.  To be included as an encounter, 
services must be documented.” (Page 5) 
 
Additional guidance relative to encounters includes: 
 
1.  To meet the criterion for "independent judgment," the provider must be acting on 
his/her own when serving the patient and not assisting another provider. For 
example, a nurse assisting a physician during a physical examination by taking vital 
signs, taking a history or drawing a blood sample is not credited with a separate 
encounter. Independent judgment implies the use of the professional skills 
associated with profession of the individual being credited with the encounter and 
unique to that provider or other similarly or more intensively trained providers.  
 
2.  To meet the criterion for "documentation," the service (and associated patient 
information) must be recorded in written or electronic form. The patient record does 
not have to be a full and complete health record in order to meet this criterion. For 
example, if an individual receives services on an emergency basis and these 
services are documented, the documentation criterion is met even though a 
complete health record is not created. Screenings at health fairs, immunization 
drives for children or the elderly and similar public health efforts do not result in 
encounters.  
 
4. Such services as drawing blood, collecting urine specimens, performing laboratory 
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do 
not constitute encounters.  
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5. A provider may be credited with no more than one encounter with a given patient in 
a single day, regardless of the types or number of services provided.  
 
6. The encounter criteria are not met in the following circumstances:  
 When a provider participates in a community meeting or group session that is 
not designed to provide clinical services. Examples of such activities include 
information sessions for prospective patients, health presentations to community 
groups (high school classes, PTA, etc.), and information presentations about 
available health services at the center.  
 When the only health service provided is part of a large-scale effort, such as a 
mass immunization program, screening program, or community-wide service 
program (e.g., a health fair).  
 When a provider is primarily conducting outreach and/or group education 
sessions, not providing direct services.  
 When the only services provided are lab tests, x-rays, immunizations, TB tests 
and/or prescription refills.  
 Services performed under the auspices of a WIC program or a WIC contract. 
 
REQUIRED STAFFING 
Staffing and the HIV/AIDS Continuum of Care Model: The HIV/AIDS Continuum of 
Care Model and the Los Angeles Commission on HIV Standards of Care have clear and 
distinct implications for staffing models needed to fully implement comprehensive 
services. Provider agencies providing HIV/AIDS AOM Care Services should develop 
staffing models with four key points in mind: 
 
1. The HIV/AIDS Continuum of Care’s “Primary Health Care Core Services” 
represents a set of multidisciplinary services that by definition requires a coordinated 
team of medically-diverse professional and auxiliary health care practitioners. While 
this collection of practitioners generally may all be categorized as medically-related, 
each health care professional must practice with a multidisciplinary understanding of 
his or her professional knowledge and skills. In other words, the practice of 
HIV/AIDS medicine…prevention or care…is not narrowly biomedical in its focus. 
Professionals must work in multidisciplinary teams with an expanded 
understanding of HIV/AIDS primary health care services. 
 
2. Experience and research has shown that services must be provided to a client through 
a coordinated and seamless approach, even though no one single provider agency 
necessarily directly employs all categories of professional and auxiliary staff needed 
to provide the full compliment of Continuum of Care services. This coordinated and 
seamless approach is actually reflected in the PHS standards and made even more 
concrete in the established HIV/AIDS practice guidelines. Provider agencies are 
required to comply with the PHS Standards of Care and Los Angeles 
Commission on HIV Standards of Care, yet provider agencies are not expected 
to directly employ all of the needed health care professionals as a way to fully 
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meet these standards. Provider agencies will need to collaborate in order to make the 
HIV/AIDS Continuum of Care accessible across the County of Los Angeles, and 
AOM Care professionals will need to collaborate across provider agency boundaries 
in order to surround a client with the full compliment of needed services. 
 
3. The multidisciplinary approach to providing services in a professionally-diverse 
Continuum of Care is not an artifact of luxury, but rather a result of the complex 
nature of HIV disease itself coupled with the challenges the populations most affected 
by HIV bring to the service setting. Making sure communities in the County of Los 
Angeles have access to any and all of the services in the HIV/AIDS Continuum of 
Care is a daily and determined act of financial problem-solving. Provider agencies 
must use financial resources from many sources in a resource-limited funding 
environment. AOM staffing patterns will combine direct hire, targeted consulting 
and contracting, and referral as a way of fulfilling the expectations in the PHS 
Standards, Los Angeles Commission on HIV Standards and the HIV/AIDS 
Continuum of Care. 
 
4. The clinical care of persons with HIV/AIDS requires clinicians with specialized 
experience in the practice of HIV medicine. Knowledge about the clinical 
management of HIV infection has rapidly evolved requiring frequent changes in state-
of-the-art practice and the integration of evidence-based advances into routine care for 
persons at risk for or living with HIV. Extensive clinical care experience with direct 
management of ARV therapy, along with significant diagnostic, therapeutic, and 
prevention education experience in the ambulatory care of the HIV-infected client is 
requisite. Provider agencies must employ, contract, or refer to AOM health care 
professionals who are prepared to provide services in a scientifically-rigorous 
(including culturally-competent) environment. 
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ELIGIBILITY, EDUCATION, AND ENROLLMENT 
SERVICES  
for the AIDS DRUG ASSISTANCE PROGRAM 
SERVICE DESCRIPTION 
 
This service description is adopted by the County of Los Angeles, Department of Public 
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the 
development and implementation of Eligibility, Education, and Enrollment Services 
for the AIDS Drug Assistance Program (ADAP). These services are provided to 
individuals living with HIV/AIDS. Federal legislation, policy and program guidance, and 
State of California statutes, regulations, and rules governing licensing and service 
provision, supersede the Ambulatory/Outpatient Medical (AOM) Care Services 
description. 
 
SERVICE 
Eligibility, Education, and Enrollment Services for ADAP 
 
TABLE OF CONTENTS Page 
Description ..................................................................................... 1 
Program Requirements .................................................................. 2 
Definition of Encounter .................................................................. 6 
Required Staffing ........................................................................... 7 
 
DESCRIPTION 
ADAP provides drugs that prolong quality of life and delay the deterioration of health to 
individuals infected with HIV who otherwise could not afford them. ADAP is funded by 
the Ryan White CARE Act (RWCA) and state funds (see www.dhs.ca.gov/aids/ 
Programs/CARE/adap.htm). 
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All clients requesting and/or 
receiving drug reimbursement 
services  
have rights and 
responsibilities outlined in 
 “People with HIV/AIDS Bill of 
Rights and Responsibilities” 
adopted by the 
 County of Los Angeles 
Commission on HIV Health 
Services (April, 2004). 
 
To access ADAP drug reimbursement services, clients must be enrolled through local 
enrollment sites. The local enrollment sites provide drug reimbursement services to HIV-
infected individuals in the County of Los Angeles who have no other means to pay for 
these services. Enrollment sites in the County of Los Angeles are reimbursed for services 
through an OAPP contractual agreement. 
 
 PROGRAM REQUIREMENTS 
The following requirements are minimum for Eligibility, Education, and Enrollment 
Services for the AIDS Drug Assistance Program. Provider agencies providing these 
services may exceed these requirements.  
 
General Requirements: The program must ensure its ability to meet the needs of clients 
by meeting the following general requirements: 
 
 Administrative and Program Policies and Procedures. The provider agency must 
develop, implement, and revise, as necessary, standardized administrative policies and 
procedures and program protocols to comprehensively guide the drug reimbursement 
Eligibility, Education, and Enrollment Services for the AIDS Drug Assistance 
Program. The procedures and protocols specific to the ADAP program are provided 
by the California Department of Public Health /Office of AIDS, including periodic 
updates. The provider agency providing enrollment services must fully comply with 
these state guidelines (see ADAP Coordinator’s Reference Guide, May 2001, and the 
Ramsell Corporation’s California State ADAP Enrollment and Eligibility Manual, 
April 2004).  
 Provider agencies must have a Client Grievance Policy and 
Procedure that is reviewed with each client in a language 
and format the client can understand. A written copy must 
be provided to each client and a signed and dated receipt 
form must be included in each client record. All staff must 
comply with the established process for client grievances. 
 
 Client Records. Provider agencies must have a formal 
process for storing, maintaining, and managing client files. 
Client file systems must be organized for ease in 
information retrieval and synthesis. Client documentation 
must be continuous and consistently current. Client records 
must be secure to ensure confidentiality and should not be disclosed without the client 
authorization, guardian authorization, or other legal requirement. Access to charts and 
records for periodic monitoring by the California Department of Public Health/Office 
of AIDS and OAPP staff is required. 
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 Confidentiality. All staff with access to client information must receive training on 
confidentiality, appropriate exchange of information, and consent processes. This 
training must be consistent with the established policies and procedures that 
professionally govern release of medical information. Provider agency consent forms 
must comply with state and federal law, must be signed by an individual legally able 
to give consent, and must include a consent for release/exchange of information for 
every individual/provider agency to whom client identifying information is disclosed, 
regardless of whether or not HIV status is revealed. 
 
 Physical Office Space. The provider agency must provide the Enrollment Coordinator 
and Eligibility Staff with space to conduct uninterrupted interviews for eligibility 
screening.  
 
 Client-Staff-Colleague Communication. Provider agencies must have current written 
policies and procedures addressing communications between the enrollment staff, 
clients, or other professionals. 
 
 Documentation. Provider agencies providing Eligibility, Education, and Enrollment 
Services for AIDS Drug Assistance Programs are required to meet all expectations 
for client and service delivery contract reporting and documentation. Provider 
agencies must utilize the County of Los Angeles’s “Casewatch” system to register the 
client’s eligibility data, demographic/resource data, enter service utilization data, 
medical and support service outcomes, and to record linkages/referrals to other 
service providers and/or systems of care.  
 
For clients not receiving Medi-Cal benefits, providers are required to document if a 
client was referred to apply for Medi-cal, and if the client recently applied for Medi-
Cal, the date applied, application status.  If the client is not referred, the provider 
must document why the client was not referred.   
 
The “Casewatch” system must be used to invoice for all delivered services, to 
standardized reporting, to import efficiency of billing, to support program evaluation 
processes, and to provide OAPP and participating contractors with information 
relative to the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies 
must ensure data quality and compliance with all data submission requirements. 
 
Eligibility: Eligibility requirements ensure that OAPP funds are used only for the 
purchase of services that cannot be paid for through other sources. Clients are eligible for 
services after a financial screening validates OAPP funds are the payer of last resort for 
the client’s care. In addition, agencies providing services must ensure clients meet all of 
the following criteria: 
 
 HIV Status. Client must provide verification of HIV status. Acceptable verification 
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa 
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and Western Blot) from the test provider, (b) a signed document from a physician 
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during 
the client’s lifetime that shows the presence of the human immunodeficiency virus, or 
(d) written verification from a psychosocial or medical case manager or other health 
and social services providers who have one of the above documents in the client’s 
file. 
 
 County of Los Angeles Residence. Clients must provide information to establish 
residency in the County of Los Angeles.  
 
 Income. Clients must provide proof/documentation of income to verify OAPP funds 
will be used as the payer of last resort for the service. Clients who do not have 
coverage under or are ineligible for Medi-Cal or other third-party payment are eligible 
for services. Income eligibility must be verified annually. 
 
 Age. Clients must be 18 years of age or older.  
 
ADAP Enrollment Sites: Provider agencies providing Eligibility, Education, and 
Enrollment Services for AIDS Drug Assistance Programs must first be approved by 
California Department of Public Health/Office of AIDS and OAPP as an ADAP 
Enrollment Site. ADAP Enrollment Sites, further, are registered by jurisdiction and must 
be registered prior to housing any Enrollment Coordinator/Eligibility Staff within the 
facility.  
 
 Staff Training. Provider agencies must cooperate in assuring the required staff 
training for the Eligibility Coordinator and Eligibility Staff is completed. The 
Enrollment Coordinator and Eligibility Staff must be certified through and receive 
training from Ramsell Corporation prior to enrolling clients in ADAP or within 90 
days of beginning enrollment services. 
 
Client Rights: All ADAP clients and people who wish to become ADAP clients have the 
following rights according to the statement of Client Rights. These rights include, but are 
not limited to (www.ramsellcorp.com/client/ca):   
 
 Information on Eligibility Requirements. Clients or potential clients must be advised 
of ADAP eligibility requirements and the right to apply for ADAP assistance by 
completing the ADAP eligibility screening process and submitting an enrollment 
application. 
 
 Confidentiality. All ADAP enrollment application and all ADAP transactions 
conducted with a participating pharmacy will be handled in a confidential manner in 
compliance with applicable state and federal laws. 
 
 Right to Appeal. The right to appeal a program denial due to income requirements or 
to appeal the inaccuracy of an ADAP co-payment computation. 
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”If you believe you have been denied your rights or treated unfairly or discourteously at any point in the 
ADAP enrollment process, or in receiving pharmacy services, you may contact your local ADAP 
coordinator for your area or the State Office of AIDS at (916) 327-6806.” 
www.ramsellcorp.com/client/ca/client_rights.php 
 
 
 
 
HIV L.A. 
Updated every six months. 
www.hivla.org 
 
 Nondiscrimination. The right to receive services without discrimination as to race, 
color, age, disability, homelessness, religion, gender, sexual orientation, or national 
origin. 
 
 Courteous and Respectful Service. The right to receive courteous and respectful 
service from ADAP Enrollment Coordinators and Eligibility Staff and participating 
pharmacies. 
 
 Grievance. The right to grieve any event related to access or to delivery of ADAP 
services that violates any of the above-stated rights.  
 
Referral and Coordination of Care: The provider agency providing drug reimbursement 
enrollment services must have written procedures and protocols in place for referring 
clients to other health and social services. The referral system must include a process for 
tracking and monitoring referrals, and for documenting the results of referrals from the 
providers of health and social services to which clients are referred. The Enrollment 
Coordinator and Eligibility Staff are required to follow the agency’s established referral 
policies and procedures when referring clients to other health and social in the HIV/AIDS 
Continuum of Care.  
 
The Enrollment Coordinator will maintain current information on 
County-wide HIV/AIDS care and prevention services, for 
example, a current HIV L.A. Directory of Services. The 
Enrollment Coordinator will maintain knowledge of local, state, 
and federal service and funding resources or service-funding 
resource limitations influencing the client’s availability or 
utilization of HIV/AIDS services.  
 
Quality Management (QM): Provider agencies funded to 
provide drug reimbursement enrollment services are required to 
have a QM Program that will facilitate the delivery of state-of-
the-art HIV/AIDS services. Provider agencies needing technical assistance (TA) guidance 
on the development of QM Programs are encouraged to consult the Quality Management 
Technical Assistance Manual (this TA document is available at www.hab.hrsa.gov/). 
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The agency must report on QM indicators specific to Eligibility, Education, and 
Enrollment Services for the AIDS Drug Assistance Program.  
 
Cultural Sensitivity and Linguistic Competence: Clients have the right to Eligibility, 
Education, and Enrollment Services for the AIDS Drug Assistance Program 
provided by qualified, HIV-knowledgeable and capable staff who is culturally-sensitive 
and linguistically-competent, who communicate and educate in culturally-congruent 
ways, and who work with the client’s health care team. The Enrollment 
Coordinator/Eligibility Staff must demonstrate cultural sensitivity and linguistic 
competency specifically in the services provided. The staff must also demonstrate cultural 
sensitivity and linguistic competency for the population receiving the services (see “The 
Provider’s Guide to Quality and Culture,” http://bphc.hrsa.gov/quality/Cultural.htm).  
 
Translation/Language Interpreter’s federal and state language access laws (Title VI of the 
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act) 
require health care facilities that receive federal or state funding to provide competent 
interpretation services to Limited English Proficiency (LEP) clients at no cost, in order to 
ensure equal and meaningful access to health care services. 
        
DEFINITION OF ENCOUNTER 
The US Department of Health and Human Services/Health Resources and Services 
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting 
Instructions for Section 330 Grantees (last updated in 2006).  The definition of an 
encounter is:  
 
“Encounters are Documented, face-to-face contact between a patient and 
a provider who exercises independent professional judgment in the 
provision of services to the individual.  To be included as an encounter, 
services must be documented.” (Page 5) 
 
Additional guidance relative to encounters includes: 
 
1.  To meet the criterion for "independent judgment," the provider must be acting on 
his/her own when serving the patient and not assisting another provider. For 
example, a nurse assisting a physician during a physical examination by taking vital 
signs, taking a history or drawing a blood sample is not credited with a separate 
encounter. Independent judgment implies the use of the professional skills 
associated with profession of the individual being credited with the encounter and 
unique to that provider or other similarly or more intensively trained providers.  
 
2.  To meet the criterion for "documentation," the service (and associated patient 
information) must be recorded in written or electronic form. The patient record does 
not have to be a full and complete health record in order to meet this criterion. For 
example, if an individual receives services on an emergency basis and these 
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services are documented, the documentation criterion is met even though a 
complete health record is not created. Screenings at health fairs, immunization 
drives for children or the elderly and similar public health efforts do not result in 
encounters.  
 
4. Such services as drawing blood, collecting urine specimens, performing laboratory 
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do 
not constitute encounters.  
 
5. A provider may be credited with no more than one encounter with a given patient in 
a single day, regardless of the types or number of services provided.  
 
6. The encounter criteria are not met in the following circumstances:  
 When a provider participates in a community meeting or group session that is 
not designed to provide clinical services. Examples of such activities include 
information sessions for prospective patients, health presentations to 
community groups (high school classes, PTA, etc.), and information 
presentations about available health services at the center.  
 When the only health service provided is part of a large-scale effort, such as a 
mass immunization program, screening program, or community-wide service 
program (e.g., a health fair).  
 When a provider is primarily conducting outreach and/or group education 
sessions, not providing direct services.  
 When the only services provided are lab tests, x-rays, immunizations, TB tests 
and/or prescription refills.  
 Services performed under the auspices of a WIC program or a WIC contract.  
 
Specific guidance on encounters related to Eligibility, Education, and Enrollment 
Services for the AIDS Drug Assistance Program includes the following: 
 
 Providers should request reimbursement when an Enrollment Coordinator or 
Enrollment Staff completes an eligibility determination after meeting face-to-face 
with a client for approximately 45 minutes or more.     
 Providers should request reimbursement for the provision of education and 
information when the Enrollment Coordinator or Enrollment Staff meets face-to-face 
with the client for approximately 20 minutes or more to provide education or 
information. 
 
REQUIRED STAFFING 
Eligibility, Education, and Enrollment Services for the AIDS Drug Assistance 
Program is provided by Enrollment Coordinators who supervise ADAP services at local 
sites and by Eligibility Staff who screen clients for eligibility to receive services, provide 
basic education about drug reimbursement services, provide clients with information on 
approved drug formulary and pharmacy sites, address client grievances and complaints, 
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maintain documentation on services provided for each client, and re-certify client 
eligibility annually, or more frequently, if needed. 
 
The ADAP Enrollment Site Program must have the following staff:  
 
 Enrollment Coordinator. 
 Eligibility Staff. 
  
There are no minimum educational or credentialing standards for an individual to be an 
Enrollment Coordinator or Eligibility Staff. However, the Enrollment Coordinator and 
Eligibility Staff must be certified through and receive training from Ramsell Corporation 
prior to enrolling clients in ADAP or within 90 days of beginning enrollment services.  
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NUTRITIONAL COUNSELING  
(MEDICAL NUTRITION THERAPY) 
SERVICE DESCRIPTION  
 
This service description is adopted by the County of Los Angeles, Department of Public 
Health, Office of AIDS Programs and Policy (OAPP), to guide providers in the 
development and implementation of Nutritional Counseling (Medical Nutrition 
Therapy) services to individuals living with HIV/AIDS. Federal legislation, policy and 
program guidance, and State of California statutes, regulations, and rules governing 
licensing and service provision, supersede the Medical Nutrition Therapy service 
description.  
 
SERVICE 
Medical Nutrition Therapy  
 
TABLE OF CONTENTS Page 
Description ..................................................................................... 1 
Program Requirements .................................................................. 2 
Definition of Encounter .................................................................. 9 
Required Staffing ......................................................................... 11 
 
DESCRIPTION 
In HIV/AIDS, clients may be at nutritional risk at any point of their illness. Medical 
Nutrition Therapy is a critical companion service to HIV/AIDS disease prevention and 
management. Medical Nutrition Therapy services are provided in accordance with the 
Los Angeles Commission on HIV Standards of Care, Medical Nutrition Therapy (final 
October 8, 2006), are provided in conjunction with routine and recurring HIV/AIDS 
primary health care services, and are preferably delivered on-site with the HIV/AIDS 
Ambulatory/Outpatient Medical (AOM) Care Services to better support a client’s access 
to, utilization of, retention in, and adherence to Medical Nutrition Therapy.  
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HIV/AIDS Resource on Food-Drug 
Interactions? 
www.foodmedinteractions.com 
 
In the County of Los Angeles’ HIV/AIDS Continuum of Care adopted on October 14, 
2004, Medical Nutrition Therapy is a Primary Health Care Core Service. Medical 
Nutrition Therapy is directly related to improving health outcomes for HIV-infected 
clients, and it combines an emphasis on disease prevention and disease management. 
Good nutrition is important in building and sustaining the immune system. Achieving 
good health and preventing malnutrition is essential in maintaining positive health 
outcomes for people living with HIV. 
 
Medical Nutritional Therapy is appropriate 
both for clients who have or have not 
initiated medication therapies for HIV 
disease management. 
 
 
 
 
 PROGRAM REQUIREMENTS 
The following are minimum requirements for the provider agency providing Medical 
Nutrition Therapy. Service providers may exceed these requirements.  
 
General Requirements: The provider agency providing Medical Nutrition Therapy 
must ensure its ability to meet the needs of the client by meeting the following general 
requirements:  
 
 Administrative and Clinical Policies and Procedures. The provider agency offering 
Medical Nutrition Therapy must develop, and revise, as necessary, related 
standardized administrative policies and procedures and clinical protocols as part of 
the overall AOM Care Services. The policies, procedures, and protocols must be 
submitted to OAPP for review and approval upon request. Revisions to the procedures 
and protocols may, upon request, require OAPP approval.  
 
 Provider agencies must have a Client Grievance Policy and Procedure that is reviewed 
with each client in a language and format the client can understand. A written copy 
must be provided to each client and a signed and dated receipt form must be included 
in each client record. All AOM professionals must comply with the established 
process for client grievances.  
  
 Clinical Care Protocols. The provider agency offering Medical Nutrition Therapy 
services must comply with the Public Health Service (PHS) guidelines 
(www.aidsinfo.nih.gov) and the Los Angeles Commission on HIV Standards of Care.  
Agency primary care professionals must utilize established practice guidelines in 
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order to facilitate consistency in providing state-of-the-art prevention and care 
services for all clients. 
   
 HIV/AIDS prevention and care practice guidelines may be downloaded or ordered in 
bulk from the following websites: Los Angeles Commission on HIV Standards of 
Care for Medical Nutrition Therapy (www.hivcommission-la.info/soc.asp), Johns 
Hopkins AIDS Service (www.hopkins-aids.edu), New York Department of Health 
AIDS Institute (www.hivguidelines.org), federal HIV/AIDS Bureau 
(www.hab.hrsa.gov), and CDC’s Division of AIDS Prevention-Treatment 
(www.cdc.gov). 
 
The agency must have a written policy, procedure, and protocol to facilitate 
compliance with the California Business and Professions Code, Section 2585-2586.8 
(www.leginfo.ca.gov/calaw.html) which, among other aspects, specifies that a referral 
shall be accompanied by a written prescription signed by the health care provider 
detailing the patient's diagnosis and including a statement of the desired objective of 
dietary treatment, unless a referring physician and surgeon has established or 
approved a written protocol governing the patient's treatment. 
 
 The provider agency offering Medical Nutrition Therapy services must comply with 
the Los Angeles Commission on HIV Standards of Care for Medical Nutrition 
Therapy and with Guidelines for Implementing HIV/AIDS Medical Nutrition Therapy 
Protocols (revised December 2002).  The provider agency will utilize established HIV 
nutrition practice guidelines and protocols in order to facilitate consistency in 
providing state-of-the-art Medical Nutrition Therapy services for all clients. 
 
Other Medical Nutrition Therapy guidelines and protocols may be obtained from 
the American Dietetic Association (www.eatright.org/Public/Other/index_ 
adap0600.cfm, Health Resources and Services Administration (www.aids-
etc.org/aidsetc?page=et-30-20-01) and as noted in the Commission on HIV Standard 
of Care for Medical Nutrition Therapy. 
 
The provider agency must utilize the “Nutrition Screen and Referral Criteria for 
Adults (18+Years) with HIV/AIDS, March 2005” 4,5  (http://www.hivaidsdpg.org/ 
Data/QM/HIV_Adult_Nutrition_Screen_Referral Criteria_200207.pdf. 
 
 HIV Prevention and Disease Management Competency. The provider agency must 
have personnel policies and procedures requiring and supporting the continued 
                                                 
4
 Adapted from: Fenton M, Heller L, Vazzo L, et al. Dietitians in AIDS Care, AIDS Project Los Angeles, 1998. Nutrition screening referral criteria included in: Guidelines form 
Implementing HIV/AIDS Medical Nutrition Therapy Protocols. Approved by the Los Angeles County Commission on HIV Health Services, September 1999. 
 
5
 Adapted from the C.A.R.E. Program and Clinics – Catholic Healthcare Org, a Ryan White CARE Act Title III Grantee providing early intervention services and primary health 
care to people living with HIV and AIDS in Long Beach, CA; developed by Tammy Darke, RD, CNSD. Adapted by Fenton M, 5/2000, then by the ADA HIV/AIDS DPG special 
working groups members in 5/2002 and 3/2005. 
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education of all HIV/AIDS health care professionals, including Registered Dietitians 
(RD) and Dietetic Technician Registered (DTR). All DTRs must work under the 
supervision of an experienced RD.  Provider agencies are expected to budget costs for 
HIV/AIDS continuing education, specifically in HIV prevention and disease 
management, to purchase practice guidelines in formats easily accessible and usable 
for primary care providers, and to provide routine access to computerized educational 
and prevention/care treatment problem-solving (i.e., www.thebodypro.com, 
www.hivinsite.ucsf.edu, www.hopkins-aids.edu, or 
www.nlm.nih.gov/medlineplus/aids.html) for all agency health care professionals, 
including RDs. 
 
 The American Dietetic Association (ADA) has developed a Scope of 
Dietetics Practice Framework and supporting documents, “Evaluation tools 
practitioners and their managers can use to gauge and channel performance” (Journal 
of the American Dietetics Association, April 2005, www.adajournal.org). These 
evaluation tools include: 
 
a. RDs Standards of Practice in Nutrition Care. 
b. Standards of Professional Performance for Dietetics Professionals (expands 
the previously titled “Standards of Professional Practice”). 
c. ADA’s Code of Ethics. 
 
 Client-Staff-Colleague Communication. Provider agencies must have current written 
policies and procedures addressing communications between the primary care staff 
(including RDs), clients, or other professionals. 
 
 Client Satisfaction. RDs providing Medical Nutrition Therapy services must 
perform semi-annual assessments of clients’ needs and satisfaction by conducting 
random, anonymous client surveys. RDs may cooperate with the agency’s general 
needs assessments and client satisfaction surveys so long as these assessments and 
surveys adequately address need for and satisfaction with Medical Nutrition 
Therapy services. 
 
 Client Records. The provider agency must maintain a client record for each client, 
documenting each face-to-face patient/practitioner encounter. Documentation of 
Medical Nutrition Therapy services must be consistent with the agency’s clinical 
policies and procedures for client record keeping. 
 
 Records Maintenance. Provider agencies must have a formal process for storing, 
maintaining, and managing client files. Client file systems must be organized for ease 
in information retrieval and synthesis. Client records must be secure to ensure 
confidentiality and should not be disclosed without the client authorization, guardian 
authorization, or other legal requirement. 
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 Case Conferencing. To fully address the HIV/AIDS Continuum of Care needs, and in 
order to coordinate patient care services, the agency must provide primary health care 
services in a multidisciplinary team approach. Case conferencing is required. Case 
conferencing should focus on client treatment concerns and challenges and must 
include perspectives from medical, social, and prevention team providers. The RD 
offering Medical Nutrition Therapy must participate regularly, in person or by 
phone, in the multidisciplinary team case conferences at the HIV/AIDS AOM Care 
Services sites.   
 
Eligibility: Eligibility requirements ensure that OAPP funds are used only for the 
purchase of Medical Nutrition Therapy that cannot be paid for through other sources. 
Clients are eligible for Medical Nutrition Therapy services after a financial screening 
that validates OAPP funds are the payer of last resort for the client’s care. In addition, 
clients must meet all of the following criteria: 
 
 HIV Status. Client must provide verification of HIV status. Acceptable verification 
includes one of the following: (a) a copy of the client’s seropositive test results (Elisa 
and Western Blot) from the test provider, (b) a signed document from a physician 
verifying the client is HIV-positive, (c) lab results (i.e., viral load) at any time during 
the client’s lifetime that show the presence of the human immunodeficiency virus, or 
(d) written verification from a psychosocial or medical case manager or other health 
and social services provider who has one of the above documents in the client’s file. 
 
 County of Los Angeles Residence. Client must provide information to establish 
residency in the County of Los Angeles.  
 
 Income. Clients must provide proof/documentation of income to verify OAPP funds 
will be used as the payer of last resort for the service. Clients who do not have 
coverage under or are ineligible for Medi-Cal or other third-party payment are eligible 
for OAPP-funded services. Income must be verified annually. 
  
Client Rights: All clients requesting and/or receiving Medical Nutrition Therapy have 
rights and responsibilities outlined in “People with HIV/AIDS Bill of Rights and 
Responsibilities” adopted by the County of Los Angeles Commission on HIV Health 
Services (April 2004). 
 
Provider agencies must have a Client Rights and Responsibilities Statement that is 
reviewed with each client in a language and format the client can understand. A written 
copy must be provided to each client and a signed and dated receipt form must be 
included in each client record. RDs must comply with the established policies and 
procedures for Client Rights and Responsibilities. 
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Did You Know? 
California has State Requirements 
For Referrals to RDs!  
Client-Centered Treatment: The provider agency providing Medical Nutrition Therapy 
must ensure that clients are given the opportunity to ask questions and receive accurate 
answers regarding all health and social services provided by the provider agency’s health 
care practitioners. In addition, clients must be given the opportunity to ask questions and 
receive accurate answers on services to which they are referred, especially (but not 
limited to) the full compliment of services making up the Primary Health Care Core 
Services in the HIV/AIDS Continuum of Care. 
 
Patient and health care provider discussions during prevention and care services 
encounters form the foundation of a relationship built on trust and confidence where 
clients are seen as active partners in the decisions about their personal health care 
regimen. RDs are encouraged to review client-oriented HIV/AIDS prevention and care 
websites to become more familiar and versatile in 
discussing HIV/AIDS from a client-centered 
approach (i.e., www.apla.org, 
www.projectinform.org, www.aidsnutrition.org, or 
www.thebody.com). 
 
Clients must be fully educated about their health 
care needs and treatment options within the standards of medical care. Client education 
must be documented in the client record with details of each intervention. 
 
Referral and Coordination of Care: The provider agency providing Medical Nutrition 
Therapy services must have written procedures and protocols in place for referring 
clients to other health and social services. The referral system must include a process for 
tracking and monitoring referrals and for documenting the results of referrals from the 
providers of health and social services to which clients are referred. RDs are required to 
follow the provider agency’s established referral policies and procedures for services 
beyond their internal Medical Nutrition Therapy Program.  
 
 California Regulations on Referrals to RDs. Referrals to RDs in California must be 
made by health care providers authorized to prescribe dietary treatments. The referral 
must be accompanied by a written prescription signed by the health care provider 
detailing the client’s diagnosis and including a statement of the desired objective of 
dietary treatment. A RD may accept or transmit verbal orders or electronically 
transmitted orders from the referring physician consistent with an established protocol 
to implement Medical Nutrition Therapy (California Business and Professions 
Code, Sections 2585-2585.8). Provider agency policies and procedures for making 
and receiving referrals for Medical Nutrition Therapy must comply with California 
regulations. 
 
 Written Reports. The RD offering Medical Nutrition Therapy must provide a 
written report of the nutrition assessment, plan, and intervention(s) to the referring 
provider agency within an agreed upon and reasonable period of time but not to 
exceed more than two weeks. Copies of the comprehensive nutrition assessment, 
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nutrition progress notes, and care plan must be sent to the referral provider agency 
and placed in the client’s file.  
 
Quality Management (QM): Provider agencies funded to provide Medical Nutrition 
Therapy are required to have a QM Program that will facilitate the delivery of          
state-of-the-art HIV/AIDS services. Provider agencies needing technical assistance (TA) 
guidance on the development of QM Programs are encouraged to consult the Quality 
Management Technical Assistance Manual (this TA document is available at 
www.hab.hrsa.gov/). 
 
The provider agency’s QM Program must include: 
 
 QM Plan. The QM Program must be based on a provider agency-wide, written QM 
Plan that addresses both HIV prevention and care services. 
 
 QM Committee. The QM Program must be guided by a provider agency QM 
Committee formally convened minimally quarterly to assure the QM Programs goals 
and objectives are met. The RD offering Medical Nutrition Therapy must 
participate regularly with the QM Committee to discuss operational and quality 
improvement issues and utilization review. 
 
 Client Feedback Process. The QM Program must describe how ongoing client 
feedback will be obtained and utilized to improve access, utilization, retention, and 
adherence to HIV preventative services and care. 
 
 Client Grievance Process. The QM Program must describe the implementation of the 
provider agency’s Client Grievance Process (see requirement for Client Grievance 
Policy and Procedure above). Client grievance data must be tracked, trended, and 
reported to the provider agency’s QM Committee for use in making improvements in 
HIV services and care. 
 
The provider agency’s QM Program must be able to meet the following expectations: 
 
 Medical Record System. Routine and recurring audits of the provider agency’s 
medical record system must demonstrate service records are organized, complete, and 
current. HIV/AIDS service delivery information must be organized clearly and 
consistently, supporting ease of review and consideration by any and all social and 
health care practitioners. Reports from these audits must describe the identification of 
concrete problems in HIV/AIDS services record keeping, together with practical 
solutions and documentation for problem-resolve. 
 
 Consistency of HIV Practice Patterns. The provider agency QM Program must make 
routine and recurring audits of service delivery records in order to assess the degree to 
which individual practitioners are providing services consistent with federal 
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guidelines for the medical management of HIV infection and other issues surrounding 
HIV infection. The federal guidelines are available at www.aidsinfo.nih.gov. 
− In order to specifically focus the provider agency’s audits for compliance with the 
guidelines, provider agencies are encouraged to adopt currently published 
HIV/AIDS practice guidelines that assist practitioners in following concrete and 
specific service protocols (i.e., Clinical Infectious Disease 2003:36, Supplement 
2:S52-62). These practice guidelines are typically available from the websites 
supported by the respective professional associations (i.e., www.hivaidsdpg.org or 
www.eatright.org) and from selective HIV/AIDS academic institutions or 
research-based organizations (i.e., www.aids-etc.org, www.hopkins-aids.edu, or 
http://hivinsite.ucsf.edu). Practitioners providing HIV prevention in medical 
settings must consult and comply with “Incorporating HIV Prevention into the 
Medical Care of Persons Living with HIV” (MMWR: July 18, 2003/Vol. 52/No. 
RR-12).  
 
 Required Provider Agency Indicators. The provider agency’s QM Program must 
identify quality assurance indicators documenting successful clinical and service 
delivery outcomes in the following areas: 
(a) Documenting the completion and incorporation of needed referrals from 
across the HIV/AIDS Continuum of Care Primary Health Care Core Services 
and the integration of referral results and recommendations into the client’s 
primary care treatment process. 
(b) Documenting the successful integration of care and treatment services in 
medical care settings. 
(c) Documenting the provider agency’s success in achieving adherence with care 
and prevention treatment plans. 
(d) Documenting the clinical outcome indicators as required by OAPP.  
 
 Required System-Wide Indicators. Finally, provider agencies are required to 
participate in all system-wide QM reviews conducted by OAPP. The specific 
indicators for the system-wide review will be identified annually by OAPP and will 
focus on four critical areas:  
(e) Reducing disparities in health outcomes for the County of Los Angeles’s social, 
racial, and/or ethnic minorities. 
(f) Increasing health outcomes for all recipients of services in the HIV/AIDS 
Continuum of Care. 
(g) Prevention of HIV infection and prevention of progression to HIV-related illness 
and disease, disability, and death. 
(h) Indicators related to the HIV/AIDS Continuum of Care’s emphasis on the 
continuity of access, utilization, retention, and adherence for clients. 
 
Cultural Sensitivity and Linguistic Competence: Clients have the right to Medical 
Nutrition Therapy services provided by a qualified, HIV-knowledgeable, and capable 
RD who is culturally- and linguistically-competent, who communicates and educates in 
culturally-congruent ways, and who works in collaboration with the client’s team. The 
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National Standards for Culturally- and Linguistically-Appropriate 
Services in Health Care 
http://www.omhrc.gov/clas/finalcultural1a.htm 
 
RD must demonstrate cultural sensitivity and linguistic competency specifically in the 
services provided. The RD must also demonstrate cultural sensitivity and linguistic 
competency with the target population receiving the services (see “The Provider’s Guide 
to Quality and Culture”: http://bphc.hrsa.gov/quality/Cultural.htm). 
 
Translation/Language Interpreter’s federal and state language access laws (Title VI of the 
Civil Rights Act of 1964 and California’s 1973 Dymally-Alatorre Bilingual Services Act) 
require health care facilities that receive federal or state funding to provide competent 
interpretation services to Limited English Proficiency (LEP) patients at no cost, in order 
to ensure equal and meaningful access to health care services. 
 
 
Documentation: Provider agencies providing Medical Nutrition Therapy are required 
to meet all expectations for client and service delivery contract reporting and 
documentation. Provider agencies must utilize the County of Los Angeles’ “Casewatch” 
system to register the client’s eligibility data, demographic/resource data, enter service 
utilization data, medical and support service outcomes, and to record linkages/referrals to 
other service providers and/or systems of care.  
 
For clients not receiving Medi-Cal benefits, providers are required to document if a client 
was referred to apply for Medi-cal, if recently applied for Medi-Cal, date/ applied, 
application status, and if not referred, must document why the client was not referred.   
 
The “Casewatch” system must be used to invoice for all delivered services, to 
standardized reporting, to import efficiency of billing, to support program evaluation 
processes, and to provide OAPP and participating contractors with information relative to 
the HIV/AIDS epidemic in the County of Los Angeles. Provider agencies must ensure 
data quality and compliance with all data submission requirements. 
 
DEFINITION OF ENCOUNTER 
The US Department of Health and Human Services/Health Resources and Services 
Administration (HRSA) publishes the Uniform Data System (UDS) Reporting 
Instructions for Section 330 Grantees (last updated in 2006).  The definition of an 
encounter is:  
 
“Encounters are Documented, face-to-face contact between a patient and 
a provider who exercises independent professional judgment in the 
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provision of services to the individual.  To be included as an encounter, 
services must be documented.” (Page 5) 
 
Additional guidance relative to encounters includes: 
 
1.  To meet the criterion for "independent judgment," the provider must be acting on 
his/her own when serving the patient and not assisting another provider. For 
example, a nurse assisting a physician during a physical examination by taking vital 
signs, taking a history or drawing a blood sample is not credited with a separate 
encounter. Independent judgment implies the use of the professional skills 
associated with profession of the individual being credited with the encounter and 
unique to that provider or other similarly or more intensively trained providers.  
 
2.  To meet the criterion for "documentation," the service (and associated patient 
information) must be recorded in written or electronic form. The patient record does 
not have to be a full and complete health record in order to meet this criterion. For 
example, if an individual receives services on an emergency basis and these 
services are documented, the documentation criterion is met even though a 
complete health record is not created. Screenings at health fairs, immunization 
drives for children or the elderly and similar public health efforts do not result in 
encounters.  
 
4. Such services as drawing blood, collecting urine specimens, performing laboratory 
tests, taking X-rays, giving immunizations, and filling/dispensing prescriptions do 
not constitute encounters.  
 
5. A provider may be credited with no more than one encounter with a given patient in 
a single day, regardless of the types or number of services provided.  
 
6. The encounter criteria are not met in the following circumstances:  
 When a provider participates in a community meeting or group session that is 
not designed to provide clinical services. Examples of such activities include 
information sessions for prospective patients, health presentations to 
community groups (high school classes, PTA, etc.), and information 
presentations about available health services at the center.  
 When the only health service provided is part of a large-scale effort, such as a 
mass immunization program, screening program, or community-wide service 
program (e.g., a health fair).  
 When a provider is primarily conducting outreach and/or group education 
sessions, not providing direct services.  
 When the only services provided are lab tests, x-rays, immunizations, TB tests 
and/or prescription refills.  
 Services performed under the auspices of a WIC program or a WIC contract.  
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Specific guidance on encounters related to Medical Nutrition Therapy includes the 
following: 
 
 An initial assessment defined by the Commission on HIV Standard of Care, is 
estimated at one hour. 
 A continuing visit, designed to meet the needs identified in the assessment, is 
estimated at 20 minutes. 
 Providers should request reimbursement for an initial assessment with a client only 
when the assessment took approximately one hour or more.   
 Providers should request reimbursement for a continuing visit with a client only when 
the continuing visit took approximately 20 minutes or more. 
 
REQUIRED STAFFING 
Medical Nutrition Therapy must be provided by a RD.  Qualifications of RDs are 
provided in the Los Angeles County Commission on HIV Standards of Care for Medical 
Nutrition Therapy as follows. 
 
 The RD must have completed a Bachelors, Masters, and/or Doctorate degree in 
nutrition and related sciences. 
 The RD must have completed a supervised internship or equivalent. 
 The RD must pass a national exam which credentials her/him as a Registered 
Dietitian by the Commission on Dietetic Registration. 
 Continuing education is required to maintain certification. 
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F 
Data Request and ESIS Form (January 2008) 
OAPP sent the data request, reproduced below, to providers in January, 2008. 
 
 
 
From: Monique Collins [mailto:mcollins@ph.lacounty.gov] 
Sent: Monday, January 07, 2008 3:33 PM 
To: OBrien, Quentin 
Cc: Michael Green 
Subject: MOP Data Request 
 
Hi Quentin- 
 
As requested, I am sending you the data request by Mercer for the MOP Rate Study. Please send 
out to all MOP Caucus representatives for their review and response.  If possible I would like to 
get the data back by Friday, January 18, 2008.  This information will help Mercer in their analysis 
to capture true costs across providers.  We hope to get a broader response from providers. 
 
(Below Mercer Instructions) 
 
1.  General Ledgers in Excel 
 
Please provide a General Ledger.  Our preference is for providers to submit a General Ledger for 
the time period March 1, 2005 through February 28, 2006 (Year 15) and (separately) for March 1, 
2006 through February 28, 2007 for Ryan White Care Act (RWCA) funds for ambulatory 
outpatient services only.  Alternatively, providers may provide a General Ledger for a different 
time period that covers at least six months in duration with a start date that begins January 1, 
2005 or later.  We recognize that not all providers may keep RWCA funding and/or ambulatory 
outpatient care services separate from other fund sources and service provision in their General 
Ledgers.  Please provide whatever information you have.  However, please identify the fund 
sources captured, the time period covered, and the services covered in the General Ledger(s) in 
the cover e-mail when you send the General Ledger(s) to OAPP.   Any submission not provided in 
Microsoft Excel will not be considered.  Any submission that does not identify in the cover e-mail 
the fund sources, time period, and services included will not be considered.   
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2.  Encounter and Staffing Information on attached Excel Spreadsheet 
 
Please complete the attached Excel spreadsheet titled Encounter and Staffing.xls.  Use 
information from your General Ledger and any back-up detail you may have.  As you scroll over 
Columns B, C, and F on the attached spreadsheet to input your organization's information, "pop 
up" boxes provide instructions.  Boxes highlighted in yellow should be completed.  
 
The most important thing about this spreadsheet is to make sure the funding information reported 
in the General Ledger(s), and now reiterated in the spreadsheet (Rows 6 through 8 and Rows 13 
through 19), relates directly to the number of encounters reported (Rows 9 and 10).  The 
expenses reported for staffing (Column B, beginning on Row 13 on the attached spreadsheet, as 
well as Column F, beginning on Row 13, if your organization submitted a second General Ledger 
for a separate time period) must tie directly to the staffing expenses identified in the 
General Ledger(s) submitted.  Any submission that does not clearly tie the expenses reported for 
staffing to the General Ledger will not be considered.  In short, the attached spreadsheet is asking 
for information on encounters as these are not provided in the General Ledgers as well as more 
specific information on staffing that is not provided on some presentations of the General 
Ledgers.  The information 
is not meaningful, however, unless the number of encounters as well as dollar amount expended 
and number of specific staff all relates directly to the General Ledger information provided. 
 
 
3.  Staffing Ratios Information 
 
At the presentation on October 31, 2007, some providers indicated they were aware of published 
studies related specifically to staffing HIV/AIDS clinics.  If you have succinct empirical information 
(internal studies, peer-reviewed professional studies, literature review information) about the 
number of annual encounters typically provided by an outpatient clinic, please provide the actual 
study or a direct website link.  
 
 
All information is requested to be sent electronically by Friday, January 18, 2007 5:00 p.m. to 
Monique Collins at mcollins@ph.lacounty.gov. 
 
Monique Collins, MPH, CHES 
State Grant Manager 
Planning and Research Division 
Office of AIDS Programs and Policy 
(213) 351-8084 
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Provider Name:
Contact Person's Name:
Contact Person's Telephone:
Contact Person's E-mail:
Time Period General Ledger 1 Covers 00/00/00 - 00/00/00
Time Period General Ledger 2 
Covers 00/00/00 - 00/00/00
Fund Sources General Ledger 1 
Covers
Fund Sources General Ledger 2 
Covers
Total Funding (i.e., expenditures) 
Identified on General Ledger 1 -$                           
Total Funding (i.e., expenditures) 
Identified on General Ledger 2 -$                           
Number of Encounters Delivered Number of Encounters Delivered
Actual or Estimated Encounters? Actual or Estimated Encounters?
General Ledger Salary Amount: Staffing in Dollars Staffing in FTE General Ledger Salary Amount: Staffing in Dollars Staffing in FTE
 - Physicians -$                           0.0  - Physicians -$                           0.0
 - Physician Assistants -$                           0.0  - Physician Assistants -$                           0.0
 - Nurse Practitioners -$                           0.0  - Nurse Practitioners -$                           0.0
 - Registered Nurses -$                           0.0  - Registered Nurses -$                           0.0
 - Nurse (Other than RN) -$                           0.0  - Nurse (Other than RN) -$                           0.0
 - Other Direct Care Professional Staff -$                           0.0  - Other Direct Care Professional Staff -$                           0.0
 - Other Non-Direct Care Staff -$                           0.0  - Other Non-Direct Care Staff -$                           0.0
-$                           0.0 -$                           0.0
Note:  The dollar amount in 
Row 20, Column B should 
directly correlate to the 
General Ledger line item(s) 
for salary.  If it does NOT, 
please explain why below:
Note:  The dollar amount in 
Row 20, Column F should 
directly correlate to the 
General Ledger line item(s) 
for salary.  If it does NOT, 
please explain why below:
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MEMO 
 
To: 
 
 
Charles L. Henry, Director 
County of Los Angels, Office of AIDS Programs and Policy 
Date: April 7, 2005 (with revisions) 
From: Mercer Human Resource Consulting (Melanie L. Sovine, Ph.D., Terri Goens, John 
Villegas-Grubbs) 
Subject: Medi-Cal Rate Comparisons 
  
Introduction 
Mercer Government Human Services Consulting (Mercer) has delivered recommended 
fee-for-service reimbursement rates for services identified as part of medical services 
under Work Order No. 6-49. Following the pattern from the prior Mercer rate study on 
substance abuse and residential services, a comparison with Medi-Cal rates was requested 
by the Office of AIDS Programs and Policy (OAPP). Mercer completed that comparison, 
and this memo relays the resulting information to OAPP.  
 
Findings 
 
1. Eligibility, Education and Enrollment Services for ADAP: The service components in 
this service description are defined and specified by the Office of AIDS, California 
Department of Public Health, and they are distinctive to how the Ryan White Care 
Act (RWCA), Part B, AIDS Drug Assistance Program is implemented in California. 
There is no comparable Medi-Cal program with which to compare rates of 
reimbursement for this service.   
 
2. Drug Resistance Testing: The rate of reimbursement for this service description is for 
the blood draw and both the pre-/post-test counseling sessions. The Mercer rate does 
not reimburse costs for the actual blood laboratory analysis. The costs for resistance 
analysis are processed through a separate voucher system; vouchers are submitted 
with the sample to the County of Los Angeles, DHS, Public Health Laboratory.   
 
Medi-Cal rates for resistance testing are available; however, these rates cover the 
costs for blood draw and actual laboratory analysis of the blood sample, and these 
rates do not reimburse for counseling. Therefore, the Medi-Cal rates do not reimburse 
for costs comparable to the costs reimbursed by the Mercer rate. 
 
Mercer did attempt to identify a similar service from other programs (e.g., STDs, 
genetic testing, diabetes) where education-counseling and blood draws prior to 
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treatment regimen initiation/changes are common. There were no Medi-Cal rates 
based on a service bundle matching OAPP’s Drug Resistance Testing.  
 
3. Referral to Medical Specialty Services: The service description reimburses for the 
medical examination required to determine the appropriate referral(s) and the referral, 
itself. The Mercer rate does not reimburse for the cost of the actual medical specialty 
service. 6 
 
Medi-Cal, at one time, reimbursed for a similar7 service through the “Fee-for-Service 
Managed Care” model. In this delivery model Medi-Cal beneficiaries were assigned a 
primary care provider for what was called “medical case management”. The primary 
care provider acted as a gatekeeper for specialty services. These providers were paid 
on a fee-for-service basis. Phased-out in June 2003, the model no longer operates in 
California. There is no comparable Medi-Cal model for this OAPP service 
description.8  
 
4. Nutritional Counseling (Medical Nutritional Therapy): There is a Medi-Cal 
reimbursement rate for Medical Nutritional Therapy; however, this rate was 
established January 1, 1993 for the AIDS Medi-Cal Waiver Program (MCWP). The 
development of AIDS Waiver Programs preceded advances in health outcomes as a 
result of HIV-related pharmaceuticals, and State health financing departments 
established them as a way to keep AIDS patients out of expensive hospital and/or 
nursing home care. 
 
The Medi-Cal rate is: Nutritional Counseling…..……… $33.48/hour9 
 
The OAPP service description and corresponding reimbursement rate currently does 
not include the costs for nutritional supplements, and neither does the above Medi-Cal 
                                                 
6
 There are local medical specialty providers who negotiate a reimbursement rate for their services that are not reflective 
of the actual costs of the service. Providers have been willing to do this as a way to help meet the medical needs of 
those who have no or limited resources to pay for the services. The Mercer rate setting architecture cannot take into 
consideration the “charity” implicit in these negotiated medical specialty rates.  
7
 Because a description of the actual service components is no longer available, the referenced Medi-Cal model is 
qualified as “similar”, but not necessarily “comparable”, to the OAPP service description for Referral to Medical 
Specialty Services.  
8
 This service description is under discussion for continuance in the rate study. This discussion has largely been carried 
out through Mercer-OAPP shared conference calls and no decision has been made as of the date of this Memo. The 
discussion stems from the fact that this service (medical exam for needed referral and making of referral) is actually a 
required and routine service component in the HIV/AIDS Ambulatory/Outpatient Medical Care Services service 
description, and therefore may be redundant. 
9
 There also is an allowance for travel time (billing up to one additional hour) under strict guidelines in the MCWP (see, 
“AIDS Waiver Program Billing Codes and Rates”, October 2004 Provider Manual, Medi-Cal Publications, 
http://files.medi-cal.ca.gov). 
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rate. In the MCWP, “Nutritional Supplements/Home Delivered Meals” are capped at 
$150.00 per client per month. This cap also was established January 1, 1993. 
 
The Mercer rate study uses current, geographically relevant Bureau of Labor Statistics 
data as an indicator of actual personnel hiring costs, and then factors these costs with 
other real-time program and administrative costs derived from actual agency cost 
reports. Therefore, the Mercer rate of reimbursement ($57.85) is a more realistic 
reimbursement rate for this service in 2005. 10 
A Note from Medicare/Medicaid:  The American Dietetic Association (ADA) 
proactively works to assist Registered Dietitians in understanding billing procedures 
and actively describes appropriate billing codes. There are Medicare/Medicaid CPT 
codes for Medical Nutritional Therapy released by the Centers for Medicare and 
Medicaid Services (CMS) and included in the American Medical Association’s 
(AMA) Current Procedural Terminology CPT 2001 book. Medi-Cal has not adopted 
these codes for reimbursement. 
Nutritional Supplements: As for the costs of nutritional supplements, OAPP is 
currently engaged in internal discussions as to whether to include this cost in the 
actual reimbursement rate or to retain this cost as a separate line-item in an agency 
contract budget. Mercer will revise the rate, if needed, and in response to OAPP’s 
final policy decision. 
5. Medical Case Management:  The OAPP service description for Medical Case 
Management is based on a specific theoretical framework developed by Sr. Callista 
Roy, PhD, RN, i.e., the “Roy Adaptation Model.” This is a decidedly professional 
nursing model that results in a “nursing diagnosis” and treatment plan that is 
implemented and monitored within a multidisciplinary health care team. There are no 
Medi-Cal medical case management programs (or codes) that correspond to the Roy 
model as employed in the OAPP service description. 
 
There is a further consideration: at this time, OAPP is phasing in this model of RN-
delivered Medical Case Management services due to limited funding. The Mercer rate 
is based on one FTE clinical nurse using 30% time in medical case management 
[patient care coordination] with a caseload of no more than 30 unduplicated clients at 
any one point in time. The Mercer rate reimburses according to days of enrollment; 
Medi-Cal rates are based on actual service encounters (e.g., evaluations, hourly visits 
and/or timed encounters [e.g., per quarter hour]) and therefore are not comparable.  
6. HIV/AIDS Ambulatory/Outpatient Medical Care Services: This service description 
has two new aspects that are not paralleled in the service model underlying current 
Medi-Cal rates. First, the service description includes new service components, 
implemented in the routine medical encounter, that are based on the PHS guidelines’ 
                                                 
10
 There is anecdotal evidence that a decision to forego Medical Nutrition Therapy is made in favor of other needed 
Waiver services because of the $13,209.00 cap per client per year for Medi-Cal Waiver services. Medical Nutrition 
Therapy is a requirement in the current HIV/AIDS PHS Guidelines. 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
 
recent emphasis on the integration of HIV prevention within primary medical care, 
the significance of treatment adherence services, and the essential attention to 
nutrition. These requirements expand the scope and duration of the routine medical 
encounter, and define enhanced areas of expertise needed by the primary care 
provider in each routine medical encounter.11 
 
Second, the service description (and corresponding rate of reimbursement) is based on 
a specific personnel model [1 FTE physician (or midlevel) to 2 clinical support 
nurses]. This “medical support team” model is derived from the PHS Section 330 
Community Health Center Program’s utilization statistics (Region 9), and is used in 
the OAPP service description as a way of assuring adequate provider support for the 
new standards of care in HIV/AIDS primary health care. 
 
 As a result the Mercer rate of reimbursement incorporating these features is not 
comparable with current Medi-Cal fee-for-service (FFS) rates of reimbursement nor 
with the service model on which the Medi-Cal rates are based.12 
  
Conclusion 
The Ryan White CARE Act has funded the planning and the development of a 
substantial, yet politically fragile, HIV/AIDS service delivery system. Federal allocations 
to the RWCA are made annually. The funding allocation, particularly the level of funding 
each year, is not guaranteed. Because the RWCA is not considered to be the sole, indeed 
not even the primary, source of funding to meet HIV/AIDS needs, HIV/AIDS providers 
must depend on other public and private sector providers to complete the HIV/AIDS 
service delivery system. Unchecked competition among providers for limited financial 
resources is a potentially destructive force in the HIV/AIDS service system, and 
competition can inadvertently be introduced into the service environment through varying 
rates of reimbursement. 
 
                                                 
11
 To clarify, Medicaid (and therefore Medi-Cal), HIV/AIDS primary care services are subject to the same PHS 
HIV/AIDS Guidelines. Mercer is not adding additional requirements in the service descriptions and thereby 
confounding comparisons, rather Mercer is updating the rates of reimbursement based on the same, shared HIV/AIDS 
Guidelines and Mercer is not aware of Medi-Cal review and revision of rates of reimbursement based on the new 
requirements. 
12
 Mercer identified many fee-for-service Medi-Cal rates for general outpatient medical care. These rates 
vary according to the type of single professional delivering the care (physician only, nurse, etc. vs. a 
medical team model) as well as by level of office visit (new vs. established, levels1-5). For some of these 
rates, there are rate augmentations for care provided to children and for care provided in emergency rooms. 
The FFS rates range from $12.00 (office visit, level 1, established patient) to $82.70 (office visit, level 5, 
new patient…$57.20 level 5, established patient). For children and emergency room visits, the ranges are 
$13.09 (office visit, level 1, established patient) to $62.41 (office visit, level 5, established patient), and in 
the ER $12.00 (level 1, established patient and $28.44 new patient) to $102.71 (level 5, new patient and 
$71.04 established patient). The Mercer rates are not based on visit type nor are they based on differences in 
service delivery settings. 
 
Medical Clinical Fee-for-Service 
Reimbursement Rate Study 
      Office of AIDS Programs and Policy    
Final Report
 
Mercer Government Human Services Consulting 
 
 
Typically, a comparison with Medicaid is completed as a way of assuring reimbursement 
rates are within an acceptable public sector range. In the RWCA programs, conceding to 
the Medicaid reimbursement rate is also an established way for meeting a legislated 
administrative management requirement for using costs-per-unit of service in 
subcontracting for service provision.13 And, reimbursing for services (and accepting 
reimbursements) within the range of Medicaid reimbursement rates has also helped to 
build the much needed collaborative public-private provider relationships.  
 
In this set of six medical services, however, comparisons with the Medi-Cal rates were 
not helpful. This is because of the particular approach used by OAPP in the delivery of a 
service and/or because of the recent revisions to PHS guidelines that are changing 
HIV/AIDS medical service delivery. The Mercer service descriptions were carefully 
based on the service delivery approaches discussed and consensed with OAPP,14 and the 
Mercer rate setting architecture is a method that weds reimbursement rates with the most 
current standards of care. Therefore, the Mercer rates are not comparable to Medi-Cal 
rates. 
                                                 
13
 As a result, some may ask why not use the Medicaid service components and corresponding rates as compared to 
establishing new service descriptions and rates. As can be seen from the Memo, OAPP contracts for services that are 
distinct from Medicaid approaches to HIV/AIDS services. While Medicaid reimbursement rates have been a place of 
“common ground” financially, routine Medicaid services have rarely been seen as model approaches for HIV/AIDS 
care. This, then, is the point of departure: no longer conceding to the Medicaid rates before financially reviewing 
whether the published rates fully “cover” the ever-updating HIV/AIDS standards of care.   
14
 Mercer and OAPP worked collaboratively to best define all service descriptions. This statement pertains to external 
requirements imposed on OAPP in certain circumstances, such as the requirements for assessing eligibility for ADAP 
directed by the CA Office of AIDS, appropriately adopted in the service descriptions regardless of their comparability 
to Medi-Cal services. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Food Bank 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Food Bank 
Occurrence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dollars per Food Bank 
Occurrence (weekly bag 
of groceries, including 
personal hygiene 
products),  
 Plus a Dispensing Rate  
 
 
Providers will also submit 
a quarterly reconciliation 
of actual expenditures for 
food costs, staffing, and 
other line items listed on 
the approved budget. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Food Bank Services may 
be accessed on an 
emergency basis ONLY. 
 
The provision of this 
service will be limited to 
twelve (12) occurrences in 
a Ryan White Program Part 
A fiscal year.  One (1) 
occurrence is defined as all 
food bank services 
provided within one (1) 
calendar week.   
 
General Provision:     
Groceries, including 
personal hygiene products 
when available, can be 
picked up on a weekly or 
monthly basis.   
 
Weekly client limit =  
$50.00 per week at  
each pickup. 
 
Monthly client limit = 
$50.00 per week multiplied 
by the number of times the 
original day of pick-up 
occurs in the month. 
 
250% I, II, III 
Client eligibility 
for this service 
must be certified 
by the Medical 
Case Manager    
 
Medical Case 
Management 
Referral and has 
applied for Food 
Stamps, as 
appropriate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes 
 
A Ryan White 
Program 
Certified 
Referral, or an 
Out-of-Network 
Referral 
including 
appropriate 
backup 
documentation, 
is required for 
this service. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Food Bank 
(continued) 
Additional Food 
Bank Occurrence 
Dollars per Food Bank 
Occurrence (weekly bag 
of groceries, including 
personal hygiene 
products),  
 Plus a Dispensing Rate 
 
 
Additional Occurrences: 
A severe change to the 
person’s medical 
condition (i.e., new HIV- 
related diagnosis/ 
symptom, wasting 
syndrome, protein 
imbalance, recent 
chemotherapy, etc.) may 
also warrant additional 
occurrences of food bank 
services. 
 
Provision for Families:  
Each additional adult who 
is HIV+ and lives in the 
same household is eligible 
to receive an additional 
$50 per week in groceries, 
subject to the same 
general provisions above.  
Each dependent (i.e., 
minors under 18 years of 
age and living in the same 
household as the client 
who is HIV+) is also 
eligible to receive $20 per 
week, subject to the same 
general provisions above. 
250% The client must be 
reassessed for the 
“warranting” 
medical condition 
every three (3) 
months.   
 
Additional 
occurrences 
require a Ryan 
White Program 
Nutritional 
Assessment Letter 
for Food Bank 
Services to be 
completed by an 
independent 
physician or 
registered dietician 
not associated with 
the Part A food 
bank provider.   
 
For Families:  
 The client must 
provide 
documentation to 
prove the 
dependent’s age 
and place of 
residence. 
Yes 
 
A Ryan White 
Program 
Certified 
Referral, or an 
Out-of-Network 
Referral 
including 
appropriate 
backup 
documentation, 
is required for 
this service. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Insurance 
Services   
[ADAP Premium 
Plus Insurance 
Program/AIDS 
Insurance 
Continuation 
Program 
(ADAP/APPI)] 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
Number of 
ADAP/APPI 
premium 
payments made 
on behalf of a 
Ryan White 
Program Client, 
Dollars per 
Insurance 
Premium, 
Unduplicated # 
of Clients 
Served, 
and 
Dollars 
Expended per 
Client 
Number of ADAP/APPI 
premium payments made 
on behalf of a Ryan White 
Program Client, Dollars 
Expended per Insurance 
Premium per Client  
 
Note: additional rules for 
reimbursement are 
pending negotiations 
between the County and 
the service provider 
 
 
Reimbursement will be 
based on documentation 
of the cost of each 
insurance premium.  
 
Maximum amount of 
assistance a client may 
receive on a monthly 
basis is $750. 
400% 
 
 
 
 
 
 
I, II, III Yes  
 
Client must have 
insurance under 
a group, 
individual, or 
COBRA policy. 
 
Client must be 
willing to sign 
all required 
forms and to 
provide 
eligibility 
information. 
 
A complete 
financial 
assessment and 
disclosure are 
required. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Insurance 
Services 
(Insurance 
Deductibles) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
Number of 
Insurance 
Deductible 
payments made 
on behalf of 
Ryan White 
Program Clients, 
Dollars per 
Deductible, 
Unduplicated # 
of Clients 
Served,  
and 
Dollars 
Expended per 
Client 
 
Number of Insurance 
Deductible payments 
made on behalf of Ryan 
White Program Clients, 
Dollars Expended per 
Client per Deductible  
 
Note: additional rules for 
reimbursement are 
pending negotiations 
between the County and 
the service provider 
Reimbursement will be 
based on documentation 
of dollars expended per 
deductible. 
 
Maximum amount of 
assistance a client may 
receive on an annual  
basis is $2,500. 
 
 
 
 
 
400% I, II, III Yes 
 
A complete 
financial 
assessment and 
disclosure are 
required. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Insurance 
Services  
(Co-payments & 
Co-insurance for 
medical visits, 
labs, diagnostics, 
and prescription 
drugs) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
 
 
 
 
 
Dollars per Co-
payment/Co-
Insurance 
Encounter, 
Unduplicated # 
of Clients Served  
and  
Dollars per 
Client 
Dollars Expended  
per Co-payment/Co-
Insurance Encounter  
 
Note: additional rules for 
reimbursement are 
pending negotiations 
between the County and 
the service provider 
Reimbursement will be 
based on documentation 
of dollars expended per 
co-payment/co-insurance 
encounter. 
 
Assistance is restricted to 
those medications listed 
on the most current 
approved Ryan White 
Program Prescription 
Drug Formulary 
 
 
 
400% I, II, III 
Physician’s 
Prescription 
Yes 
 
A complete 
financial 
assessment and 
disclosure are 
required. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Insurance 
Services    
(Monthly 
Premium 
Payments for 
Enrollment in 
Federal Health 
Insurance 
Exchange 
Programs) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
 
 
 
Number of 
Health Insurance 
Exchange 
premium 
payments made 
on behalf of a 
Ryan White 
Program Client, 
Dollars per 
Insurance 
Premium, 
Unduplicated # 
of Clients 
Served, 
and 
Dollars 
Expended per 
Client 
Number of Health 
Insurance Exchange 
premium payments made 
on behalf of a Ryan White 
Program Client, Dollars 
Expended per Insurance 
Premium per Client  
 
Note: additional rules for 
reimbursement are 
pending negotiations 
between the County and 
the service provider 
 
 
Reimbursement will be 
based on documentation 
of the cost of each 
insurance premium.  
 
Maximum amount of 
assistance a client may 
receive on a monthly 
basis is $750.  This 
amount is subject to 
change. 
400% 
 
 
 
 
 
 
I, II, III Yes  
 
Client must have 
active health 
insurance under 
a group or 
individual plan 
that has, at a 
minimum, all 
medications on 
the most recent 
Florida AIDS 
Drug Assistance 
Program 
Formulary. 
 
Client must be 
willing to sign 
all required 
forms and to 
provide 
eligibility 
information. 
 
A complete 
financial 
assessment and 
disclosure are 
required. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Legal Assistance Hour of legal 
consultation 
and/or advocacy 
provided by an 
attorney or 
paralegal 
Cost of one 
hour of legal consultation 
and/or advocacy provided 
by an attorney or 
paralegal 
 
 
 
 
 
$90.00 per Hour 200% I, II, III Yes 
 
A Ryan White 
Program 
Certified 
Referral, or an 
Out-of-Network 
Referral 
including 
appropriate 
backup 
documentation, 
is required for 
this service. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Medical Case 
Management 
(including MAI) 
 
Type of One-
Minute Activity 
with or on behalf 
of Client  
(Face-to-Face or 
Other)  
and 
Unduplicated # 
of Clients Served 
 
OR 
 
Type of One-
Minute Activity 
Performed by a 
Case 
Management 
Supervisor (chart 
review, 
consultation, 
etc.) 
 
One unit equals one 
minute of actual time 
 
$1.00 / Minute 
 
 
 
400% I, II, III Yes 
Medical Case 
Management:  
Peer Education 
and Support 
Network 
(PESN) 
(including MAI) 
 
Type of One-
Minute Activity  
with or on behalf 
of Client (Face-
to-Face or Other)  
and 
Unduplicated # 
of Clients Served 
 
One unit equals one 
minute of actual time 
 
$0.50 / Minute 
 
 
 
400% I, II, III Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Mental Health 
Therapy/ 
Counseling 
(Level I) 
Individual and 
Group 
 
(PhD, EdD, or 
PsyD; and 
licensed by the 
State of Florida 
as a Licensed 
Clinical 
Psychologist, 
LCSW, LMHC, 
or LMFT) 
½ Hour 
Counseling 
Session and 
Unduplicated # 
of Clients Served 
Individual: 
½ Hour Counseling 
Session  
per Client 
 
 
 
 
 
Group: 
½ Hour Counseling 
Session  
per Counselor 
 
 
Individual: 
$32.50 per unit 
 
(MAX: 32 encounters per 
fiscal year and 5 units or 2 
½ hours per session; 1 
encounter = 1 day of 
service) 
 
Group: 
$35.00 per unit 
(minimum of 3 Ryan 
White clients to 
maximum of 15 total 
clients) 
400% I, II, III Yes 
Mental Health 
Therapy/ 
Counseling 
(Level II) 
Individual and 
Group 
 
(MS, MA, 
MSW, or MEd; 
and licensed by 
the State of 
Florida as a 
LCSW, LMHC, 
or LMFT) 
½ Hour 
Counseling 
Session and 
Unduplicated # 
of Clients Served 
Individual: 
½ Hour Counseling 
Session  
per Client 
 
 
 
 
 
Group: 
½ Hour Counseling 
Session  
per Counselor 
 
Individual: 
$32.50 per unit 
(MAX: 32 encounters per 
fiscal year and 5 units or 2 
½ hours per session; 1 
encounter = 1 day of 
service) 
 
Group: 
$35.00 per unit 
(minimum of 3 Ryan 
White clients to 
maximum of 15 total 
clients) 
400% I, II, III Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Oral Health Care 
 
Client Office 
Visit, Oral 
Health Care 
Procedure 
Provided, 
and 
Unduplicated # 
of Clients Served 
 
Multiplier applied to 
procedure rate listed in 
the State of Florida 
Medicaid Dental Services 
Fee Schedule, revised for 
January 1, 2014; 
reimbursement rates 
based on the American 
Dental Association’s  
2014 Current Dental 
Terminology (CDT 
2014), codes for dental 
procedures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maximum Multiplier  
Rate of 3.0 
 
Maximum Annual Limit  
(Ryan White Part A 
Program Fiscal Year) for 
Oral Health Care 
Services:  $3,000 per 
client 
 
Very limited exceptions 
to the annual cap may be 
approved by the County, 
with consultation from the 
Miami-Dade HIV/AIDS 
Partnership’s Oral Health 
Care Subcommittee as 
needed, on a case-by-case 
basis for the provision of 
preventative oral health 
care services only. 
 
(NOTE:  This service is 
limited to procedures 
found on the most current 
Ryan White Program Oral 
Health Care Formulary.) 
 
 
 
400% I, II, III 
 
 
 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outpatient 
Medical Care 
[including 
Minority AIDS 
Initiative (MAI)] 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
Client  
Medical Visit 
 and 
Unduplicated # 
of Clients Served 
Multiplier applied to 
reimbursable procedure 
rate listed in the Year 
2014 Florida Medicare 
Part B Physician Fee 
Schedule (Participating, 
Locality/Area 04), file 
dated December 31, 2013 
revised, for Evaluation 
and Management (E&M) 
codes for outpatient 
medical care and 
psychiatric visits only.  
Inpatient and emergency 
room services are not 
covered. 
 
All other non-E&M 
procedures will be 
reimbursed at the 2014 
applicable Medicare rate 
as referenced in this 
outpatient medical care 
section.   
 
 
 
 
 
 
Maximum multiplier rate 
of 1.50 will be applied to 
Medicare reimbursable 
rates for Evaluation and 
Management codes for 
outpatient medical care 
and psychiatric visits 
only. 
 
 
 
 
 
 
 
 
 
No multiplier will be 
applied to non-E&M 
procedures. 
 
 
 
 
 
400% I, II, III 
Referral from a 
primary care 
physician is 
required for 
outpatient specialty 
care, except for 
psychiatric services 
which may be 
requested by a 
mental health care 
professional 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outpatient 
Medical Care 
(including MAI) 
 
(cont’d) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
 
 
 
 
 
 
 
 
(see previous 
page) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medical Procedures 
performed at Ambulatory 
Surgical Centers (ASCs) 
will be reimbursed at rates 
found in the 2014 Florida 
Medicare ASC Fee 
Schedule, by HCPCS 
Codes and Payment 
Rates, for Core Based 
Statistical Area (CBSA) 
Miami (33124), modified 
January 8, 2014. (Update 
pending) 
 
Medical Procedures 
performed at Outpatient 
Hospital centers will be 
reimbursed at rates found 
in the approved Medicare 
Addendum B Outpatient 
Prospective Payment 
System (OPPS) by 
HCPCS Code for CY 
2014 Fee Schedule 
(January 2014), dated 
December 19, 2013. 
 
 
 
 
No multiplier will be 
applied to the Medicare 
ASC Reimbursement 
Rates.  Billing is 
restricted to organizations 
with on-site or affiliated 
ASCs only. 
 
 
 
 
 
 
 
No multiplier will be 
applied to the Medicare 
OPPS Reimbursement 
Rates.  Billing is 
restricted to organizations 
with on-site or affiliated 
outpatient hospital centers 
only. 
 
 
 
 
 
 
 
 
400% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I, II, III 
Referral from a 
primary care 
physician is 
required for 
outpatient specialty 
care, except for 
psychiatric services 
which may be 
requested by a 
mental health care 
professional 
 
Any referral to 
specialty medical 
care and outpatient 
hospital or 
ambulatory 
surgical centers on 
behalf of a Ryan 
White Program 
client must include 
documentation or a 
notation that the 
service requested is 
a Ryan White 
Program-allowable 
condition (i.e., is in 
relation to a 
client’s HIV 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outpatient 
Medical Care 
(including MAI) 
 
(cont’d) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
 
 
 
 
 
 
 
 
(see previous 
page) 
(see previous page) 
 
 
 
(see previous page) 
 
 
 
 
 
 
 
(see previous 
page) 
diagnosis, a related 
co-morbidity, a 
condition 
aggravated or 
exacerbated by 
HIV, or a 
complication of 
HIV treatment).  
Please refer to the 
OMB-GC/RW’s 
clarification letter 
dated December 
20, 2013, and the 
accompanying list 
of Sample 
Conditions. 
 
 
 
 
 
(see previous 
page) 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outpatient 
Medical Care 
(including MAI) 
  
(cont’d) 
 
Labs / 
Injectables 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
 
 
 
 
 
(see previous 
page) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Laboratory procedures 
will be reimbursed at rates 
included in the 2014 
Medicare Clinical 
Diagnostic Laboratory 
Fee Schedule, for Florida 
(FL), revised for January 
2014.   
 
Injectables will be 
reimbursed at rates 
included in the 2014 
Medicare Part B Drug 
Average Sales Price 
(ASP) Drug Pricing Files, 
Payment Allowance 
Limits for Medicare Part 
B Drugs, dated December 
17, 2013. 
 
 
 
 
 
 
 
 
 
 
 
No multiplier will be 
applied to laboratory fees. 
 
 
 
 
 
 
 
No multiplier will be 
applied to injectable fees. 
 
400% I, II, III 
Referral from a 
primary care 
physician is 
required for 
outpatient specialty 
care, except for 
psychiatric services 
which may be 
requested by a 
mental health care 
professional 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outpatient 
Medical Care 
(including MAI) 
  
(cont’d) 
 
 
Consumable 
Medical Supplies 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
Number of 
Clients Served, 
Consumable 
Medical Supply 
Distributions per 
Client (for 
Administering 
Prescribed 
Medications 
Only),  
and  
Dollar Amount 
Spent per Client 
Allowable flat rate listed 
in the Medicare Durable 
Medical Equipment and 
Supplies Fee Schedule, 
for Florida (FL), revised 
for January 2014. 
 
If no Medicare Rate is 
available for approved 
DME and consumable 
medical supplies, 
providers will be 
reimbursed at the 
Medicaid DME for 
Recipients of All Ages fee 
schedule rates, dated 
December 2013.  In such 
case, providers must 
submit a request to the 
County for a 
Supplemental 
Reimbursement Rate.  
Allowable items are 
limited. 
 
 
 
 
 
 
No multiplier will be 
applied to DME fees. 
 
400% I, II, III 
Referral from a 
primary care 
physician is 
required for 
outpatient specialty 
care, except for 
psychiatric services 
which may be 
requested by a 
mental health care 
professional 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Outreach 
Services 
(including MAI) 
 
Type of 15-
Minute Outreach 
Encounter  
[Face-to-Face or 
Other (i.e., 
Telephone 
Contact, Referral 
Activity, etc.)] 
 and 
Unduplicated # 
of Clients Served 
 
See the full 
Service 
Definition for 
details regarding 
the minimum 
required new 
connections 
(50%), and the 
re-connections 
(50%), to 
outpatient 
medical care 
and/or medical 
case 
management 
Line Item Budget  
 
Reimbursement will be 
based on a line item 
 budget (for actual expenses 
incurred per month by the 
outreach service provider). 
 
Outreach services will be 
paid based on full-time 
equivalent (FTE) 
employees providing 
direct services as outlined 
in the corresponding 
service definition, as well 
as on the basis of other 
allowable direct and 
administrative costs.  
 
Reimbursement of 
salaries will be based on 
the approved budget and 
productivity as recorded 
by hours spent doing 
allowable outreach 
activities, HIV+ people 
contacted, their risk 
factors, and the # of HIV+ 
people connected to care.  
All administrative and/or 
indirect expenses (other 
than those associated with 
the delivery of outreach 
services) are capped at 
10% of the total award for 
the service category. 
 
N/A I, II, III Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Prescription 
Drugs  
(including MAI 
for all 
components) 
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
Individual Drugs 
Dispensed, # of 
Filled 
Prescriptions, $ 
Spent per Drug, 
 and 
Unduplicated # 
of Clients Served 
 
PHS of Injectable/  
Non-Injectable 
Medication Plus Flat Rate 
Dispensing Fee  
 
OR 
 
AWP of Injectable/  
Non-Injectable 
Medication Minus 
Discount Rate 
PHS Price Plus Flat Rate 
Dispensing Fee 
 
 
 
OR 
 
AWP Minus Applied 
Discount Rate of No Less 
Than 10% 
 
 
(NOTE:  This service is 
limited to medications 
found on the most current 
Ryan White Program 
Prescription Drug 
Formulary.  Prescription 
drug providers should use 
the most cost-effective 
product, either brand or 
generic, whichever is less 
expensive at the time of 
dispensing.) 
 
 
 
 
 
 
400% I, II, III  
and  
Physician’s 
Referral or 
Prescription, with 
Letter of Medical 
Necessity or Prior 
Authorization 
Form, if applicable 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Prescription 
Drugs:   
Consumable 
Medical Supplies 
(for 
Administering 
Prescribed 
Medications 
only)  
 
(NOTE: THIS 
INFORMA-
TION IS 
SUBJECT TO 
CHANGE 
UPON 
FURTHER 
GUIDANCE 
RELATED TO 
IMPLEMENTA
-TION OF THE 
AFFORDABLE 
CARE ACT.) 
 
 
 
Number of 
Clients Served, 
Consumable 
Medical Supply 
Distributions per 
Client (for 
Administering 
Prescribed 
Medications 
Only),  
and  
Dollar Amount 
Spent per Client 
 
Allowable flat rate listed 
in the Medicare Durable 
Medical Equipment and 
Supplies Fee Schedule, 
for Florida (FL), revised 
for January 2014. 
 
If no Medicare Rate is 
available for approved 
DME and consumable 
medical supplies, 
providers will be 
reimbursed at the 
Medicaid DME for 
Recipients of All Ages fee 
schedule rates, dated 
December 2013.  In such 
case, providers must 
submit a request to the 
County for a 
Supplemental 
Reimbursement Rate.  
 
 
 
 
 
 
 
 
No multiplier will be 
applied to approved DME 
or consumable medical 
supplies. 
400% I, II, III 
and 
Physician’s 
Referral or 
Prescription, with 
Letter of Medical 
Necessity, if 
Applicable 
Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Substance Abuse 
Counseling – 
Outpatient           
(Level I) 
Individual and 
Group 
 
½ Hour 
Counseling 
Session and 
Unduplicated # 
of Clients Served 
Individual: 
½ Hour Counseling 
Session  
per Client & Family 
Member 
 
Group: 
½ Hour Counseling 
Session  
per Counselor 
 
Individual: 
$30.00 per unit 
 
 
 
 
Group: 
$34.00 per unit 
 
(minimum of 3 Ryan 
White clients to 
maximum of 15 total 
clients) 
 
 
400% I, II, III Yes 
Substance Abuse 
Counseling – 
Outpatient                     
(Level II) 
Individual and 
Group 
 
½ Hour 
Counseling 
Session and 
Unduplicated # 
of Clients Served 
Individual: 
½ Hour Counseling 
Session  
per Client and/or Family 
Member, as appropriate 
 
Group: 
½ Hour Counseling 
Session  
per Counselor 
Individual: 
$27.00 per unit 
 
 
 
 
Group: 
$30.00 per unit 
 
(minimum of 3 Ryan 
White clients to 
maximum of 15 total 
clients) 
 
 
400% I, II, III Yes 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Substance Abuse 
Counseling – 
Residential              
(including MAI) 
 
# of Days of 
Residential 
Substance Abuse 
Treatment  
per Client  
and 
Unduplicated # 
of Clients Served 
Cost of One Day of 
Residential Counseling 
Treatment Per Client 
$125.00 per client day 
 
[up to a maximum of 120 
days within a 12-month 
period; 12-months begins 
on the 1st day of client’s 
residential treatment 
regardless of Part A / 
MAI provider] 
 [includes the cost of 
family member(s) 
participating in the 
substance abuse 
counseling session 
provided during day of 
treatment] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
300% I, II, III Yes 
 
A Ryan White 
Program 
Certified 
Referral, or an 
Out-of-Network 
Referral 
including 
appropriate 
backup 
documentation, 
is required for 
this service. 
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RYAN WHITE PROGRAM COST AND ELIGIBILITY SUMMARY – FY 2014 (YR 24)  
IMPORTANT:  To be eligible for local Ryan White Program Part A and Minority AIDS Initiative (MAI)-funded services,  
the HIV+ client must be a permanent resident of Miami-Dade County and meet local income level requirements. 
 
SERVICE 
CATEGORY 
(listed in  
alphabetical 
order) 
REPORTING 
UNIT 
REIMBURSEMENT 
UNIT 
REIMBURSEMENT 
CAP 
MAXIMUM % 
OF 2014 
FEDERAL 
POVERTY 
LEVEL 
ELIGIBLE HIV 
STATUS* 
REQUIRED 
MEDICAID/ 
OTHER 
SCREENING 
 
Transportation 
Vouchers 
 (Discounted 
EASY Tickets) 
 
Dollars per 
Voucher,  
# of Vouchers,  
and 
Unduplicated # 
of Clients Served 
Dollars per Voucher 
 Plus a Dispensing Rate 
Not to Exceed 15% 
Cost of Vouchers  
Plus Dispensing Rate 
 Not to Exceed 15% 
150% I, II, III 
Medical Case 
Management 
Referral 
 
Case Manager re-
certification 
required every 6 
months. 
 
 
Yes 
 
Clients must be 
screened for 
eligibility of 
Miami-Dade 
County Golden 
Pass Program, 
Special 
Transportation 
Services (STS), 
Miami-Dade 
Transit 
Transportation 
Disadvantaged 
Program, 
Medicaid, etc. 
-------- 
A Ryan White 
Program 
Certified 
Referral, or an 
Out-of-Network 
Referral 
including 
appropriate 
backup 
documentation, 
is required for 
this service. 
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Appendix 4  
New York City: Performance-Based Reimbursement 
 
  
Performance-based reimbursement
Public Health Solutions’ reimbursement approach aligns contractor payment with performance.  We do
this in four ways:
Per Member, Per Day (Care Coordination) – see attached (21% of the value of our portfolio)
Fee-for-Service (41% of the value of our portfolio)
Deliverables-Based (6% of the value of our portfolio)
Hourly (4% of the value of our portfolio in dollars)
Regardless of reimbursement model, all contracts must complete a line-item budget which is reviewed
for cost allowability and reasonability; service projections, which must demonstrate reasonable staff
effort and caseloads; a scope of work, which clearly outlines project expectations, with staff
responsibility; and a general contract agreement which lays out all relevant requirements and
regulations governing the contract.
Fee-for-Service
Overview: Services are associated with reimbursement rates, payable based on reporting of client-level
data in eSHARE, the EMA’s client-level data system.  Each month we analyze eSHARE data to process
payment.  The product of reported billable services for the month and their associated reimbursement
rates is our payment to contractors.  Projected services multiplied by their associated reimbursement
rates equals the total contract award.
Mechanics: Each month contractors enter service data into eSHARE. eSHARE data are extracted and
transferred to Public Health Solutions’ payment system, which organizes them for payment, multiplying
services by reimbursement rate and subjecting data to certain payment rules (see below). Ultimately,
the system generates a payment which is reviewed by a Contract Manager and a supervisor before
being processed.
Contractors receive a monthly report called the Master Itemization Report (MIR), which lists and
summarizes services recognized by our system.  Potentially disallowable services (e.g., duplicate
services, violations of frequency limits, and problems identified through site visits) are flagged for
possible recoupment.  Contractors reconcile the MIR against their own records.
Rate development: Some rates are negotiated with individual contractors. In that case, we establish a
ceiling rate for each service type. More commonly, we compute rates and publish them in Requests for
Proposals so that prospective applicants can determine whether they wish to apply for funding. Most
payment points are outputs (e.g., counseling sessions, HIV tests, meals served); others are short-term
outcomes (e.g., linkages to care, housing placement, workshop completion). In general, calculated rates
and rate ceilings reflect the following inputs:
2Expenses: Salary (at levels/job titles we deem reasonable and appropriate), fringe benefits (average
nonprofit rate), OTPS (with allowances for special services such as food for food and nutrition programs
or rent for housing assistance programs), administration (we allow 12% because several large contracts
in the EMA have very low administrative spending, keeping us below 10% in the aggregate).
Service time: We make assumptions about how long a service should take (including preparation,
charting and data entry), and thus how productive we expect a worker and program to be.  We
understand that some clients do not show for scheduled appointments despite the program’s
mobilization to serve them, and build in a no-show allowance in our rate calculations.
Outcomes and incentive payments: Some of our reimbursement points are culminating events such as
linkage to care, graduation and housing placement.  We assign rates to these events using a
combination of benchmarking and programmatic knowledge, since their inputs (time and human
resources) vary significantly among programs.
We review and, as indicated, adjust reimbursement rates approximately every two to three years based
on analysis of service intensity, time and costs.  When funding permits, we sometimes provide modest
increases to reflect rises in the cost of living.
Rules: Some services have supplemental payment rules specific to the service category.  For example,
HIV testing, mental health counseling services and housing placement have frequency caps.  Group
services have minimum group sizes.  Some services, like HIV confirmatory testing and Transitional Care
Coordination graduation, have service prerequisites.  Other services, like outreach activities in a
homeless youth initiative, are capped as a percentage of the overall contract amount.
Monitoring:
Programmatic: On-site visits include a retrospective review of documentation of service provision,
client eligibility, provider eligibility and adherence to service models and funding guidelines.  Deficient
documentation and failure to adhere to client and/or provider eligibility and service model
requirements can result in recoupment.  Monitoring staff also review monthly narrative reports
highlighting achievements and challenges.
Fiscal: Audit packages (financial statements, A-133, management letters) are reviewed annually, with
any relevant findings pursued with senior fiscal staff.  At the end of the year, we request a line-item
expense report by “service family” (a cluster of services usually sharing a reimbursement rate), which is
used to inform future rate adjustments.
Spending Management: Several times during the year we analyze spending to determine whether
contracts are on track to spend their full award.  Using established criteria, we “take down,” or reduce,
low-performing contracts and redirect that funding to contractors who are exceeding their prorated
targets.  Contractors with “takedowns” can appeal our decision.  We rescind takedowns in
approximately 30% of appeals.  Contractors have an incentive to overperform since, pending availability
3of funds, we can pay them for exceeding their contract award amounts. As a result of our aggressive
spending management, we spend almost 100% of program funds.
Deliverables
Some programs are reimbursed on completion of program deliverables.  We often employ this approach
during programs’ start-up periods, when deliverables include activities such as staff training, space
rental, establishment of a Consumer Advisory Board and completion of policies and procedures. Some
services have very challenging and/or delayed fee-for-service outcomes, so we reserve a portion of the
contract award for draw-down through completion of regular deliverables such as programmatic reports
or training.  Such contracts have a hybrid reimbursement model, with some deliverables and some fee-
for-service.
Hourly
Our EMA reimburses legal services providers on an hourly basis – the recording methodology to which
attorneys are accustomed.  Hourly rates are capped based on reasonableness and average costs.
________________________________
Reflections
A recent survey of service providers indicates that after seven years, almost 60% think that on balance,
the benefits of performance-based reimbursement outweigh its challenges.  Benefits include the ability
to earn more for exceeding targets and to modify their budgets as they deem necessary, without the
need for funder approval.   The challenges are emphatically financial: lower-than-projected performance
means they may not cover their fixed costs.  Performance deficiencies can come about as the result of
staff vacancies, damage to facilities which compromises service capacity, difficulty recruiting clients and
client no-shows. In addition, during the transition to performance-based reimbursement, program
administrators have described the need to employ program and clinical staff who are data-oriented,
that is, who are able and willing to project, track and analyze service revenue at the caseload and
program level.  In addition, quality management for data processing has emerged as critical, so that
providers develop the understanding of their client-level data entry as billing vouchers or accounts
receivable.
From the EMA’s perspective, information systems have been the key to the success of our system,
translating client-level data entry into program payments.  We work with numerous systems:  eSHARE,
the repository of client information (enrollment, demographics and services) used by service providers;
a contract management system developed and used by Public Health Solutions for contracting and
payment, the Master Contractor for DOHMH; and a “bridge” system that allows us to import data from
eSHARE into our contract management system, applying program rules to correctly calculate payments
and highlight potentially unallowable items.  The contract management system, known as MAPS,
generates reports for contractors and EMA staff to ensure accurate payment and reporting (both at the
contract level and the aggregate grant level) and to support operational management and improvement.
4Public Health Solutions’ contract management staff are responsible for programmatic and fiscal
operations, which requires a level of program and fiscal analysis capacity not assumed in a more
conventional line-item budget contract (where fiscal staff manage budgets and billing and program staff
monitor program deliverables). DOHMH staff provide technical assistance on program models, eSHARE
and quality management.
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New York City Department of Health & Mental Hygiene
Bureau of HIV/AIDS Prevention & Control
Reimbursement Plan for Ryan White Care Coordination (RWCC)
Overview
Beginning in March 2012, Ryan White Care Coordination (RWCC) reimbursement has a three-part structure:
(1) Per-member-per-day payments for enrollment in the various tracks
(2) Milestone payments for transitions that step a patient down to a lower intensity track
(3) Fee-for-service for Directly Observed Therapy (DOT) and Outpatient Bridge Medical Care (OBMC)
This document describes the method by which RWCC costs were determined and used to generate the rates for
payment.
Cost calculation
RWCC- specific inputs and assumptions include:
Table 1: Inputs and assumptions for unit service costs
Salary information was culled from contract review and other contractor solicited input
in 2008 and reflect recommended staffing credentials from the RWCC RFP and protocol.
Annual salary of a Navigator $35,000.00
Annual salary of a Care Coordinator $50,000.00
Annual salary for field DOT $30,000.00
Annual salary for center DOT* $50,000.00
Other inputs and assumptions
Field travel time (per event) 30 min (used for field DOT)
Markups: Indirect personnel**; OTPS; Fringe; Admin 20%; 25%; 30%; 12%
Medical care in low intensity 1 visit/4 months
Medical care in high intensity 3 visits/2 months
Service frequencies are dictated by the Care Coordination Protocol
*Salary is for a licensed practical nurse (LPN)
**The markup is defined as a percent added to the base direct service salary to account for indirect personnel time (e.g. the
time it takes for a supervisor to oversee the work done)
Reimbursement Rate Calculation
(1) Per-member-per-day (PMPD) payments for enrollment in the various tracks.
A) Base PMPD Rates
Base PMPD payment calculations were originally set in 2011 using a method of assembling service costs
within program tracks. The time period for calculation was set at one day to obviate the need for
prorating or complex rules for track assignation for payment. A month was considered to have 30.42 days
on average.
B) Adjusting PMPD rates by carving out DOT as an activity reimbursed on a fee-for-service (FFS) basis
DOT when administered as a daily service added complexity and uncertainty to our rules for making
payments on a PMPD basis. Because of the nature of the service it is not prone to overuse and
consequent cost inflation, it is therefore amenable to FFS payment with a few simple controls (e.g. limit
one per day).
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C) Adjusting for Medicaid Community Follow-up Program (CFP)
Based on conversations with the New York State Department of Health AIDS Institute, the following
services are reimbursable under the COBRA Community Follow Up Program (CFP): Plan development;
Appointment assistance (excluding Accompaniment); Accompaniment; Benefits assessments. The
following services are not reimbursable under the CFP: Health Promotion (Basic, Quarterly, Monthly,
Weekly – including Adherence Education); DOT. This identified the need for integration and therefore cost
adjustments for enrollees receiving services from both the CFP and RWCC.
Table 2: Net rates after adjusting for DOT, and CFP
Track Expected #
Mos. In
Track
Base (Unadjusted)
PMPD
Final PMPD after DOT
Carve-out
Final PMPD w/CFP
Adjustment
A 12 $1.07 $1.07 $0.58
B 3 $1.68 $1.68 $0.91
C1 6 $14.86 $14.86 $8.02
C2 7.5 $22.98 $22.98 $12.41
D 6 $32.80/$49.76* $22.98 $12.41
*Clinic-based vs. field-based DOT before DOT carve out.
PMPD Payment Rules
The payability of each day’s enrollment will be validated on the basis of a threshold (T) of services provided during
the preceding time period (P).
For clients enrolled in CFP, Health education/promotion services are the only services that count toward
validation.
For clients enrolled in Ryan White only, services which count toward validation include the following: Case finding,
Intake assessment, Medical assessment/reassessment, Other assessment/reassessment, Care plan/service plan,
Case conference, Accompaniment, Assistance with entitlements and benefits, Assistance with health care,
Assistance with housing, Assistance with social services, and Health education/promotion. (Note that services
must be face-to-face; those performed over the phone do not count toward validation.)
Table 3: PMPD payment rules
Expected
frequency
Look Back
Period
(P)
Payment
Threshold
(T)
Rule
Track D 4.345 30 2 If actual units of services
over previous P days >= T, pay
PMPD for today, IF NOT do not pay
Track C2 4.345 30 2 “
Track C1 3 92 2 “
Track B 2 183 1 “
Track A 2 183 1 “
In addition to the provision of these services according to the timeframes specified, for clients enrolled in Ryan
White only there is another way a day may be validly payable: by having an Outreach for patient re-engagement
service within a 7-day look back period. This method of validating payment is only permitted for a 60 day period
beginning with the last recorded face-to-face service.
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These payment rules were implemented in month ten of the new reimbursement model (December 2011). The
tracks and threshold value for payment are shown in Table 3. (It is anticipated that sometime in 2012, these
payment rules may be expanded to require periodic adherence assessments for all tracks except A.)
(3) Milestone payments for transitions that step a patient down to a lower intensity track
The RWCC model is based on the idea that intensive navigation-type case management can stabilize even some of
the most complex cases, that health behavior skills can be augmented over time, and that service delivery,
therefore, should be tailored to individual need and intensification or scale back of services implemented as
warranted. Milestone payments are used in order to promote provider attention to patient movement through
the program. A milestone is defined as an allowed transition from a track of higher intensity to one of lower
intensity that lasts for 60 days or longer without regression to a higher intensity track in that period.
Milestone payments are set to be equal to one month (i.e. 30.42 days) of the capitated rate of the track exited
from (after calculating those rates net the milestone amount). Exceptions: Both the A and B track (graduation)
milestones would have excessively low values by this method and are set at $75. There is no hard data behind
determining the size of the milestone payment. Rather, we chose a reasonable starting point relative to the basis
– PMPD – with the idea that it can be adjusted in following years depending on the degree to which it incentivizes
the desired outcome. Milestone payments were calculated based solely on unblended RW funds because CFP
funds could only be attributed to a part of PMPD payment and were adjusted for DBR carve out.
Table 4: Milestone payment amounts
Transition ID Milestone payment
1 $75.00
2 $75.00
3 $290.60
4 $753.20
5 $462.61
6 $449.39
*The valuation is equivalent to that of the stepwise progression
Milestone payment rules
For any enrollment, a provider may be paid either the set of milestones {3,5} or else {4}.
Only transitions that represent clinical progress are payable; those initiated by patient request or refusal
of higher level service are not payable.
Each milestone may be paid only once over the course of a patient enrollment. Some transitions will
naturally be repeated due to regression, but only the first within an enrollment will be payable as a
milestone.
In order to limit circumvention of the above rule no client may be formally dis-enrolled until 60 days after
loss of contact or end of participation. Any return of the enrollee to service during the 60 day window
constitutes a continuation of the prior enrollment.
A milestone can only be paid 60 days or more after the transition occurred to ensure the definition of a
milestone was met.
(4) Fee-for-service for DOT and OBMC services.
Incorporation of DOT service costs added unwarranted complexity to PMPD rate setting. Both home and center-
based DOT service were, therefore, carved out of the capitated rate to be reimbursed separately on a fee-for-
service basis. OBMC services were always set to be reimbursed separately on a fee-for-service basis and were
never part of the PMPD rate setting process; OBMC has been fee-for-service since December 2009.
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Table 5: Fee-for-service DOT and OBMC rates
Rate
Cost per unit of center-based DOT $9.82
Cost per unit of field-based DOT $26.78
OBMC Initial visit with labs $300
OBMC medical visit $175
OBMC Navigator visit $100
